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VSummary
During cell division cells must ensure that their chromatids are equally distributed onto the result-
ing daughter cells in order to maintain their ploidy. The spindle assembly checkpoint (SAC) is an
intricate mechanism in mitosis that monitors correct attachment of the spindle apparatus to kine-
tochores, a complex protein structure on the centromeric region of chromosomes. Two components
of the SAC machinery, the Bub1 and BubR1 kinases, are protein paralogs originating from a com-
mon ancestor gene that underwent gene duplication and was then subject to significant functional
specialisation during evolution. Bub1 is a key player at the kinetochore due to its role in recruit-
ing additional checkpoint proteins including BubR1. In contrast, BubR1 is an integral part of the
SAC effector, the mitotic checkpoint complex (MCC). The kinase activity of Bub1 is further implied
in regulating chromosome congression and alignment, while BubR1 kinase activity remains amatter
of debate. The assessment of themechanism of Bub1 regulation and the characterisation of Bub1 in-
teractions at the kinetochore, particularly with respect to their implications for Bub1 kinase activity,
formed the main focus of this dissertation.
The reconstitution of Bub1:Bub3 and BubR1:Bub3 complexes is reported in this thesis, along with a
hydrodynamic characterisation that demonstrates both complexes to have 1:1 stoichiometry, with-
out additional oligomerisation. As both dimeric complexes are shown to bind to each other, the
resulting complex can be stably assembled on a phosphorylated fragment of Knl1, the kinetochore
receptor of Bub1:Bub3. The work presented in this thesis also highlights the importance of a site in
themiddle region on Bub1 for the additional recruitment of another checkpoint component, Cdc20,
which forms the basis for MCC assembly.
The comprehensive characterisation of the kinase domains of Bub1 and BubR1 described in this
thesis resolves conflicting reports of kinase activity and shows that BubR1 kinase domain binds nu-
cleotides, but is unable to deliver catalytic activity in vitro. Conversely, Bub1 is an active kinase that
undergoes autophosphorylation on the P+1 substrate-binding loop, which is crucial in conferring
Bub1 activity. Neither BubR1:Bub3 nor Knl1modulate the kinase activity of Bub1 in vitro, suggesting
the Bub1 kinase domain is regulated autonomously by autophosphorylation. The crystal structure
of the phosphorylated Bub1 kinase domain presented here illustrates a hitherto unknown confor-
mation of the P+1 loop docked into the active site of the Bub1 kinase. This conformation provides
deeper insight into the mechanism of Bub1 kinase activation, which involves the structural rear-
rangement of the P+1 loop upon phosphorylation.
The work of this thesis is complemented with an analysis of the kinetochore substrates of Bub1 and
for the first time identifies a common sequencemotif on the substrates of Bub1 kinase. The discovery
of highly conserved residues on Bub1 kinase indicates a functional surface implicated in substrate
binding. Further findings suggest that DNA binding might additionally aid in directing Bub1 to nu-
cleosomes. In the context of the current literature, the results reported in this dissertation contribute
to a more profound understanding of Bub1 kinase activity from a structural and mechanistic point
of view.
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Zusammenfassung
Während der Zellteilung muss die Zelle sicherstellen, dass das genetische Material der Chromoso-
men, in Form von Chromatiden, gleichmäßig auf beide Tochterzellen aufgeteilt wird. Dieser Pro-
zess ist entscheidend für die genetische Integrität der Zelle, da Ungleichverteilung der Chromatiden
zu Zellanomalien und damit Störung des Organismus führen kann. Der mitotische Kontrollpunkt
(englisch: spindle assembly checkpoint, SAC) bezeichnet einen komplexen zellulären Apparat des-
sen Aufgabe es ist zu gewährleisten, dass alle Chromosomen an der mitotischen Spindel angehef-
tet sind. Dies erfolgt über vielschichtige Proteinstrukturen, die sogenannten Kinetochore. Zwei es-
sentielle Bestandteile der Kontrollpunkt-Maschinerie sind die Proteinkinasen Bub1 und BubR1, die
funktionelle Paraloge darstellen, welche sich durchGenverdoppelung evolutiv in verschiedene Rich-
tungen spezialisiert haben. Bub1 ist ein essentieller Grundbaustein der Kinetochorarchitektur, da es
weitere Proteine, unter anderem BubR1, rekrutiert. Im Gegensatz dazu ist BubR1 ein Bestandteil des
Kontrollpunkt-Effektorkomplex. Die enzymatische Aktivität von Bub1 ist wichtig für die Regulation
der Zusammenkunft und Orientierung der Chromosomen amZelläquator während derMitose. Eine
enzymatische Aktivität von BubR1 ist hingegen nicht eindeutig nachgewiesen. Den Umfang dieser
Arbeit bilden die Untersuchung sowie Charakterisierung der Bub1 Regulationsmechanismen und
Interaktionen am Kinetochor, insbesondere in Bezug auf deren Auswirkung auf die enzymatische
Aktivität von Bub1.
Die in dieser Dissertation dargestellte Rekonstitution von Bub1:Bub3 und BubR1:Bub3 Proteinkom-
plexen ermöglichte deren Charakterisierung als stöchiometrische 1:1 Komplexe. Desweiteren konn-
te gezeigt werden, dass diese Proteinkomplexe sowohl aneinander binden, als auch an ihren Ki-
netochorrezeptor, das Protein Knl1, gekoppelt werden können. Ferner konnte eine Region inner-
halb von Bub1 bestimmt werden, die ausschlaggebend für die Bindung von Cdc20 ist und damit die
Grundlage für die Zusammensetzung des Effektorkomplexes des Kontrollpunkts darstellt.
Die detaillierte Beschreibung der Kinasedomänen von Bub1 und BubR1 ermöglichte die Auflösung
der bestehenden Kontroverse bezüglich der Kinaseaktivität von BubR1; zwar bindet BubR1 Nukleo-
tide, es kann aber kein Phosphat auf Substratproteine übertragen. Im Gegensatz dazu ist Bub1 eine
aktive Kinase, die ihre Substratbindungsschleife (P+1 Schleife) intramolekular phosphoryliert, was
den wesentlichen Schritt der Kinaseaktivierung darstellt. Weder BubR1:Bub3, noch Knl1 beeinflus-
sen die Bub1 Kinaseaktivität in vitro, was nahelegt, dass die Bub1 Kinasedomäne allein durch Au-
tophosphorylierung reguliert wird. Die Kristallstruktur der phosphorylierten Bub1 Kinasedomäne,
die innerhalb dieser Dissertation beschrieben wird, zeigt eine bisher unbekannte Konformation der
Substratbindungsschleife, wobei diese im aktiven Zentrum von Bub1 verankert ist. Diese Konforma-
tion erlaubt Rückschlüsse auf den Aktivierungsmechanismus von Bub1, der eine strukturelle Um-
ordnung in Folge der Phosphorylierung des P+1 Segments beinhaltet.
Die Analyse von Bub1 Kinetochorsubstraten ermöglichte es, erstmalig ein spezifisches Aminosäu-
resequenzmotiv von Bub1 Substraten zu identifizieren. Die Oberfläche der Bub1 Kinase offenbart
ferner evolutionär stark konservierte Aminosäuren, welche in die Interaktion mit Proteinsubstraten
involviert sind. Im Kontext mit der aktuellen Literatur leisten die im Rahmen dieser Dissertation ge-
wonnenen Ergebnisse einen fundamentalen Beitrag zu einem tiefergehenden Verständnis der struk-
turellen undmechanistischen Regulierung der mitotischen Kinase Bub1.
11 Introduction
Life in its simplest form originates from a single cell. During the course of evolution, a multitude
of multicellular organisms and species developed by replication of cellular units into various highly
differentiated cells. While the reproduction of single cells is required for germ line development and
ultimately continuation of a species, the same species also possesses multiple somatic cells which
need to proliferate in order to assemble an entire organism. Generally, cells differentiate and enter
a state of quiescence, whereas continuous or uncontrolled cell duplication constitutes pathological
behaviour, culminating in cancer. Remarkably, regardless of the actual cell type (somatic or germ
line) or the number of cells constituting an organism, the mechanism by which cells propagate re-
mains largely identical. Every single cell needs to comply with the same criteria in order to repro-
duce, which is controlled in a process called cell division or mitosis.
1.1 Basic principles of cell division
1.1.1 The cell cycle
Cell division is a highly regulated process, which poses an organisational challenge for the cell [1, 2]
as it comprises the conversion of one cell into two, creating viable and genetically identical progeny.
       I    N   T   E   R   P   H   A
   S
   E
M I T O S I S
G2 *1
S
Figure 1.1: The cell cycle.
The phase termed interphase or G0, shaded in grey, be-
gins with a gap phase G1, followed by S-phase where
the cell duplicates its genetic material, gains size and
replicates its genetic material and organelles, leading
to another gap phase G2, and ultimately to a phase of
cell division (mitosis), creating two identical daughter
cells. Importantly, both entry into S-phase and mitosis
but also mitosis itself are controlled by cellular check-
points ensuring the fidelity of cell division.
Division of a cell requires the precise duplica-
tion (S-phase) and segregation of genetic ma-
terial (M-phase or mitosis) [1, 2], schemati-
cally depicted in Figure 1.1. The driving force
of this process is the activity of tightly reg-
ulated Cyclin-dependent kinases (Cdks) that
phosphorylate a number of targets, which re-
sults in pronounced changes in nuclear and cy-
toskeletal cell architecture. The activity of Cdks
is controlled in a timely and ordered fashion by
individual proteins (cyclins) that allow oscillat-
ing cell cycle-stage specific regulation at three
distinct points of the cell cycle.
In vertebrates, cyclin E and A trigger and reg-
ulate the entry into synthesis (S-) phase; after
passing a DNA damage checkpoint, the chro-
mosomes replicate, producing two identical
copies of the geneticmaterial and its associated
proteins. The gap phases G1 and G2 between
S- and M-phase allow time for cell growth and
metabolism, the duplication of organelles and
monitoring of the external environment. Pro-
gressing through the G2 checkpoint that selects for correctly duplicated chromosomes and favour-
able conditions is governed by cyclin B (see also Figure 1.8), which allows entry into mitosis (M-
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phase). Mitosis is an elaborate multi-step process where chromosomes are segregated from each
other, followed by cell division (cytokinesis) [3, 4]. Importantly, mitosis is also subject to a check-
point, themitotic checkpoint or spindle assembly checkpoint (see also Section 1.4). This checkpoint
acts in metaphase, monitoring correct spindle assembly and chromosome attachment, thereby en-
suring error-free cell division andmaintenance of ploidy, which is a hallmark of genome stability.
1.1.2 Mitosis
Fibrillar structures of the spindle were first described in 1882 by the German anatomist Walther
Flemming, which led to the term mitosis, derived from the greek m–toc (mítos, thread). Mitosis de-
scribes the process of nuclear division and has ever been a very active research topic in cell biology.
It still strives to characterise the main players and general mechanisms that drive accurate chromo-
some segregation and define cell division.
PROPHASE
PROMETAPHASE
METAPHASE
ANAPHASE
TELOPHASE
CYTOKINESIS
intact nuclear
envelope
condensed
chromosome
kinetochore
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kinetochore
attached to
mitotic spindle
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contractile ring
Figure 1.2: Schematic cycle of mitosis.
Mitotic division consists of 5 distinct phases followed by cytokinesis. They are defined by the condensation of
sister chromatids (prophase) that become attached to the mitotic spindle after nuclear envelope breakdown
(prometaphase). Chromosomes are bi-oriented and aligned on the spindle equator by the mitotic spindle
(metaphase). Elimination of sister chromatid cohesion initiates movement of sister chromatids to opposite
poles of the spindle (anaphase). Chromosomes are then packaged into separate nuclei while a contractile ring
divides the cell in the final step of mitosis (telophase) resulting in two identical daughter cells (cytokinesis).
1.1 Basic principles of cell division 3
Mitosis can be divided into five distinct phases (Figure 1.2) and subsequent cytokinesis. In prophase,
chromosomes are condensed into a compact shape by a protein complex called condensin [5], while
the spindle apparatus starts forming from centrosomes. Prometaphase is defined by nuclear enve-
lope breakdown and initiation of chromosome attachment to the spindlemicrotubules by large pro-
tein assemblies on the centromere, known as kinetochores. During metaphase, the chromosomes
are aligned at the so-called metaphase plate between both spindle poles, allowing bi-orientation of
chromosomes, which signifies that both sister chromatids are connected to spindle microtubules
emanating from opposite spindle poles. Sister chromatids are held together by the protein complex
cohesin [6] that is cleaved by separase, thus triggering anaphase and the segregation of chromo-
somes towards opposite spindle poles. At telophase, the two sets of chromosomes decondense and
a new nuclear envelope is assembled, completing the process of mitosis. A contractile ring forms,
leading to the division of the cytoplasm and ultimately to cytokinesis.
The accuracy of mitotic events is crucial for cell viability. Errors during the duplication and sepa-
ration of chromosomes cause birth defects due to aberrations of the chromosome number (aneu-
ploidy) in haploid germ cells. Aneuploidy can further contribute to the onset and progression of
cancer in somatic cells [7, 8].
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1.2 Kinetochore organisation and function
The first report of structures responsible for chromosome movement appeared in 1894, describing
the ‘Leitkörper’ (‘the leading body’) at the interface between chromosomes and the mitotic spin-
dle in salamander spermatocytes [9]. This structure is now known as the kinetochore, which is
derived from the greek k–nhsvic (kinesis, movement) and q∏roc (choros, place or region). Kineto-
chores are characterised as the functional connection between two biological polymers, DNA and
  Inner centromere
chromatid cohesion
CPC regulation
    Outer kinetochore
microtubule binding
microtubule motor activity
signal transduction
  Inner kinetochore
chromatin interface
kinetochore formation
Figure 1.3: General structure of the centromere.
Left, mitotic chromosome sectioned along the spindle
plane axis, showing only one kinetochore attached to
microtubules emanating from the left. Key structural el-
ements are indicated by arrows. The inner centromere,
locus of chromatid pairing, cohesion and error correc-
tion links outer kinetochore to chromatin via the in-
ner kinetochore. The outer kinetochore, the site of mi-
crotubule binding, also regulates microtubule dynam-
ics and checkpoint signalling. The interzone between
inner andouter kinetochore is proposed to harbour ten-
sion receptors and contribute to checkpoint signalling;
modified from [10]. Upper right: mitotic chromosome
stained for DNA (blue), kinetochores (green) and co-
hesin (red), which is required for sister chromatid cohe-
sion until anaphase [11]. Lower right: schematic view of
a chromosome attached to the mitotic spindle.
microtubules that is required to allow the parti-
tioning of chromatids by themitotic spindle ap-
paratus.
1.2.1 The structural composition of kineto-
chores
Kinetochores are large assemblies of nearly 100
proteins that follow a hierarchical order to at-
tain a connection of chromosomal DNA with
spindle microtubules [12, 13]. The impres-
sive number of protein components reflects the
level of intricacy and versatility of the process
of chromosome segregation. Kinetochores are
molecular machines that are tightly regulated
and largely conserved from yeast to mammals,
highlighting that the kinetochore architecture
and function are conserved [14, 15]. Studies
mostly based on protein knock-down or ectopic
localisation experiments were used to elucidate
conserved pathways and hierarchy of kineto-
chore assembly that are now increasingly cor-
roborated by direct interactions identified by
biochemical experiments.
In few organisms including some fungi and
Saccharomyces cerevisiae, the kinetochore po-
sition is defined by a highly conserved 125 bp
stretch of DNA, termed point-centromere [15,
16], which anchors a single microtubule [17].
This arrangement differs from the organisation
in fission yeast or vertebrates, where centromeres span between kilo- to megabase regions (regional
centromeres) [10, 18] that attach to a bundle of 15-20 microtubules [19] or expands along the entire
chromosome length as in Caenorhabditis elegans (holocentric kinetochores) [20]. In the latter cases
the location of the centromeres is thought to be determined by epigenetic marks or the centromere-
specific histone CENP-A rather than specific DNA-sequences [21, 22].
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The kinetochore is composed of several distinct layers that were first observed in the late 1960s by
electron microscopy. A more detailed structure of kinetochores has been observed nearly 40 years
later revealing a trilaminar structure [23], where the inner and outer layers are electron dense, sep-
arated by an electron-lucent mid-zone (Figure 1.3). This modular assembly (observed in Figure 1.3
and schematically depicted in Figure 1.4) is organised into larger functional sub-complexes that are
commonly, yet tentatively, categorised into four parts.
(1) The inner centromere comprises microtubule-associated or -tracking proteins and an er-
ror correction module including the chromosomal passenger complex (CPC) [24, 25] that reg-
ulates kinetochore-microtubule attachments [26] in a tension-dependent manner (discussed
in more detail in Sections 1.3 and 1.4).
(2) The inner kinetochore or constitutive centromere associated network (CCAN), which con-
tains proteins binding to DNA or nucleosomes persists throughout the cell cycle providing a
platform for the assembly of other proteins [27, 28] (Section 1.2.2).
(3) The outer kinetochore orKNL1-MIS12-NDC80 (KMN) network physically bridges between
the inner centromere and microtubules (Section 1.2.3); it is visible as discrete electron dense
layer in Figure 1.3.
(4) An additional soluble fraction or fibrous corona, which presumably comprises proteins of
the spindle assembly checkpoint, is only visible during mitosis at unattached kinetochores.
This mechanism synchronises the state of correct kinetochore-microtubule attachment with
cell cycle progression. It is a feedback control system that delays anaphase onset until all sis-
ter chromatids are properly attached to opposite spindle poles, a detailed description of this
process can be found in Section 1.4.
1.2.2 The constitutive centromere associated network (CCAN)
The discovery of inner kinetochores was initiated with the finding that autoimmune sera from pa-
tients affected by calcinosis,Raynaud’s syndrome, esophageal dysmotility, sclerodactyly and telangi-
ectasia (CREST) syndrome recognised the centromere region [29]. This was later confirmed to be the
inner kinetochore or constitutive centromere associated network, in the following denoted as CCAN,
which constitutes the innermost layer of kinetochores as shown in Figure 1.4. CCAN components
lack enzymatic activity, being indicative of themain role of the CCAN as a structural platform for the
assembly of structural and regulatory microtubule-binding entities of the kinetochore.
The CCAN is a large protein network consisting of at least 16 sub-complexes (Figure 1.4) that are
commonly referred to as centromeric proteins (CENP), individually assigned with a letter. Many of
its members were initially identified by proteomics or sequence analysis [15, 27, 28, 30]. Later, these
findings were complemented by biochemical experiments to find that the CCAN is organised in sub
complexes that build an ordered hierarchical structure.
The conserved hallmark that specifies the centromere and therefore the position of the CCAN is the
presence of the CENP-A protein. As a centromere-specific variant of the canonical histone H3 [31],
CENP-A is found inmultiple nucleosomes along the centromere [32, 33, 34]. Recruitment of all inner
and outer kinetochore proteins relies on CENP-A [35], demonstrating the key importance of CENP-A
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as the building block for kinetochore assembly.
CENP-A containing nucleosomes directly interact with two CCAN components, namely CENP-C, a
highly elongated protein and essential structural CCAN component [10, 36, 37] and CENP-N [38].
CENP-C has been identified as a receptor for a CENP-H/I/K/M sub-complex [38, 39]. The CENP-
H/I/K/Mcomplex is in turn required to recruit a third sub-complex containing theCENP-O/P/Q/R/U
subunits [28, 30, 39, 40]. The generality of this assemblymechanism, however, is unclear, as only few
CCAN proteins have been identified so far in Caenorhabditis elegans and Drosophila melanogaster.
In these organisms, the inner kinetochore assembly seems to rely fully on CENP-A and -Cmolecules,
which is consistent with the observation that most other CCAN subunits are not essential in Saccha-
romyces cerevisiae [41]. CENP-C is further important in the maintenance of kinetochore localisation
as it is involved in replenishing CENP-A in centromeric nucleosomes [28, 42].
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Figure 1.4: Themodular organisation of the kinetochore structure.
Dashed lines indicate direct connections with centromeric DNA or chromatin. Continuous lines indicate re-
cruitment dependencies. The composition of CCAN sub-complexes were inferred from reconstitution or from
similarity of depletion phenotypes. For details see text, modified from [43].
TheCENP-T/W/S/X complex consists of histone-fold domain-containing proteins that forma tightly
interacting complex [27, 30] that is able to bind and supercoil DNA [44]. CENP-T and the CENP-
H/I/K/M subunits were shown to be co-dependent for kinetochore localisation [30, 43, 45] placing
them downstream of CENP-C. There is ongoing controversial discussion about whether the hierar-
chy of recruitment mostly relies on CENP-C or CENP-T [28, 30, 39, 40, 43, 45]. Speculatively, it is
likely that the CENP-T and CENP-C pathway exhibit a certain degree of interdependence, which rec-
onciles different hypotheses.
CENP-A, CENP-T/W, CENP-C, and CENP-H/I/K/M complexes were implicated to varying extents in
contributing to the assembly of the outer kinetochore [30, 40, 46], as indicated in Figure 1.5. Both
CENP-C and CENP-T are direct binders of nucleosomes or centromeric chromatin [36, 47] and in-
teract with components of the outer kinetochore leading to a model where CENP-T and CENP-C
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mediate outer kinetochore assembly from two different loci at the centromere in an interdependent
pathway (Figure 1.5), which is described in more detail in Section 1.2.3.
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1.2.3 The outer kinetochore KNL1-MIS12-NDC80 (KMN) network
The CCAN network provides a platform that specifically recognises the centromeric region of chro-
mosomes, while the 10-subunit KMN (KNL1-MIS12-NDC80) network has been identified as the pro-
tein complex, which binds to this scaffold and allows direct interaction with
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Figure 1.5: Schematic structural view of kineto-
chore architecture. The contributions of the consti-
tutive centromere-associated network (CCAN) subunits
CENP-A (Cse4), CENP-C and CENP-T to the recruit-
ment of the outer kinetochore (KMN) are shown in de-
tail. One microtubule-attachment site is shown for
simplicity. CENP-C interacts directly with the CENP-
A nucleosome and MIS12 complex. CENP-T binds
centromeric chromatin and NDC80 complex. CENP-
T and MIS12 complex are competing binding partners
for NDC80 complex. Knl1 anchored via MIS12 com-
plex andNDC80 are plus-endmicrotubule binders, thus
act as interface for kinetochore-microtubule interac-
tion. The yeast Dam1 complex and its supposed human
homolog, Ska complex are thought to support these in-
teractions. Modified from [41].
kinetochore microtubules [48, 49]. Initial work
was mostly performed in yeasts but shortly af-
terwards the KMN was shown to be highly con-
served in other species as well [50, 51, 52,
53]. The main task of this network is to sus-
tain and transmit forces emanating from mi-
crotubules of the mitotic spindle to the cen-
tromere and therefore to function as a tension-
sensing machinery. Furthermore, this appa-
ratus is able to monitor the microtubule at-
tachment status and quality of attachment,
in an effort to regulate the recruitment of
both the correction machinery and the activa-
tion of the spindle assembly checkpoint [54,
55].
The KMN is linked to the inner kinetochore
through direct interactions with the two CCAN
components CENP-C and CENP-T that bind
to the MIS12 complex and the NDC80 com-
plex, respectively. In vertebrates, the con-
served MIS12 complex localises to the inner
plate of kinetochores, indistinguishable from
CENP-A and -C [53], while Ndc80 localises to
the outer plate (Figure 1.5). Thus, the ar-
rangement of MIS12 complex and Ndc80 leads
to a structure spanning from the inner cen-
tromere to the outer microtubule-binding in-
terface.
The MIS12 complex consists of the four sub-
units Dsn1, Mis12, Nnf1 and Nsl1 that form a
rod-shaped elongated tetramer [53, 56, 57, 58] that localises to the inner kinetochore, establishing
direct contact to CENP-C via the Nnf1 subunit [45, 59, 60]. The MIS12 complex is important for
chromosome segregation as MIS12 mutants show both lower amounts of NDC80 complex at kine-
tochore and exhibit defects in establishing bi-orientation and tension across sister chromatids [56,
57]. These findings are in line with the role of MIS12 in outer kinetochore assembly where it serves
as a structural platform for NDC80 and KNL1 complex binding [53, 58].
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The NDC80 complex is a crucial organisational element of the outer kinetochore structure and con-
tains the extended coiled-coil subunits Ndc80 (also known as Hec1), Nuf2, Spc24 and Spc25 [42,
61, 62, 63, 64, 65]. RNAi interference of Ndc80 leads to a kinetochore-null phenotype, highlight-
ing its importance in the maintenance of stable kinetochore-microtubule attachments, kinetochore
morphology and chromosome alignment as well as kinetochore localisation of mitotic checkpoint
components [54, 64, 65, 66, 67, 68]. Structurally, the Spc24:25 dimers are oriented towards the kine-
tochore and bind the MIS12 (Nsl1) and KNL1 (Knl1) complexes [69, 70], the elongated structure of
the complex presumably translating the tension frommicrotubules to the inner kinetochore [50, 51].
The N-terminal region of CENP-T interacts directly, in a phosphorylation-dependent manner, with
the Spc24:25 dimer [45, 58, 71, 72, 73], which is mutually exclusive with the binding of Spc24:25 to
MIS12 [71, 72, 73] (Figure 1.5). The head domains of Ndc80 and Nuf2 proteins bind to microtubules
directly [51, 74, 75] and regulate the dynamics of kinetochore microtubules [52] (Section 1.3.1).
Some studies suggest a microtubule-dependent role for the Ndc80 complex in regulating the sta-
ble association of the checkpoint proteins Mad1:Mad2 and dynein with kinetochores [42, 54, 64, 68,
76]. Its role in checkpoint inactivation remains controversial but it emerges that spindle checkpoint
signalling is abolished under conditions of complete removal of Ndc80 by RNAi [67]. This might be
mediated by the interaction of the NDC80 complex with the checkpoint kinase Mps1, which is es-
sential for checkpoint activity [54] (see also Section 1.4).
The KNL1 complex consists of a long protein Knl1 (also known as Blinkin, AF15q14, Spc105) and
Zwint that binds to the C-terminus of Knl1 [40, 55, 58, 77]. Knl1 binds to microtubules via its N-
terminus [51, 78] while its C-terminus is required for kinetochore localisation to the MIS12 complex
[53, 58]. Knl1 has a role in the recruitment of spindle assembly checkpoint components, both directly
(N-terminus) and indirectly (C-terminus) via Zwint, which is involved in the kinetochore recruitment
of ZW10 [79]. ZW10 is a component of the Rod-Zwilch-ZW10 (RZZ) complex, that constitutes an inte-
gral part of the checkpoint, discussed comprehensively in Section 1.4. Additionally, the N-terminus
of Knl1 is required for the recruitment of protein phosphatase 1 (PP1), an antagonist of Aurora B
activity, that is involved in the regulation of kinetochore-microtubule attachments [55, 80] (see also
Section 1.3.2) as well as mitotic checkpoint silencing [81] (see also Section 1.4.3). This role is consis-
tent with a kinetochore-null phenotype, which can be observed when Knl1 is depleted, where cells
fail to assemble a functional kinetochore-microtubule interface [77].
1.3 Control of kinetochore-microtubule attachment 11
1.3 Control of kinetochore-microtubule attachment
The kinetochore is the interface between chromosomes andmicrotubules of themitotic spindle. The
ability of kinetochores to bind to growing or disassembling microtubules [82, 83] and stabilising the
attachedmicrotubules [82] is crucial for their role inmonitoring and regulation of initialmicrotubule
capture, achieving bi-orientation, and maintaining end-on attachments that generate the required
force and tension for chromosome segregation.
1.3.1 The regulation ofmicrotubule dynamics
In 1951, Inoue proposed the first model of dynamic equilibrium of spindle assembly and chromo-
some movement [84]. Microtubule structures are highly dynamic, characterised by a state termed
“dynamic instability” that changes between states of spontaneous disassembly, pause and growth
[85, 86]. Dynamic instability is a feature required to allow the correction of erroneous attachments of
kinetochores (Figure 1.6) and also the stabilisation of correct, load-bearing kinetochore-microtubule
attachments.
As the NDC80 complex is the principal microtubule-binding site, it is also a major site of regulation
of microtubule-binding. The Dam complex from budding yeast and its possible functional homolog
in humans, the Ska complex, also both bind microtubules and establish contacts with Ndc80, possi-
bly enhancing the overall processivity of microtubule binding [87, 88, 89]. Ablation of Ska complex
in cells displays a similar kinetochore-null phenotype as NDC80 inhibition [88, 90, 91] emphasising
its role in mediating microtubule interaction.
amphitelic syntelic
monotelic merotelic
kinetochore
microtubule
sister chromatids
Figure 1.6: States of kinetochore-microtubule
attachment.
Amphitelic orientation (correct attachment,
bi-orientation), both sister kinetochores are
bound to microtubules originating from proxi-
mal poles. Monotelic attachment, intermediate
condition with only one kinetochore attached
to the spindle. In syntelic attachment, both
sisters connect to the same pole. Merotelic
attachment, one sister is attached to both poles,
a condition occuring frequently during mitosis.
The dynamics of kinetochore-microtubule interactions are mainly regulated by reversible phospho-
rylation events at the kinetochore, resulting frombalanced kinase- andphosphatase activities, among
which Aurora B kinase and PP2A phosphatase with its regulatory subunit B56 [92]. A number of
KMN components are targets of Aurora B activity and exhibit reduced microtubule binding affin-
ity upon phosphorylation [78]. In particular, Aurora B phosphorylates multiple sites on positively
charged segments within the N-terminal tail of Ndc80 [75, 93], which neutralises the charges, hence
decreases the microtubule-binding affinity in vitro and reduces the microtubule-induced clustering
effects of the Ndc80 complex [51, 52, 75, 93]. In good agreement with these findings, the activity of
Aurora B has been found to be crucial for kinetochore microtubule destabilisation and microtubule
attachment error-correction in vivo [51, 52, 78, 94].
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Additionally, Aurora B phosphorylation prevents premature stabilisation of erroneous attachments
by negatively regulating the association of Ska complex with the NDC80 complex and microtubules
[89, 95]. Aurora B is also known to phosphorylate Knl1, the Dsn1 subunit of the MIS12 complex and
CENP-U at the inner kinetochore [78, 96]. However, the effects of these phosphorylation events on
microtubule binding are still poorly characterised.
1.3.2 The error-correctionmachinery
Attachment errors, likemonotelic, syntelic ormerotelic attachments (Figure 1.6), are common [97] as
microtubule filaments encounter kinetochores by chance. The ability to discriminate between cor-
rect and incorrect, labile microtubule attachments, thereby selectively stabilising the
p asei
P
P P
P P
P
P
P
P
P
P
Spindle
pole
Centromere
Kinetochore
Tension OFF
SAC ON
Tension ON
SAC OFF
Microtubule
CPC complexes
Figure 1.7: Error-correction in context of the spindle assembly check-
point.
Schematic description of the relative arrangement of the centromere-
kinetochore interface in the absence (above, OFF) and presence of ten-
sion (below, ON). Note that the absence of tension is coupled to SAC
activity, which is silenced under conditions of tension. The magnifica-
tion of the respective centromere-kinetochore interface demonstrates
the change in phosphorylation status (P) of kinetochore substrates in
response to tension. In the absence of tension, kinetochores are close
to centromeres (green), where high kinase activity is present. In this
configuration, substrates at the centromere (P, yellow circle) as well as
the kinetochore (P, grey circle) are phosphorylated. Conversely, in the
presence of tension, the distance of kinetochores from the centromere
increases, allowing distal kinetochore substrate dephosphorylation by
phosphatases (piase), while phosphorylation of close centromere sub-
strates persists; modified from [98].
former and preventing the sta-
bilisation of the latter is a cru-
cial process for chromosome in-
tegrity that is achieved by a
tension-sensitive apparatus of
the cell [99, 100, 101].
Aurora B has been identified as
key player in the destabilisa-
tion of erroneous attachments
by phosphorylating KMN com-
ponents described above (Sec-
tion 1.3.1). Aurora B is a subunit
of the chromosomal passenger
complex (CPC), along with the
proteins Incenp, Survivin, and
Borealin [102, 103]. Attach-
ment errors can be artificially
stabilised if the activity of the
Aurora B kinase is inhibited with
a small molecule inhibitor [94,
104, 105, 106]. Re-activation
of Aurora B, however, strik-
ingly results in the correction
of improper attachments after
inhibitor washout [106]. Au-
rora B/Ipl1 mutants in yeast lead to massive chromosome missegregations because the release of
kinetochore-microtubule attachments is impaired [107]. This highlights the importance of Aurora B
as an essential component of the error-correction mechanism. The exact details of how incorrect
attachments are sensed in a tension-dependent manner and how this is then translated to the dif-
ferential activity of Aurora B remain unclear. Small molecule inhibitor studies also identified the
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checkpoint kinase Mps1 to be implied in error-correction downstream of Aurora B [108].
According to the model presented in Figure 1.7, error correction is modulated by differential ac-
cess of Aurora B to its kinetochore substrates. Faulty attachments are associated with lack of inter-
kinetochore tension [26, 104], which allows Aurora B coupled to centromeres via the CPC [102, 103]
to phosphorylate its kinetochore substrates [80] (Section 1.3.1).
Uponbi-orientation, the inter-kinetochore tension and -distance increase, leading to a displacement
of centromere-bound Aurora B out of reach of its substrates [107]. This hypothesis was corroborated
by elegant anchor-away experiments in which an Aurora B kinetochore substrate at a sufficiently
large distance from the centromere became dephosphorylated upon microtubule attachment [26].
Furthermore, inter-kinetochore stretch, leading to a distance of 35-40 nmbetween kinetochores, was
shown to be sufficient to satisfy and disable the spindle assembly checkpoint [109] (also schemati-
cally depicted in Figure 1.7).
Despite this sensible, though simplified model, it is conceptually unclear how stable attachments
can initially be formed at the onset of mitosis, as the kinetochore substrate phosphorylation of Au-
rora B peaks in prometaphase, or whenmicrotubules are depolymerised by nocodazole [80]. Impor-
tantly, Aurora B phosphorylation is counteracted by the activity of kinetochore-boundphosphatases,
such as protein phosphatases 2A (PP2A) and 1 (PP1) [80, 92]. PP1 recruitment to the N-terminus of
Knl1 in metaphase, which is negatively regulated by Aurora B activity, results in dephosphorylation
of Aurora B substrates and stabilisation of kinetochore-microtubule attachments [80]. PP2A together
with a B56 regulating unit promotes dephosphorylation of kinetochore substrates at unattached
kinetochores to facilitate kinetochore-microtubule attachment and to maintain low phosphoryla-
tion levels on bi-oriented chromosomes. However, little is known about the PP2A- or PP1-specific
substrates and how their activities are regulated at the kinetochore.
The mechanism of error correction is closely linked with the machinery of the spindle assembly
checkpoint, as checkpoint proteins, such as Mps1, Bub1 and BubR1 and Polo-like kinase 1 (Plk1)
[2] contribute to the regulation of kinetochore-microtubule attachment. The attachment is regu-
lated in a feedback mechanism that influences both Aurora B and PP2A-B56 recruitment directly or
indirectly. In particular, Aurora B targeting to centromeres depends on Bub1-mediated phosphory-
lation of histone H2A as well as Mps1 activity [110, 111, 112], whereas recruitment of PP2A-B56 to
the kinetochore requires Plk1-dependent phosphorylation of BubR1 [113, 114]. This connection of
error correction with spindle assembly checkpoint signalling is recapitulated by the fact that intra-
kinetochore stretching couples both the spatial regulation of Aurora B activity and the state of check-
point signaling [109] (Figure 1.7).
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1.4 Molecularmechanisms of the spindle assembly checkpoint
During metaphase, erroneous attachments are destabilised and eliminated by the error correction
machinery to promote bi-orientation of all chromosomes (see also Section 1.3.2) and induce acti-
vation of the spindle assembly checkpoint. This checkpoint (henceforth termed SAC) is a second
safety mechanism of the cell, triggered by unattached or mono-oriented kinetochores, that conse-
quently delays anaphase onset and exit frommitosis until all chromosomes are properly attached to
the spindle [2, 98]. In the absence of SAC signalling, cohesin is cleaved, allowing exit from mitosis
irrespective of kinetochore-microtubule attachments, which results in increased frequency of chro-
mosomemissegregation and aneuploidy [2, 7].
1.4.1 The assembly of amitotic checkpoint complex
SAC proteins were first identified genetically by screens for mutants in Saccharomyces cerevisiae that
fail to respond to improper microtubule attachments introduced by anti-microtubule drugs [115,
116]. Components of the SAC include the mitotic-arrest deficient (Mad) proteins Mad1, Mad2, and
Mad3/BubR1 (human ortholog) [115], the budding uninhibited by benzimidazole (Bub) proteins
Bub1 kinase and Bub3 [116, 117], monopolar spindle protein 1 (Mps1) kinase [118], Ipl1/Aurora B
(human ortholog) kinase [119], and Sgo1 [120], all of which are highly conserved among eukaryotes.
Despite knowing the identity of the main players, the exact molecular mechanism of how attach-
ment errors at the kinetochore are converted into signals that inhibit anaphase onset remains insuf-
ficiently understood.
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Figure 1.8: The spindle assembly checkpoint is a timing device to ensure faithful chromosome segregation.
Schematic view of the sequential phases of mitosis (see Section 1.1.2 for details). Prometaphase starts after nu-
clear envelope breakdown (time zero). Unattached sister kinetochores (red dots) emit a “Wait!” signal, which
arrests cells in mitosis. This signal corresponds to the production of MCC (BubR1, Bub3, Mad2, Cdc20) com-
plexes by the SAC that inhibit the APC/C. This allows Cdk1–cyclin B (CycB) to remain active while separase (Sep)
activity is restrained by securin (Sec). Chromosomes that fail to achieve correct attachment until metaphase
continue to activate the SAC until all sister kinetochores are attached (green dots) to kinetochore fibers before
anaphase. Upon full correct attachment, the SAC is satisfied, the APC/C becomes activated, cyclin B and securin
are ubiquitylated (u) and destroyed in an APC/C-dependentmanner. Separase is activated cleaving cohesin be-
tween sister chromatids, allowing anaphase onset while Cdk1 is inactivated ultimately leading to mitotic exit.
Modified from [121, 122].
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SAC proteins delay precocious chromosome segregation in anaphase through the inhibition of a
complex of the E3 ubiquitin ligase known as the anaphase-promoting complex/cyclosome (APC)
[123, 124] and its co-activator Cdc20 [125, 126]. APC/CCdc20 catalyses the ubiquitination and de-
struction of cyclin B [127] and securin [128], leading to inactivation of themitotic driver kinase Cdk1
and the release of active separase [129, 130, 131] (Figure 1.8). The proteolytic activity of separase
cleaves cohesin and destroys the linkage between sister chromosomes, thus triggering anaphase and
chromosome segregation.
The SAC inhibits APC/CCdc20 activity by catalysing the formation of an inhibitory complex, referred
to as themitotic checkpoint complex (MCC), which is a heterotetramer composed of Cdc20, Mad2,
BubR1 and Bub3 [132, 133, 134] (Figure 1.9, 1.8). The individual contributions of the MCC compo-
nents to APC/CCdc20 inhibition remain controversially discussed as Mad2 and BubR1 bind to two
distinct binding sites on Cdc20 [125, 135]. Some studies argue towards Mad2 binding to Cdc20 to
have a dominant role [136], while others claim BubR1 provides the inhibitory activity of APC/CCdc20
[137, 138]. The notion that BubR1 and Mad2 might act synergistically, reconciles this discrepancy
[132, 133, 134, 136, 137, 138, 139, 140]. The sequestration of Cdc20 signifies a disruption of Cdc20
association with APC/C subunits [134] as BubR1 binding to Cdc20 blocks D-box sites in Cdc20 re-
quired for recognition by the APC/C [134, 141]. Moreover, the incorporation of Cdc20 into the MCC
promotes APC/C-dependent autoubiquitylation of Cdc20, which reduces Cdc20 levels and allows for
complete inhibition of the remaining Cdc20 pool by the SAC [142, 143]. The inhibition of APC/CCdc20
by the SAC therefore stabilises securin and allows for time to correct errors in chromosome attach-
ment and alignment (Figure 1.8).
Unattached kinetochores that delay a vertebrate cell for several hours in mitosis [144] represent the
source of SAC signalling. Significantly, most SAC proteins, including Mps1, Bub1, Mad1, Mad2,
BubR1, Bub3 and Cdc20, are shown to associate to unattached kinetochores (also depicted in Fig-
ure 1.9) and the majority is removed from kinetochores upon microtubule attachment [145]. Con-
sistent with the central role of checkpoint proteins in initiating and maintaining mitotic arrest at
unattached kinetochores, the recruitment of checkpoint kinase Mps1 to the kinetochore is required
for mitotic arrest [146]. Conversely, elegant experiments show that constitutive kinetochore target-
ing of Mad1 is sufficient to sustain SAC signalling also at attached kinetochores since Mad1 removal
from kinetochores is impaired [147].
Interestingly, although kinetochores are at the basis of SAC signalling, kinetochores are not abso-
lutely essential for MCC formation. In human cells theMCCwas shown to already be present during
interphase, before kinetochore recruitment of SAC components [132]. The interphasic presence of
the MCC was confirmed in yeast lacking functional kinetochores [148, 149, 150]. This soluble pool
of MCC in human cells, however, is not sufficient to delay chromosome segregation when mitosis
perturbed by microtubule poisons. Rather, the preformed MCC is thought to be required to set a
minimum time for mitosis and for the inhibition of the APC/C in initial prometaphase, when kine-
tochores are still assembling and recruiting SAC proteins [67].
A key function in the kinetochore-based SAC signalling is the catalytic step of promoting the as-
sembly of locally enriched MCC components into sub-complexes for final assembly, in particular
Mad2:Cdc20 complexes [67, 133, 151] to interact with a constitutive BubR1:Bub3 complex [152, 153].
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Mad2 exists in a “closed” conformer that is competent to bind Cdc20 and kinetochore receptorMad1
and an “open” conformer that does not associate with Cdc20 [154, 155, 156, 157]. It is therefore
crucial to convert the “open” into the “closed” conformer to allow the formation of inhibitory MCC
complexes. The “Mad2 template” model postulates a mechanism for the Mad2 conversion that is
catalysed by binding of closedMad2 to kinetochore-localisedMad1 [151, 158]. This forms the source
of closed Mad2 needed for the formation of Mad2-Cdc20 complexes (Figure 1.9). The molecular
details of how Mad2:Cdc20 and BubR1:Bub3 sub-complexes then cooperate to form the final MCC
still remain at issue. It has been shown that binding of Mad2 to Cdc20 is necessary for binding of
BubR1 to Cdc20 and that BubR1 uses a lysine-glutamate-asparagine (KEN) sequence for Cdc20 bind-
ing [159]. Moreover, the crystal structure of a Saccharomyces cerevisiaeMCC complex reveals aMad2
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Figure 1.9: SAC activation at unattached kinetochores.
Mps1 is recruited to kinetochores in an Aurora B depen-
dent manner to phosphorylate Knl1. Phosphorylated Knl1
binds Bub1:Bub3 that in turn recruits BubR1:Bub3 com-
plexes. In metazoans, Knl1-Zwint together also recruits
the Rod-Zwilch-ZW10 (RZZ) complex, although the precise
mechanism is unknown. These proteins collaborate to re-
cruit a heterodimer of Mad1:Mad2 (in closed conformation)
to the kinetochore. The Mad1:Mad2 complex catalyses the
conversion of soluble open Mad2 into closed Mad2, which
associates with Cdc20 in the cytoplasm. Mad2-Cdc20 com-
plexes are then bound by BubR1:Bub3 to form the MCC that
is competent to inhibit the APC/C.
bound to Cdc20, which also interacts with
BubR1 and exposes Cdc20 for efficient
BubR1 binding [134], thus lending sup-
port to previous assertions where Mad2-
binding of Cdc20 was shown necessary
for BubR1 binding [133, 159]. The ac-
tual composition of the MCC, particularly
with regard to Bub3, is still unclear as in
Schizosaccharomyces pombe Bub3 is not
incorporated in the MCC [160]. An re-
cent model [161] and other observations
alluded to a role of a second molecule of
Cdc20 binding to the MCC [150, 159, 162],
the significance of which remains to be es-
tablished.
It has been suggested recently that Mad2
released from the final inhibitory BubR1-
Cdc20-Mad2 complex can then again fa-
cilitate the formation of additional MCC
complexes [138]. This provides a model
forMCCamplification froma kinetochore-
derived Mad2-Cdc20 complex into the cy-
tosol, implying that the major contribu-
tion for APC/CCdc20 inhibition is provided by BubR1-Cdc20. Additionally, phosphorylation of Cdc20
by Bub1 kinase [163], of Mad2 by Mps1 kinase [164] or Aurora B dependent BubR1 phosphorylation
[165] may also contribute to the efficient assembly of MCC complexes.
1.4.2 Activation of checkpoint signalling
The initiation of a checkpoint signal corresponding to the production of inhibitory MCC requires
the recruitment of essential checkpoint components to unattached kinetochores [145]. Studies in-
vestigating recruitment dependencies of checkpoint proteins start to unravel themechanism of SAC
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activation to be a partly hierarchical but also an inter-dependent feedback pathway (Figure 1.9).
In the presence of microtubule-depolymerising drugs, Aurora B is required for the kinetochore re-
cruitment of SAC proteins [67] and Aurora B or Mps1 inhibition severely impairs SAC signaling [104,
105, 108] placing both kinases upstream of the signalling pathway. The KMN network was shown to
be essential for SAC signalling and SAC component recruitment in all eukaryotes examined [48, 49,
54, 63, 104, 108, 166]. This is in part explained by Aurora B-dependent phosphorylation of Ndc80,
a protein which is implicated in the recruitment of the essential checkpoint kinase Mps1 [54, 166,
167], although the mechanism remains elusive (Figure 1.9). Additionally, the N-terminus of Knl1
was identified as a crucial hub for the establishment of checkpoint signalling [55, 168, 169, 170, 171].
Recent evidence shed light on the necessity of Mps1 activity in the checkpoint, in particular: Mps1
phosphorylates KNL1 at threonine residues within conservedMELT (M[D/E][I/L/V/M][S/T]) repeats
[172, 173, 174, 175], thereby creating a docking site for Bub3 in complex with Bub1 (Figure 1.9). This
Bub1:Bub3 complex in turn is necessary and sufficient for recruitment of the BubR1:Bub3 complex
[176, 177, 178, 179, 180]. Evidence from yeast suggests that Bub1 is also directly implicated in the
recruitment of Mad1:Mad2 [181, 182] while the dependence in human cells is less clear [183]. Fur-
ther proteins are reported to provide further low-affinity binding sites as well, such as the NDC80
complex [54, 64] and the Rod-Zwilch-ZW10 (RZZ) complex [184], the latter being also dependent on
Mps1 activity for its kinetochore targeting [108, 146, 185].
Collectively, SAC activation can be viewed as a two-branched model where checkpoint components
localise to the Ndc80 complex (Mps1, Mad1:Mad2 and RZZ), whereas others associate with Knl1-
Zwint (Bub1, BubR1 and Bub3). Mad1:Mad2 and RZZ might be stabilised by additional association
with Knl1-bound Bub1 and Zwint, respectively (Knl1 branch highlighted in Figure 1.9). This config-
uration of SAC proteins is the foundation that leads to the generation of MCC inhibitory complexes,
however, the mechanism of the interplay of Bub1:Bub3, BubR1:Bub3 complexes with Mad1:Mad2
and Cdc20 still remains to be established.
1.4.3 Silencing of checkpoint signalling
Progression through mitosis requires the mitotic checkpoint to be silenced upon achievement of
bi-orientation and kinetochore attachment to the mitotic spindle. Continuation requires both the
removal of mitotic checkpoint proteins from kinetochores, as any of them is able to sustain check-
point activation [147, 186] and the disassembly of theMCC to allow activity of the APC/C. The APC/C
activity in turn then leads to the ubiquitination and degradation of securin, thus activation of sepa-
rase and sister chromosome separation (Figure 1.8).
As checkpoint activation is largely kinase-dependent, it is fair to assume that phosphatases play a
central role in silencing. Indeed, the recruitment of PP1 to the N-terminus of Knl1 is implicated
in checkpoint silencing on top of its role in regulating microtubule dynamics (Section 1.3.2), high-
lighting the close interplay of both processes [81, 187]. In particular, a Knl1 mutant deficient for
PP1 binding shows higher levels of the checkpoint components Bub1 and BubR1 at kinetochores
[188]. Furthermore, PP1 was shown to dephosphorylate MELTmotifs in yeast and its overexpression
reduces Bub1 levels at kinetochores [172]. In mammalian cells, PP2A-B56 was identified as a phos-
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phatase removing Mps1-mediated Knl1 phosphorylation sites, which results in the removal of Bub1
and BubR1 from kinetochores [189].
The RZZ complex is proposed to contribute to SAC silencing, through the recruitment of Spindly
upon microtubule attachment. Spindly localisation to kinetochores is in turn required for dynein-
dynactin localisation [190, 191]. The dynein-dynactin complex is a minus end-directed motor pro-
tein that strips RZZ and boundMad1:Mad2 complexes from kinetochores [192] in a process referred
to as kinetochore shedding. This model, however, only applies for higher eukaryotes as neither RZZ
nor Spindly have obvious homologs in yeast.
In a second branch, MCC disassembly is required to provide free Cdc20 in order to activate the
APC/C. Additionally, in metazoans, the mitotic checkpoint silencing protein p31comet binds specif-
ically to the closed form of Mad2 [193] and its overexpression results in less Mad2 bound to Cdc20
[194]. The AAA-ATPase TRIP13 is a direct binder of p31comet [195]. Depletion of TRIP13 delays the
metaphase-to-anaphase transition and p31comet mediated mitotic checkpoint silencing. Recent ev-
idence has emerged that the enzymatic activity of TRIP13 in cooperation with p31comet provides the
energy required to disassemble stable MCC and to drive mitotic checkpoint silencing [195].
Moreover, the APC/C-dependent non-degradative autoubiquitylation of Cdc20 [143] promotesMCC
disassembly and contributes to SAC silencing, thus leading to mitotic exit (also depicted in Fig-
ure 1.8). Discerning molecular mechanisms in order to characterise the interplay and connections
between SAC kinase and phosphatase activity at the kinetochore, depending on the microtubule
binding status, is the focus of current and future work.
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1.5 Checkpoint kinases Bub1 and BubR1
Bub1 and BubR1 are essential and paralogous proteins at the core of the spindle assembly check-
point machinery. Their domain architecture is remarkably similar (Figure 1.10) suggesting they
evolved from the same progenitor gene [196, 197], however, their mitotic function is distinctly di-
vergent. Several independent duplication events occurred during speciation, in all cases followed by
substantial sub-functionalisation, resulting in their separate roles [196, 197].
1.5.1 Themitotic functions of Bub1 and BubR1
Bub1 and BubR1were originally characterised as a conserved components of the SAC [115, 116, 145],
recruited to kinetochores in response to unattached ormisaligned kinetochores. More recently, Bub1
was also shown to play a role in chromosome alignment [177, 198] as well as BubR1 [196, 199]. Ex-
actly how Bub1 and BubR1 perform their many functions on amolecular level, and whether all of its
many interactions are phylogenetically conserved, is yet unclear.
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Figure 1.10: Domain structure of checkpoint components.
Domain positions and protein construct boundaries of a Knl1 fragment comprising the N-terminal MELT-
motif and KI1 and KI2, are indicated by residue number. TPR-tetratricopeptide repeat, Bub3BD-Bub3 binding
domain, ABBA-cyclin A, Bub1, BubR1, Acm1 (ABBA) motif [200, 201] or F-box [202], KEN-lysine-glutamate-
asparagine motif, CDI/II-conserved domain I/II (as defined in [183]), WD-tryptophan-aspartate, MIM-Mad2
interactionmotif.
Kinetochore recruitment of Bub1 and BubR1
Like its orthologs, human Bub1 possesses N-terminal tetratricopeptide repeats (TPR), followed
by a binding motif for Bub3, two conserved motifs, and a C-terminal kinase domain. The overall
organisation of BubR1 (Mad3 in yeast) is similar to Bub1, as shown in Figure 1.10 [183]. Bub1 as
well as BubR1 each form a constitutive 1:1 complex with the checkpoint protein Bub3, a 7-bladed
b-propeller, throughout the cell cycle [117, 135, 152, 203]. The interaction of Bub1with Bub3 ismedi-
ated by its Bub3-binding domain (also referred to as GLEBSmotif ) [203]. The Bub3-binding domain
is both necessary and sufficient for kinetochore localisation of Bub1 and BubR1 [66, 176]. The exact
dependence of Bub3 binding on kinetochore recruitment is controversial, as in human cells, deple-
tion of Bub3 does not affect Bub1 kinetochore recruitment although it might affect the localisation
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of BubR1 [67]. Depletion of Bub1 or BubR1, however, was found to reduce kinetochore recruitment
of Bub3 in Xenopus egg extracts [204] was shown to be required to recruit Bub3 to the kinetochores
of fission yeast [176] and vertebrates [177, 204]. Biochemical studies initially identified the first 300
residues of the N-terminal region of murine Bub1 to be sufficient for kinetochore localisation [152]
that comprises the TPR domain and the Bub3-binding domain. Further studies demonstrated that
the Bub3-binding domain is sufficient for kinetochore localisation, which is consistent with the find-
ing that mutations in the Bub3-binding domain prevent kinetochore localisation of Bub1 [183] and
BubR1 [139, 205].
Bub1 recruitment was shown to be dependent on the phosphorylation of so-called MELT motifs on
Knl1 byMps1 [172, 173, 174, 175], which creates a docking site for Bub3 bound to Bub1, not however
Bub3 bound to BubR1 [171, 179]. Indeed, Bub1 is required for kinetochore recruitment of BubR1
[66, 177, 206] and they directly interact in a region, which is immediately followed by their respective
Bub3-binding domains [179].
In vertebrates, the kinetochore binding mechanism of Bub1 and BubR1 is more complex. The TPR
domains of Bub1 and BubR1 interact with vertebrate Knl1 KI1 and KI2 motifs, respectively[199, 207,
208] (Figure 1.10). However, the TPR domains are dispensable for Bub1 or BubR1 recruitment to
the kinetochore [152, 208]. This is consistent with the finding that the KI1 or KI2 motif on Knl1 is
not required for Bub1 recruitment [173]. However, deletion or mutation of the KI motif or a TxxF/Y-
motif preceding the MELT-sequence, that is also conserved only in vertebrates, strongly reduced the
recruitment of the Bub1:Bub3 and BubR1:Bub3 in vitro and in vivo. Furthermore the deletion de-
creased the ability tomount a SAC response and led to impaired chromosome alignment, suggesting
that this additional interaction stabilises the overall association of Bub1:Bub3 with Knl1 and pro-
motes the subsequent recruitment of BubR1:Bub3 [171, 209].
Bub1 and BubR1 function at the kinetochore
Themain contribution of Bub1 to checkpoint signalling constitutes its role as a scaffolding protein
localising at kinetochores during early mitosis. Bub1 bound to kinetochores recruits downstream
checkpoint components to the kinetochore, including BubR1 and Bub3 [177, 178, 179, 198, 204, 210]
as well as the RZZ complex [180] and the Mad1:Mad2 complex [181, 182, 183, 211, 212].
Consistently, in yeast Bub1 andMad1 have been shown to form a complex in vitro in the presence of
Mad2 and Mps1 [211] while the complex formation of Bub1 and BubR1 was suggested by yeast-two
hybrid assays [55, 199] and confirmed in human cells later in vitro and in vivo [179]. Molecular de-
tails of the interaction of both complexes are not available so far.
BubR1, unlike Bub1, contributes to the checkpoint directly, as it is a crucial component of the MCC
together with Bub3, Mad2 and Cdc20 [132]. BubR1 contains two KEN boxes that have been impli-
cated in Cdc20 binding and thus APC/C inhibition (Figure 1.10). Recent structural analysis of fission
yeast MCC has revealed that BubR1/Mad3 uses its N-terminal KEN box, which precedes the TPR do-
main (and is absent in Bub1), to establish direct interactions with both Mad2 and Cdc20 [134, 138,
141, 199, 213]. The second KEN box is required to block substrate binding to the APC/C [139]. Addi-
tionally, the TPR domains of BubR1 also directly interact with Cdc20, consistent with the observation
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that mutating the TPR or the KEN boxes of BubR1 disrupts its ability to bind Cdc20 and impairs SAC
signaling [55, 139, 159].
More recently, an additionalmotif, present on cyclinA,Bub1,BubR1 and Acm1 (hence termed ABBA
motif or F-box, because it contains two conserved phenylalanines), was implicated in BubR1 bind-
ing to Cdc20 as well [200, 201, 202]. Cdc20 localisation was shown to depend on the ABBA motif of
Bub1 [210], specific binding of Cdc20 was also attributed to contributions of the KENmotifs [214].
In addition to their essential role in SAC signalling, Bub1 and BubR1 also contribute to chromosome
congression during prometaphase by stabilising correct kinetochore–microtubule interactions and
destabilising erroneous contacts [106, 115, 152, 177, 205]. This regulation is mediated by BubR1-
associated PP2A [113] and the intrinsic kinase activity of Bub1 [111, 176, 183, 215].
1.5.2 The role of Bub1 and BubR1 kinase activity
Protein kinases catalyse the phosphate transfer from ATP to protein substrates, a modification that
canmodulate the activity of an enzyme or regulate specific protein-protein interactions. Kinases are
important enzymes representing two percent of the proteome, which corresponds to more than 500
different protein kinases. Pseudo-kinases are presumed to account for ten percent of the kinases
encoded in the mammalian genome [216]. Protein kinases have evolved to work as highly dynamic
molecular switches in signalling networks to allow quick responses to specific cues, for example the
state of microtubule attachment to kinetochores.
Generally, protein kinases are thought to be maintained in a basal, inactive state and recruited only
transiently upon different stimuli. Structurally, kinase activation is often associated with the release
of an inhibitory domain allowing the dynamic assembly of hydrophobic regulatory spines (R-spines)
[217] as a distinctive structural feature in kinases that is a prerequisite for kinase activity [216].
Both Bub1 and BubR1 possess a C-terminal kinase domain, yet the extent of BubR1 kinase activity
is a matter of debate. It has been proposed previously that BubR1 kinase activity is required for SAC
function or initiation [150, 218, 219] as well as SAC silencing. BubR1 involvement in SAC silencing
was inferred from the inactivation of BubR1 kinase activity uponmicrotubule capture by the kinesin
CENP-E [218, 219]. Additionally, BubR1 activity was implied in regulating chromosome alignment
[213, 220, 221]. Other studies, however, demonstrated BubR1 kinase activity to be dispensable for
the spindle checkpoint and chromosome alignment [150, 153, 159, 196, 222, 223]. More recently, it
was proposed that BubR1 is an inactive pseudo-kinase whose kinase domain critically contributes
to the overall stability of the protein [196]. This may explain previous discrepancies, in particular be-
cause it was shown that pointmutations normally utilised to disrupt kinase activity largely decreased
the overall structural stability of BubR1 [196] and is also in line with the fact that in other organisms
as the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe BubR1/Mad3 lack a kinase
domain altogether.
Contrary to BubR1, Bub1 is a bona fide kinase [163, 214, 224]. Catalytically inactive Bub1 in mice
exhibits increased chromosome segregation errors and aneuploidy [225]. The catalytic activity of
Bub1 is believed to play a marginal role in the SAC [183, 204, 215, 226, 227, 228]. In contrast, Bub1
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kinase activity is required for chromosome alignment and congression [111, 176, 183, 215, 226, 228]
and was further shown to be important for error-correction [110, 225].
Two substrates of Bub1 activity aside fromBub1 itself have been identified in human cells, Cdc20 and
histone 2A (H2A) [111]. Cdc20 has been implied in the contribution to checkpoint-dependent inhibi-
tion of APC/C [163], the significance of this contribution remains yet to be confirmed. The role of the
phosphorylation on H2A has been studied more extensively. In mitosis, Bub1 phosphorylates T120
(S121 in yeast) on the C-terminal tail of H2A [110, 111, 229] promoting centromere accumulation of
shugoshin (Sgo) [163, 227, 229, 230, 231] and PP2A [232, 233], which is instrumental in maintaining
sister chromatid cohesion. Centromere-localised Sgo has been suggested to serve as an adaptor that
facilitates the centromeric accumulation of Aurora B [110, 111]. Bub1 activity thus contributes to the
Sgo-dependent recruitment of Aurora B kinase and also to the establishment and protection of cen-
tromeric cohesion [112, 225, 228, 234]. Aside from the function of Bub1 kinase activity, themolecular
mechanism of substrate binding and Bub1 substrate specificity also remain unknown.
Despite the key function of Bub1 kinase activity, it remains largely unclear how its activity is regu-
lated on a molecular level. Intra-molecular regulation by the N-terminal TPR domain (Figure 1.10)
was shown to contribute to kinase activation [208, 225] using material immuno-precipitated from
cells. This could not be confirmed by means of recombinant proteins in another study [224]. A
crystal structure of the Bub1 kinase domain (PDB ID 4R8Q) reveals an N-terminal extension of the
kinase wrapping around the N-lobe of the kinase domain in a cyclin-like manner, thus contributing
to structural integrity of the kinase and constitution of an intact R-spine. Consistently, this extension
is essential for kinase activity [214]. This crystal structure further demonstrates that the P+1 loop,
a short motif following the activation loop that contributes to substrate recognition, creates a steric
obstruction expected to prevent effective access of substrates to the active site [214]. The P+1 loop,
however, undergoes a profound rearrangement following auto-phosphorylation, ultimately relieving
the auto-inhibited conformation and activating Bub1 kinase [224] (PDB ID 4QPM). Conversely, there
is no evidence that phosphorylation of the activation loop plays a role in the case of Bub1, which is
crucial for the activation ofmany kinases [235, 236]. Very recently, evidence emerged that Bub1 auto-
phosphorylation outside the kinase domain may contribute to its own kinetochore turnover [237],
revealing an additional feature of kinase auto-regulation. A thorough characterisation of Bub1 ki-
nase activity elucidating regulatory intramolecular properties of Bub1 or revealing control by other
kinetochore proteins is missing so far.
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2 Scope of the thesis
Bub1 is one of the crucial mitotic checkpoint proteins that govern cell division. Understanding the
molecular regulation of Bub1 activity is of key importance to unravel the functional principles of
chromosome segregation in general. Elucidating the factors involved in the activation and regula-
tion of Bub1 upon kinetochore binding forms the major focus of this dissertation.
In this study, I set out to assess the mechanism of Bub1 regulation and thoroughly characterise
known interactions of Bub1 and BubR1 at the kinetochore and their implications for Bub1 kinase
activity in vitro. Towards this end, a combinatorial approach of biochemical and biophysical meth-
ods was used.
The Bub1:Bub3 and BubR1:Bub3 complexes were expressed and purified recombinantly in order to
reconstitute kinetochore protein complexes in vitro for biochemical and functional analysis. Fur-
thermore, Bub1 and BubR1 kinase domain were produced recombinantly to first allow the assess-
ment of BubR1 and Bub1 activity and subsequently the kinetic characterisation of Bub1 kinase ac-
tivity. Second, the use of X-ray crystallography allows structural analysis of the recombinant Bub1
kinase, which provides insight into the mechanisms and determinants involved in the regulation of
kinase activity. A variety of kinetochore proteins were tested for their potential as a Bub1 substrate.
The identified substrates were ultimately used for the determination of the Bub1 substrate speci-
ficity.
The results obtained by this thesis will advance the general understanding of the molecular regula-
tion of Bub1 kinase activity and the physical relevance of the Bub1:Bub3 and BubR1:Bub3 complex
at the kinetochore with regard to the recruitment of other checkpoint components during mitosis.
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3 Results and Discussion
3.1 Biochemical characterisation of Bub1 and BubR1 complexes
The introduction illustrated the current understanding of Bub1 and BubR1 function at the kineto-
chore and the spindle assembly checkpoint. In order to study Bub1 and BubR1 interactions and
function, I first set out to reconstitute these complexes in vitro.
3.1.1 Expression and purification of Bub1 and BubR1 constructs
Bub1 and BubR1 kinases have been suggested to have diverged from one progenitor gene into pro-
tein paralogs in a gene-duplication event. Both proteins independently underwent speciation and
individual sub-functionalisation [196, 197], still, both share a similar overall domain architecture
(Figure 3.1).
TPR WD KinaseBub3BD KinaseCDI   CDIIABBA KEN
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Figure 3.1: Domain architecture of Bub1, BubR1 and Bub3 proteins.
Domain positions and protein construct boundaries are indicated by residue number. TPR-tetratricopeptide
repeat, Bub3BD-Bub3 binding domain, ABBA-ABBA-motif, KEN-lysine-glutamate-asparagine motif, CDI/II-
conserved domain I/II, WD-tryptophan-aspartate.
The DNA sequences coding for full-length human Bub1 and BubR1 were cloned into custom pFH
insect cell vectors that code for a TEV-protease cleavable His6-tag to yield His6-tagged proteins (se-
quences can be found in the Appendix Section 6.10). Bub3 was cloned into a second expression
cassette on the vector, which allowed co-expression in one virus. It has previously been observed
that Bub1 constructs exceeding amino acid 284 tend to be unstable, therefore co-expression of Bub3
was used for the stabilisation of longer Bub1 constructs in vitro. In contrast, BubR1 could be stably
expressed and purified as a MBP-fusion without Bub3. Bub1 was also cloned into a pFG vector to
obtain glutathione-S-transferase (GST)-tagged Bub1, along with Bub3 in a second expression cas-
sette. The vector was recombined into a bacmid, then transfected in Sf9 insect cells where it was
amplified and subsequently used for protein expression in Sf9 or Tnao38 cells. Individual steps are
recapitulated in Sections 5.2.1 and 5.2.2.
Bub1 and BubR1 co-expressed with Bub3, henceforth termed Bub1:Bub3 and BubR1:Bub3, respec-
tively, were obtained in a three-step purification using Ni-affinity, anion exchange and size exclu-
sion chromatography, yielding both complexes in homogeneity (Figure 3.2, Section 5.2.2). GST-
Bub1:Bub3 was purified equivalently using GSH-affinity chromatography.
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Figure 3.2: Bub1:Bub3 and BubR1:Bub3 complexes can be purified to homogeneity.
Size exclusion chromatogramme of His6-Bub1:Bub3 and BubR1:Bub3 from a S200 10 300 column; a molecular
weight standard is indicated in grey; green-Bub1:Bub3, blue-BubR1:Bub3. Below, SDS PAGE analysis of the
fractions indicated by a dashed line in the chromatogramme. Right, the pooled fractions of the peaks indicated
by a solid bar on the SDS PAGE gels below are analysed by SDS PAGE and Coomassie blue staining.
Both complexes exhibit nearly identical behaviour during purification and elute from gel filtration
chromatography as single peaks that run at a molecular weight larger than their theoretical size.
A point mutant of Bub1, D917N, that abrogates kinase activity has been constructed and purified
in the same way. Bub1 D917N exhibits the same behaviour in purification while the mutation of
K821R, that is also supposed to abolish kinase activity, was found to be expressed but is unstable in
the course of purification. The typical yield for Bub1:Bub3 or BubR1:Bub3 complexes range from
0.5-1.5 mg per 1 l insect cell culture.
3.1.2 Bub1:Bub3 and BubR1:Bub3 form a complex and bind Knl1 in gel filtration
Bub1:Bub3 and BubR1:Bub3 complexes elute at higher molecular weight from gel filtration than
expected from their theoretical mass, suggesting non-globular shapes, additional oligomerisation,
or both. To investigate the effective state of the complexes, analytical ultracentrifugation exper-
iments were performed. This method allows determination of the molecular weight and shape,
hence the identification of the protein complex stoichiometry, derived from sedimentation veloci-
ties. Bub1:Bub3 and BubR1:Bub3 present nearly identical behaviour in sedimentation and the analy-
sis of the sedimentation distribution curves c(S) concludes one predominant species. The calculated
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molecular weights for the Bub1:Bub3 complex (150 kDa) and the BubR1:Bub3 complex (144 kDa)
from the sedimentation analysis identified themas heterodimers (Figure 3.3 andAppendix Figure 6.1).
The frictional ratio of 2.2 for both complexes is indicative of highly elongated structures, thus ex-
plaining the high apparent molecular weight in size exclusion chromatography.
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Figure 3.3: Sedimentation velocity analytical ul-
tracentrifugation of Bub1:Bub3 and BubR1:Bub3.
Normalised c(s) distribution curves for Bub1:Bub3
(green) and BubR1:Bub3 (blue). A predominant
peak at 4.7 S20,w is apparent for Bub1:Bub3 and at
4.5 S20,w for BubR1:Bub3, indicating one dominant
sedimenting species that corresponds to a theoret-
ical molecular weight of 150 kDa and 144 kDa, re-
spectively, the theoretical mass of a 1:1 complex is
indicated for both in parentheses. Frictional ratios
were determined as 2.16 for Bub1:Bub3 and 2.21 for
BubR1:Bub3.
The direct interaction of Bub1 and BubR1 was suggested previously [206] and was more recently es-
tablished and characterised [179, 180]. The complex of Bub1:Bub3 binds to the kinetochore protein
Knl1, an interaction that is mediated by Bub3 binding to a phosphorylatedMELT-motif on Knl1 [172,
173, 174, 175]. Bub1 contributes to this interaction by a short loop motif, whereas the same motif
in BubR1 does not confer any binding affinity towards a phosphorylatedMELT-motif. Therefore, the
recruitment of BubR1:Bub3 may be directly mediated by dimerising with Bub1:Bub3 [175, 179].
In an effort to recapitulate these interactions in vitro, I set out to reconstitute the complex using full-
length proteins. Indeed, Bub1:Bub3 and BubR1:Bub3 form a stable and homogenous complex in gel
filtration as apparent from the peak shift and co-migrating bands on a SDS PAGE gel (Figure 3.4). The
addition of MBP-Knl1138°225, a fragment of Knl1 that corresponds to the first MELT-motif as well as
the KI1 and KI2 motifs (Figure 3.8), pre-phosphorylated by Mps1, produces an additional peak shift
of the complex (Figure 3.4). The binding of MBP-Knl1138°225 also leads to a noticeable compaction
of the peak (purple) in contrast to the corresponding peak of Bub1:Bub3-BubR1:Bub3 (black). SDS
PAGE analysis of the peak fractions demonstrates that MBP-Knl1138°225 is a stoichiometric compo-
nent of the complex. In summary, these results lend strong support to a model in which Bub1:Bub3
is able to interact concomitantly with phosphorylated Knl1 and BubR1:Bub3 at the kinetochore.
The complex ofMBP-Knl1138°225-Bub1:Bub3-BubR1:Bub3 has a theoretical size of 375 kDa. It is con-
ceivable that the conformation is rather stable, as Bub1 and BubR1 bind each other directly. Bub1
and BubR1 are also each both bound to Bub3, the protein which tethers Bub1 to Knl1. The TPR
domains of BubR1 and Bub1 likely also interact with the respective KI2 and KI1 motifs on Knl1, per-
haps strengthening the overall interaction. Unfortunately, attempts to crystallise this complex failed
(summarised in Table 5.12), therefore I undertook initial attempts to characterise this complex by
electronmicroscopy (EM). On EM grids, the complex is prone to disassembly and showsmany small
and heterogeneous species in negative stain EM. In preliminary tests, to circumvent the complex
disassembly and to favour compact structures, the complex could be stabilised by complex cross-
linking using glutaraldehyde in a glycerol gradient (GraFix).
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Figure 3.4: Assembly of a Bub1:Bub3-BubR1:Bub3 complex onto Knl1 in gel filtration.
Bub1:Bub3 (green) and BubR1:Bub3 (blue) form a stable complex in size exclusion chromatography (black)
and can be assembled as a complex onto phosphorylated MBP-Knl1138°225 (purple) on a S6 10 300 column. A
marker run on this S6 10 300 column is shown as a dashed grey line. A bar of the respective colour indicates
fractions of the formed complexes analysed by SDS PAGE and Coomassie blue staining (right).
Concurrently, in order to determine the stability of the MBP-Knl1138°225-Bub1:Bub3-BubR1:Bub3
complex and obtain information regarding a complex suitable for structural studies, a limited prote-
olysis experiment was performed (Figure 3.5). MBP-Knl1138°225-Bub1:Bub3-BubR1:Bub3 proved to
be resilient to low concentrations of proteases (1:100). Upon incubation with higher concentrations
of proteases, Bub1 and BubR1 are proteolysed, whereas Bub3 as well as Knl1, remain largely intact.
This indicated that the Bub3 molecules and Knl1 may be organised in the centre of the complex or
are otherwise shielded from proteolysis. Primarily the N-termini of Bub1 and BubR1 (Figure 3.1) are
involved in complex assembly, whereas large parts towards the C-termini of Bub1 and BubR1 are
probably rather flexible and prone to be proteolysed.
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buffer and analysed by SDS PAGE stained with Coomassie blue.
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Efforts to obtain structural insight into the overall organisation of this complex by EM are still ongo-
ing, combined with the strategy to identify stable constructs suitable for crystallisation.
3.1.3 Bub1 assembles theMCC in vitro
Following the successful formation of the full-length Bub1:Bub3-BubR1:Bub3 complex on phospho-
rylated Knl1 (Section 3.1.2), we wondered whether this complex was the basis for the assembly of the
mitotic checkpoint complex MCC that in addition to BubR1 and Bub3 consists of Cdc20 and Mad2.
Both Bub1 and BubR1 possess KEN boxes and ABBA motifs (Figure 3.1) that confer Cdc20 binding
[134, 139, 200, 201].
In order to test the assembly of the MCC on the Bub1:Bub3-BubR1:Bub3 complex, a pull-down as-
say using GST-Cdc20 as bait was implemented. GST-Cdc20 was incubated with Bub1:Bub3 and/or
BubR1:Bub3 (Figure 3.6), the binding of the prey was assessed by SDS PAGE (Figure 3.6).
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It is evident that GST-Cdc20 is able to pull down both Bub1:Bub3 and BubR1:Bub3 complexes indi-
vidually. While GST-Cdc20-Bub1:Bub3 seems to be a stoichiometric and tight complex, the binding
of GST-Cdc20 to BubR1:Bub3 seems to be less tight and substoichiometric. Importantly, Bub1:Bub3
binding to Cdc20 does not compete with complex formation of BubR1:Bub3-Cdc20 or binding of
Bub1:Bub3 to BubR1:Bub3 as they associate into a 5-subunit complex (Figure 3.6). This suggests
that Bub1 might be the initial receptor for Cdc20 binding and also for assembly of a Bub1:Bub3-
BubR1:Bub3-Cdc20 complex as a precursor-MCC.
Given that Bub1:Bub3-BubR1:Bub3-Cdc20 is a stable complex, I opted to establish how the com-
plex is organised on a molecular level. Since Bub1:Bub3 appeared to bind Cdc20 stoichiometrically
compared to substoichiometric binding of BubR1:Bub3 to Cdc20 (Figure 3.6), I usedmutants in both
Bub1 KENboxes (KEN to AAA), in combinationwith amutation in the ABBAmotif (FHVF to AHVA) in
a GST-Cdc20 pull-down to assess which sites were required for efficient Cdc20 binding (Figure 3.7).
Bub1:Bub3 bound GST-Cdc20 in a stoichiometric complex as also shown in Figure 3.6. In con-
trast, both KEN1 and ABBA mutants show reduced binding to GST-Cdc20 as compared to wild-type
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Figure 3.7: Mutation of the ABBA and KENmotifs of Bub1 affect Cdc20 binding.
Top, domain organisation of Bub1 with detailed view of the sequence of ABBA and KEN motifs and the mu-
tations used in the particular motif. Below, affinity-purified Bub1:Bub3 constructs were used as prey for GST-
Cdc20 immobilised on GSH affinity resin, GST was used as a negative control; protein input and bound com-
plexes were analysed by SDS PAGE and Coomassie blue staining. KEN and ABBA refer to mutations in the
respective motifs as indicated in the schematic drawing above; WT-wild-type.
Bub1:Bub3, whereas mutating KEN2 barely affected GST-Cdc20 binding. Additionally, the combi-
nation of ABBA and KEN1 mutations led to a further, more drastic reduction of Cdc20 binding. A
stronger reduction of Cdc20 binding could also be observed with a KEN1/KEN2 double mutant, yet
to a lesser extent. Likely, KEN1 and the preceding ABBA-motif represent a major binding site for
Cdc20 although KEN2 also retains binding affinity or contributes to Cdc20 binding. It is therefore
conceivable that Bub1 recruits Cdc20 via its ABBA-KEN1 motif, bringing Cdc20 into close proximity
with BubR1:Bub3, which is also bound to Bub1, thus serving as a platform to build the MCC.
In order to deconvolute the organisation of the complex, I sought to investigate the interactions
within the Bub1:Bub3-BubR1:Bub3-Cdc20 complex in more detail. To this end, the Bub1:Bub3-
BubR1:Bub3-GST-Cdc20 complex was assembled onto MBP-Knl1138°225, phosphorylated by Mps1.
This assembly was subsequently subjected to cross-linking by disuccinimidyl suberate (DSS), a com-
pound that covalently cross-links primary amines of lysine side chains within the vicinity of approx-
imately 11 Å of each other. The cross-linked complex was proteolytically digested and analysed by
mass spectrometry to determine sites of protein interaction (Figure 3.8). A comprehensive list of all
identified cross-linked peptides can be found in the Appendix Tables 6.3 and 6.4.
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Figure 3.8: Cross-linking analysis of a Knl1138°225-Bub1:Bub3-BubR1:Bub3-Cdc20 complex.
Left, the Knl1138°225-Bub1:Bub3-BubR1:Bub3-Cdc20 complex was purified on a S6 10 300 column, pooled and
analysed by SDS PAGE and Coomassie blue staining. Right, visualisation of complex interactions after cross-
linking with DSS, proteolytic digest and analysis of resulting peptides by mass spectroscopy. Intramolecular
cross-links are depicted in red, intermolecular cross-links in blue; the residue numbers of the constructs are
indicated on the outer circle. The GST-/MBP-tag of Cdc20 (yellow) or Knl1 (purple) are represented in a lighter
shade of yellow and purple, respectively. Note that Bub1 (green) and BubR1 (blue) both bind Bub3 and that the
central Bub3 (grey) in the schememost likely represents twomolecules of Bub3.
As Bub1 andBubR1were both found to be bound to Bub3 in the Bub1:Bub3-BubR1:Bub3-GST-Cdc20
complex, in all likelihood the complex contains two molecules of Bub3. These two distinct Bub3
molecules are indistinguishable by cross-linking and thus are represented as one Bub3 in Figure 3.8.
Bub3 appears to be a central component that establishes contacts to all other proteins in the com-
plex. The main interactors of Bub3 are the N-termini of Bub1 and BubR1, which share cross-links
with Bub3. The sites of interaction on Bub1 and BubR1 are distributed around the Bub3-binding site
of Bub1 (residues 235-255) and BubR1 (residues 395-405). This site on Bub1 and BubR1 is immedi-
ately followed by a region of direct interaction between Bub1 and BubR1, which is in perfect agree-
ment with our recent definition of a minimal Bub1:Bub3-BubR1:Bub3 interaction site [179]. This
Bub1-BubR1 binding site analysis allows to define the region of interaction more closely to residues
280-330 for Bub1 and 430-480 for BubR1. Cross-links appear exclusively in the N-terminal half of
Bub1 and BubR1. Interaction of their TPR domains with Knl1 can only be observed for BubR1, not
Bub1. Cdc20 appears to be tethered to the complex by the Bub1:Bub3 complex, as also alluded to
in the previous paragraphs and Figures 3.6 and 3.7. The identified interaction by cross-link here
suggests that the N-terminus of Cdc20 (before the start of the propeller) contacts Bub1 in the same
region where also Bub3 and BubR1 bind to Bub1. This could in turn also account for the observed
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cross-link between Cdc20 and Bub3 as well as be the basis for Cdc20 delivery to BubR1, as this is a
site of close contact for all three proteins, Bub1, BubR1 and Cdc20.
It should be noted that the absence of cross-links does not signify lack of interaction. In the case
of MBP-Knl1138°225, the presence of intramolecular cross-links between Knl1138°225 and the MBP-
tag might indicate that the MBP-tag partly shields the Knl1 fragment from binding other proteins,
particularly the TPR domains of Bub1 or BubR1. Conversely, an interaction present in the complex
but not visible by cross-linking might be restricting access of the cross-linking agent DSS.
Taken together, we conclude that the ABBA-KEN1 motif is required for Bub1-Cdc20 interaction, as
shown in Figure 3.7. Additionally, cross-linking analysis suggests that theN-terminus of Cdc20might
also engage in contacting Bub1. This is intriguing for two reasons: First, the identified Bub1-Cdc20
cross-link is located in a region immediately preceding the Cdc20-Mad2 interaction site, which puts
yet another MCC component (besides Bub3 and BubR1) at the same site of interaction. Second, the
N-terminus of Cdc20 has also been reported to be phosphorylated by Bub1 [163]. The direct interac-
tion of Bub1-Cdc20 nowplaces theN-terminus of Cdc20 in direct reach of the kinase activity of Bub1.
TheMBP-Knl1138°225-Bub1:Bub3-BubR1:Bub3-GST-Cdc20 complex is the basis of howwe could en-
vision themitotic effector complex to be formed. The prevailing question that arises is how theMCC
complex is then released from kinetochore-bound Bub1 to bind and inhibit the APC/C.
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Figure 3.9: Formation of a solubleMCC complex.
(A) The complex of GST-Bub1:Bub3-Cdc20 is preformed and bound to beads. Addition of increasing amounts
of BubR11°571:Bub3 leads to a stoichiometric bound complex, with only the excess of BubR11°571:Bub3 in the
soluble fractions. (B) The complex of GST-Bub1:Bub3-BubR11°571:Bub3-Cdc20 binds Mad2, using an excess
of Mad2 leads to the solubilisation of MCC components. GSH-beads without bait were used as a control for
unspecific binding. Soluble fractions and fractions bound to beads were analysed by SDS PAGE and Coomassie
blue staining.
In a pull-down assay using GST-Bub1:Bub3 as prey, Cdc20 and BubR11°571:Bub3 form a complex
on GST-Bub1:Bub3 (Figure 3.9 A). The complex cannot be displaced from Bub1 and solubilised by
adding an excess of BubR11°571:Bub3, as revealed by the SDS PAGE analysis. Only BubR11°571:Bub3,
which is added in excess, is present in the soluble (UNB in Figure 3.9 A) fractions. These data sug-
gest that BubR1:Bub3 addition to a GST-Bub1:Bub3-Cdc20 complex is not sufficient for the release
of Cdc20-BubR1:Bub3 from the complex on Bub1.
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Since BubR1:Bub3 is incapable of competing Cdc20 off Bub1, we reasoned thatMad2, as fourthMCC
component, could be the releasing factor. By using the same setup as in Figure 3.9 A, we assem-
bled Cdc20 and BubR11°571:Bub3 on GST-Bub1:Bub3 and then titratedMad2 onto the complex (Fig-
ure 3.9 B). In the GST-Bub1:Bub3-bound fractions, we identify the components of theMCC bound to
Bub1. Upon the addition of increasing concentrations of Mad2, a soluble pool (UNB in Figure 3.9 B)
of MCC protens is detectable, which is reflected in the decrease of bound BubR11°571. However, the
quantity of Mad2 required to produce soluble MCC amounts to a 20-fold excess over the other MCC
components (Figure 3.9). The fact that themajority of theMCCproteins is still bound to Bub1 argues
that other release factors are still missing. A possible contributor facilitatingMCC formation and not
being part of the experimental setup used above is Mad1, an essential protein of the checkpoint
response [125, 238, 154]. Furthermore, a secondmolecule of Cdc20might be essential for the forma-
tion of the MCC, or more specifically, the release of Cdc20 from Bub1, as it could compete for Bub1
binding resulting in the liberation of a BubR1-Cdc20 complex. Another alternative for catalysing
the formation of the MCC could be the kinase activity of Bub1, whose contribution to checkpoint
signalling remains doubtful and debatable, but was nevertheless also claimed to be of importance
[163, 214]. Cdc20 has been reported to be phosphorylated by Bub1, resulting in the inhibition of the
APC/CCdc20[163]. Also Bub1 itself is a substrate for Bub1 kinase activity, although the effect of these
autophosphorylations remains uncertain.
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3.2 Biochemical characterisation of Bub1 and BubR1 kinase activity
It was alluded to in the introduction that the extent and role of Bub1 as well as BubR1 kinase activity
remains ambiguous. In order to address this controversial issue, I set out to methodically estab-
lish and characterise the degree of Bub1 and BubR1 kinase activity in vitro. Various BubR1 kinase
domain constructs were generated, in order to answer the prevailing question. In the following,
the most commonly used BubR1 construct encompassing residues 705-1050 will be referred to as
BubR1kinase. The corresponding construct of Bub1 kinase domain containing amino acids 725-1085
will be named Bub1kinase for ease of reference (Figure 3.10 A).
3.2.1 Expression and purification of Bub1 and BubR1 kinase constructs
BubR1kinasewas cloned into a pFH vector, expressed and purified as described in Sections 5.2.1 and
5.2.2; along with Bub1kinase, which was already available in a pFG vector. Both constructs were pu-
rified by affinity chromatography (Ni2+ for BubR1kinase, GSH for Bub1kinase), followed by anion ex-
change (Bub1kinase was collected as a practically pure protein from the flow-through) and size exclu-
sion chromatography. The proteins were pooled after size exclusion chromatography, as depicted in
Figure 3.10 B and C.
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Figure 3.10: Bub1 kinase and BubR1 pseudo-kinase are purified to homogeneity.
(A) Bub1 and BubR1 kinase domain organisation with indicated construct boundaries. (B) Purified Bub1kinase
and BubR1kinase were separated by SDS-PAGE and analysed by Coomassie blue staining. Their respective sizes
are indicated on the right. (C) Bub1kinase (yellow) and BubR1kinase (orange) elute as pure and globular proteins
in size exclusion chromatography. Pooled fractions are indicated by a bar of the respective colour. A molecular
weight standard is given in grey.
BubR1kinase and Bub1kinase eluted as globular proteins from gel filtration, as monomers of around
40 kDa. SDS PAGE analysis reveals the homogeneity of the final protein pools (Figure 3.10 B). As an
initial indication for kinase activity, Bub1kinase and BubR1kinase were assessed with regard to their
potential to undergo autophosphorylation. Therefore, Bub1kinase and BubR1kinase were incubated
with ATP andMgCl2, any change in mass after the reaction was analysed by ESI-MS (Figure 3.11).
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Figure 3.11: ESI-MS of Bub1kinase and BubR1kinase.
Themass of BubR1kinase before and after incubation with ATP reflects its theoretical unmodifiedmass 40.6 kDa
(upper and lower right) whereas Bub1kinase autophosphorylates in the presence of ATP (upper and lower left).
The theoretical weight is given in parentheses.
BubR1kinase does not autophosphorylate, as demonstrated by its mass, being the theoretical size of
approximately 40611 Da, irrespective of the presence or absence of ATP. In contrast, an evident in-
crease in mass could be observed for Bub1kinase, from 41789 Da to 41870 Da upon incubation with
ATP. The shift of the peak to a higher mass corresponds to the addition of one phosphate (80 Da)
shown in Figure 3.11. A small fraction of Bub1kinase remained unphosphorylated, which is apparent
from the small persisting peak at 41789 Da. Furthermore, the sample contains a small but signifi-
cantly larger species of Bub1 (41901 Da), which correlates with other autophosphorylation products.
This observation leads to the elementary conclusion that while Bub1kinase is able to autophosphory-
late, BubR1kinase is not.
3.2.2 Nucleotide binding of Bub1kinase and BubR1kinase in vitro
I next asked whether the absence of autophosphorylation of BubR1kinase, as opposed to Bub1kinase,
reflected a lack of nucleotide binding ability of BubR1kinase. To address this question I took advantage
of fluorescent properties of mant-ATP [239] a nucleotide-analog whose emission at 450 nm changes
upon alteration of the fluorophore environment (as the incorporation into the kinase active site).
I performed a titration experimentwhere I titratedmant-ATPup to 1mM, then added 1 µMBub1kinase
or BubR1kinase to all conditions. The resulting change in fluorescence of free mant-ATP to bound
mant-ATP-kinase complex is plotted against total mant-ATP concentration (Figure 3.12).
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In this setting, BubR1kinase exhibited the same degree of mant-ATP binding as Bub1kinase, with KD
in the range of 300-400 µM. This indicates that BubR1kinase, despite the lack of kinase activity, is still
able to bind nucleotides (Figure 3.12).
0 200 400 600 800 1000
0
2
4
6
8
10
12
14
flu
or
es
ce
nc
e 
45
0 
nm
 (a
.u
.)
PDQW$73ȖS (µM)
     K    = 297 µM  ± 25
     K    = 431 µM  ± 41
D
DBubR1kinase
Bub1kinase
Figure 3.12: Bub1kinase and BubR1kinase are
mant-nucleotide-binding proteins.
Fluorescence emission (excitation: 340 nm) of
Bub1kinase (yellow) or BubR1kinase (orange) and
mant-ATP alone were subtracted from the emis-
sion of Bub1kinase/BubR1kinase with mant-ATP.
The change in fluorescence emission at 450
nm was plotted as a function of total mant-
ATP concentration (1˜-1000 µM) using 1 µM
Bub1kinase/BubR1kinase in all measurements. The
data were fitted with a one-site binding equation
using Origin 9.0 to obtain a KD of 297 µM for
Bub1kinase and 431 µM for BubR1kinase.
The relatively low affinity of BubR1kinase and Bub1kinase for mant-ATP, in comparison to previous
measurements with other kinases (for example reference [240]), could reflect an unfavourable inter-
action of the mant group with the kinase scaffold, thereby reducing the overall binding affinity for
themodified nucleotide. Nevertheless, I could verify thatmant-ATP is a substrate of Bub1 (Appendix
Figure 6.3), therefore the similarity of binding affinity for Bub1kinase and BubR1kinase suggests that
they are both competent to bind nucleotides.
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Figure 3.13: Nucleotide-binding of Bub1kinase and BubR1kinase is specific.
Titration of mant-ATP to Bub1kinase (yellow) or BubR1kinase (orange) as in Figure 3.12, (left). After achieving
maximal binding of mant-ATP (1 mM), an ATP analog, AppCp, was added at the indicated concentrations, re-
sulting in dose-dependent reduction of themant-ATP fluorescence signal (right). (excitation: 340 nm, emission:
450 nm)
To further confirm the specificity of nucleotide-binding and exclude unspecific binding ofmant-ATP,
I performed a competition experiment by titrating an unlabeled uncleavable ATP analog, AppCp,
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onto the putative complex of Bub1kinase-mant-ATP, or BubR1kinase-mant-ATP, respectively. Upon in-
creasing concentrations of AppCp, the fluorescence signal of bound mant-ATP dropped in a dose-
dependent manner, which is consistent with mant-ATP being replaced by AppCp in the active site
(Figure 3.13). Thus, this experiment confirms that mant-ATP specifically binds to the ATP-binding
site of both kinases.
3.2.3 BubR1 is an inactive pseudo-kinase
Given that BubR1kinaseproved capable of nucleotide binding, I wanted to investigate whether it was
also able to phosphorylate protein substrates. The kinase activity of BubR1kinase and full-length
BubR1:Bub3 was tested onMBP, histone H1 and the Borealin:Survivin complex, all of which are pro-
teins that are used as surrogate kinase substrates for lack of known and establishedBubR1 substrates.
The phosphorylation reactionswere then analysed by SDS PAGE and phosphostaining using the Pro-
Q® Diamond Phosphoprotein Gel Stain (Figure 3.14).
Figure 3.14: BubR1 is not an active
kinase.
Maltose binding protein (MBP),
histone H1 and Borealin/Survivin
were incubated with 50 nM BubR1
constructs and ATP, then analysed
by SDS PAGE and Coomassie blue
staining (below). Phosphates were
visualised using the Pro-Q®Diamond
Phosphoprotein Gel Stain (above).
10 nM Bub1:Bub3 was used as
a positive control. BR1–BubR1,
BR1B3–BubR1:Bub3, M–protein
marker.
BR
1K
ina
se
MBP H1 Borealin/Survivin
BR
1B
3
ProQ Diamond Phosphostain
25
37
50
75
100
150
25
37
50
75
100
150
MBP (40.6 kDa)
Bub3 (37.2 kDa)
BubR1Kinase (40.6 kDa)
H1 (31 kDa)
Borealin (31.3 kDa)
MBP (40.6 kDa)
Bub3 (37.2 kDa)
BubR1Kinase (40.6 kDa)
H1 (31 kDa)
Borealin (31.3 kDa)
-  +  -  -  +  -  -  +  -  -  BubR1Kinase
-  -  +  -  -  +  -  -  +  -  BubR1:Bub3
-  -  -  -  -  -  -  -  -  +  Bub1:Bub3
Coomassie
MW
(kDa)
M
BubR1 failed to hydrolyse nucleotides or phosphorylate MBP, histone H1 or Borealin in this assay.
In contrast, Bub1 successfully phosphorylated Borealin at five-fold lower kinase-to-substrate ratio
(Figure 3.14, last lane). Presumably, the BubR1 kinase domain containing the formerly functionally
relevant residues was preserved due to structural reasons [196]. Protein stability is a particularly
plausible argument with regard to our finding that Bub1 protein stability depends upon the integrity
of the kinase as well, as seen in a disruptive K821R kinase mutant. The ability of BubR1 to still bind
nucleotides might have a similar stabilising purpose. We cannot entirely exclude that there are sub-
strates actually phosphorylated by BubR1, or that there is a missing factor required for activating
BubR1, a role that has been suggested for CENP-E [218, 219]. However, our findings in combination
with the fact that the catalyticmotifs in BubR1 are divergent from the kinase consensus [196] provide
compelling evidence that although Bub1kinase and BubR1kinase are both ATP-binding proteins, only
Bub1kinase is an active, phosphorylating enzyme. BubR1 will therefore in the following be regarded
and depicted as a pseudo-kinase.
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3.2.4 Kinetic characterisation of Bub1 kinase activity
Bub1 is known to be an active kinase, as confirmed in the preceding section. However, a comprehen-
sive characterisation and determination of regulating factors of Bub1 kinase activity are still missing.
In order to quantify kinase activity in more detail, I used the ADP-GloTM Kinase Assay. This assay
detects ADP generated in a phosphorylation reaction, which is linearly correlated with a lumines-
cent signal created in a subsequent reaction. This relation thus permits the quantification of kinase
activity, the plot of an ADP-standard is shown in Figure 6.2 (Appendix). The detailed protocol can be
found in Section 5.2.4, the working principle of the assay is schematically depicted in Figure 5.1.
Bub1 activity is not regulated by Bub1 domains outside the kinase domain
To date, the role of molecular regulation of Bub1 by intrinsic (intramolecular domains, autophos-
phorylation) and extrinsic (binding proteins, phosphatases) factors remains unclear. TheN-terminal
TPR domain (Figure 3.1) has previously been shown to have an essential role in sustaining kinase ac-
tivity, as determined in kinase assays performed with immuno-precipitates fromHeLa cells or MEFs
[208, 225]. This could not be confirmed in vitro [224], using recombinant Bub1 with a deleted TPR
domain and full-lengthBub1. To address this discrepancy, bothBub1kinase and full-lengthBub1:Bub3
were tested for their ability to phosphorylate H2A or Borealin (Figure 3.15 A-B) and assessed for their
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Figure 3.15: Kinetic characterisation of Bub1 complexes.
(A-C) Bub1kinase and Bub1:Bub3 (each 10 nM) exhibit the same catalytic activity towards H2A (A) and Borealin
(B), both also hydrolyse ATP at the same rate (C). Themutation D917N abrogates ATPase activity, H2A was used
as a substrate; KD-kinase dead. (C). The kinase activity was determined using the ADP-GloTM Kinase Assay and
is plotted as a function of substrate concentration to allow fitting with the Michaelis-Menten equation using
Origin 9.0 with R2=0.99 (Bub1kinase on Borealin/Survivin (B/S) R2=0.97). Error bars are SD of a mean of at least
two independent experiments. (D) Kinetic parameters of the Michaelis-Menten fits as determined in (A-C).
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potential in ATP hydrolysis (Figure 3.15 C) by the ADP-GloTM Kinase Assay. The initial reaction ve-
locities were obtained from the amount of ADP generated in a time-course of the phosphorylation
reaction and they are shown as a function of substrate concentration in Figure 3.15. The data were
fitted using Origin 9.0 (OriginLab Corp., Northampton, USA) and bymeans of theMichaelis-Menten
equation described in Equation 5.1.
We find that Bub1kinase and Bub1:Bub3 are equally able to phosphorylate H2A and Borealin effi-
ciently using substoichiometric amounts of kinase (Figure 3.15 A-B). Furthermore, the rate of ATP-
hydrolysis of Bub1kinase and Bub1:Bub3 is equivalent. Kinase activity can be specifically and effi-
ciently inhibited bymutating the catalytic aspartate (D917) in Bub1kinase and the full-length protein.
Both, Bub1kinase and Bub1:Bub3 showed very similar catalytic properties in terms of KM and kcat/KM
values that are measures of substrate affinity and efficiency of phosphorylation, respectively (Fig-
ure 3.15 D). The lack of any striking difference argues that Bub1 activity is not regulated intramolec-
ularly or by Bub3. Of note, with reference to the KM value and the catalytic efficiency (kcat/KM),
H2A is found to be a worse substrate for Bub1 than Borealin. Although the maximal velocity of the
reaction and therefore kcat is rather high, the overall efficiency is lowered due to a low KM for H2A.
Bub1 binding to nucleosomes enhances its affinity towards H2A
We were surprised to see that Borealin seemed to be a better substrate than H2A in vitro. We
wondered whether Bub1 activity could be directed on a level of substrate specificity and asked if
phosphorylation of nucleosomes rather than H2A alone was a more efficient process. For this pur-
pose, I incubated reconstituted nucleosomes containing either histone H3 or its centromere variant
CENP-A with Bub1:Bub3 or Bub1kinase. Phosphorylation was assessed by SDS PAGE using the Pro-
Q® Diamond Phosphoprotein Gel Stain (Figure 3.16 A).
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Figure 3.16: Bub1 does not discriminate between H2A incorporated in H3- or CENP-A nucleosomes.
(A) H2A or H2A contained in H3- or CENP-A nucleosomes is efficiently phosphorylated by Bub1kinase kinase
domain and Bub1:Bub3 full-length complex (each 10 nM). Kinase reactions were analysed by SDS PAGE and
Coomassie blue staining (right), phosphates were visualised using the Pro-Q® Diamond Phosphoprotein Gel
Stain (left). Note that DNA is also stained by this compound. (B) The kinase activity of 10 nM Bub1:Bub3, is
plotted as a function of substrate concentration that allows fitting with the Michaelis-Menten equation using
Origin 9.0 with R2=0.95 (H3) and 0.99 (CENP-A). Error bars represent SD of a mean of at least two independent
experiments. (C) Kinetic parameters of the Michaelis-Menten fits obtained in (B).
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We observe that H2A is efficiently phosphorylated by Bub1kinase and Bub1:Bub3 regardless of its in-
corporation into nucleosomes. Conversely, a subtle differencemanifests when comparing the kinet-
ics of the phosphorylation of H2A contained in nucleosomes to free H2A as measured by the ADP-
GloTM Kinase Assay. The KM of the reaction (a measure of substrate affinity) improves to 5-10 µM as
compared to 30 µM for H2A, which leads to a four-fold enhanced overall catalytic efficiency kcat/KM
(Figure 3.16 C, 3.15 D). The increase in catalytic efficiency argues that nucleosomes are a better sub-
strate for Bub1 than H2A alone. This might suggest that H2A by itself lacks features implicated in
recognition by Bub1 and that the phosphorylation of H2A could be enhanced by nucleosome bind-
ing of Bub1.
The notion that Bub1 directly binds to nucleosomes was tested in an electrophoretic mobility shift
assay (EMSA). Both, autophosphorylated and dephosphorylated Bub1kinase were compared in their
ability to bind to CENP-A- or H3-nucleosomes, or free DNA. Upon mixing Bub1kinase with nucle-
osomes, I observe a band shift to higher molecular weight with increasing amounts of Bub1kinase,
indicating complex formation.
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Figure 3.17: Bub1kinase binding to H3- and CENP-A containing nucleosomes.
EMSA showing DNA and nucleosome binding of Bub1kinase and H3- or CENP-A nucleosomes. The right lane of
each agarose gel shows a DNA ladder as reference.
We note that Bub1kinase binds both CENP-A- and H3-nucleosomes with similar apparent affinity
(Figure 3.17), which is consistent with Bub1 phosphorylating H2A in both CENP-A- and H3 contain-
ing nucleosomes (Figure 3.16). Furthermore, binding of nucleosomes was found to be independent
of the phosphorylation status of Bub1kinase as shown in Appendix Figure 6.4. However, Bub1kinase
also readily binds to DNA at least in this experimental setting (Figure 3.17), providing a potential ex-
planation for improved binding of Bub1 to nucleosomes as compared to free H2A (Figure 3.15 and
3.16).
Bub1 activity is not regulated by extrinsic factors
Having established that Bub1 kinase activity is not regulated by other domains within Bub1, we
wondered whether there were other extrinsic factors modulating kinase activity. We successfully ex-
pressed and purified Bub1:Bub3 and BubR1:Bub3 complexes recombinantly (as described in Sec-
tion 3.1.1 and 3.1.2). The reconstitution of different Bub1 complexes allowed us to test whether
BubR1 or addition of Knl1 would alter kinase activity of Bub1 as measured by the ADP-GloTM As-
say (Figure 3.18).
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Figure 3.18: Complexes of Bub1 exhibit the same kinase activity toward a GST-H2A substrate.
The kinase activity is plotted as a function of substrate concentration to allow fitting with theMichaelis-Menten
equation using Origin 9.0 with R2=0.99. Error bars represent SD of a mean of at least two independent exper-
iments. (D) Kinetic parameters of the Michaelis-Menten fits as determined in (C). a.u.-arbitrary units. 10 nM
kinase complex was consistently used in all experiments.
Kinase activity was tested against the H2A tail-peptide as substrate, using full-length H2A with the
ADP-GloTM Kinase Assay yielded similar results (Appendix Figure 6.5, 3.15). We could not detect
any effect on Bub1 activity upon formation of the Bub1:Bub3-BubR1:Bub3 complex, with or without
Knl1, which is also largely consistent with previous findings [224]. Collectively, our results argue that
Bub1 kinase activity is not regulated by extrinsic factors, neither on an intra- nor intermolecular level.
3.2.5 Bub1 is an autophosphorylated kinase
It has been suggested recently that Bub1 undergoes autophosphorylation and thereby regulates its
own activity [224]. When incubated with 1 mM ATP for 16 hours, Bub1kinase indeed autophospho-
rylates (Figure 3.11 and 3.19 A) and LC-MS/MS confirmed S969 on the substrate binding loop (P+1
loop) to be the phosphorylated residue. We then asked if phosphorylation of S969 was a prerequisite
for kinase activity. To this end, we created alanine (S969A), glutamate (S969E) and aspartate (S969D)
mutants of S969 in Bub1kinase (Figure 3.19 B and C).
After incubation with ATP and subsequent SDS PAGE analysis, no phosphorylation-dependent shift
could be detected for the Bub1kinase mutations or dephosphorylated Bub1kinase. Importantly how-
ever, a phosphorylation-dependent shift is clearly discernible forwild-typeBub1kinase (Figure 3.19 B),
strongly suggesting that S969 is the major autophosphorylation site within the kinase domain.
As Bub1 activity did not seem to be regulated by extrinsic factors, we wondered whether we could
confirm an intramolecular effect of kinase regulation by autophosphorylation. We assessed the ac-
tivity of the S969A and S969D mutants on H2A using the ADP-GloTM Kinase Assay and found that,
while the phospho-mimicking mutation S969D is able to phosphorylate H2A efficiently, the S969A
mutation markedly reduced kinase activity (Figure 3.19 D and E). Consistently, also S969E rescues
kinase activity (Appendix Figure 6.6).
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Figure 3.19: Bub1 autophosphorylates at S969, a phosphorylation site that confers kinase activity.
(A) Bub1kinase undergoes autophosphorylation, which is reversible by treatment with l-phosphatase. Bub1
samples were analysed by SDS PAGE and Coomassie blue staining (right). Phosphorylation was visualised using
the Pro-Q® Diamond Phosphoprotein Gel Stain (left). (B) Bub1kinase wild-type (WT), S969A, S969D and S969E
were incubated with ATP or l-phosphatase (l-pp) and analysed by SDS PAGE and Coomassie blue staining
using Phos-tag to detect a phosphorylation-specific shift. (C) Amino acid sequence of the Bub1 P+1 loop with
mutations of S969 highlighted in blue (S969A), red (S969D) and green (S969E). (D) The phosphomimetic S969D
restores kinase activity while S969A is catalytically inactive. The kinase activity plotted as a function of substrate
concentration allows fitting with the Michaelis-Menten equation with R2=0.99 (WT), R2=0.97 (S969D). Error
bars represent SD of a mean of at least 2 independent experiments. 10 nM kinase was consistently used in all
experiments. (E) Kinetic parameters of the Michaelis-Menten fits as determined in (D).
In conclusion, our results confirm that autophosphorylation at S969 is required for efficient catalysis
while other domains within Bub1, namely the TPR, or binding partners such as BubR1, Bub3 or Knl1
do not affect kinase activity. We see, however, that the composition of substrates, particularly in
the case of H2A, can influence the kinase affinity and hence the phosphorylation efficiency. This
represents an advanced possibility to subtly tune kinase activity.
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3.3 Structure of a phosphorylated Bub1 kinase domain
The structure of unphosphorylated Bub1 kinase (Bub1724°1085) [214] is known. In this structure, the
P+1 loop is obstructing the active site, leaving Bub1 in a conformation that was incompatible with
substrate binding (see Figure 3.22 left). As we have shown that S969 is both a prerequisite for Bub1
kinase activity (Figure 3.19) and a site of autophosphorylation, we were intrigued to see the struc-
tural and mechanistic consequences of this phosphorylation.
Bub1kinase was preparatively autophosphorylated and subjected to co-crystallisation with ADP (Fig-
ure 3.20). The initial conditions and strategy are summarised in Section 5.2.5.
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Figure 3.20: Crystallising phosphorylated
Bub1kinase.
Autophosphorylated Bub1kinase was analysed by
SDS PAGE and Coomassie blue staining (left) and
co-crystallised with ADP. After 48 h, diamond-
shaped crystals grew to full size of 200 µm
diameter in a refined crystallisation condition
of 15 % PEG 3500 and 0.2 M NaCl at 4±C using
the sitting-drop vapour diffusion method (right).
M-molecular weight standard.
3.3.1 Phosphorylated Bub1kinase structure determination by X-ray crystallography
We obtained diffracting crystals and determined the structure by using the structure of unphospho-
rylated Bub1724°1085 (PDB ID: 3E7E) [214] as a referencemodel formolecular replacement. Note that
the structure deposited with PDB code 3E7E, is now superseded by the structure with the PDB code
4R8Q. This later structure is the result of a re-refinement where ATP, which had been originally mod-
eled in the structure [214], was replacedwith ADPand a secondMg2+ ion [224]. Surprisingly, our final
structure of phosphorylated Bub1kinase is remarkably similar to the structure of unphosphorylated
Bub1, although the cell parameters and space group of both structures are different (Figure 3.21,
Figure 3.22). Bub1724°1085 crystallises with onemolecule per asymmetric unit, while the asymmetric
unit for the final model of phosphorylated Bub1kinase comprises two monomers of Bub1kinase. The
table containing collected diffraction data and refinement statistics can be found in the Appendix
Table 6.1.
The refined structure showed clear, inconspicuous density for both the phosphorylated residue S969p
and the entire P+1 loop (Figure 3.21). The phosphate of S969 points directly toward the co-crystallised
ADP molecule and further resides in space that would be occupied by a substrate residue (Fig-
ure 3.21, Figure 6.9). The position of S969p and its immediate proximity to the gamma-phosphate of
a putative ATPmolecule led us to suspect that this conformation represents the autophosphorylation-
intermediate immediately following ATP hydrolysis. This conformation is likely stabilised by con-
tacts of symmetrymates in the crystal. The phosphate faces a highly negatively charged environment
(Appendix Figure 6.7), composed of the directly neighboring residues E967 and D917N (Figure 3.21)
that would be expected create a repulsive force towards the phosphate.
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Figure 3.21: The structure of phosphorylated Bub1kinase.
Left, ribbon diagramme showing a phosphorylated structure of Bub1kinase. N and C indicate the N- and C-
termini, respectively. The P+1 loop harbouring the phosphorylated S969 is highlighted in green. The activation
loop is depicted in blue and the catalytic loopResiduesD946, D917, S969 andADP are shown as sticks, oneMg2+
atom is represented by a grey sphere. Right, detailed view of the active site of Bub1 showing S969p pointing
towards the catalytic aspartate D917 and ADP. The electron density around the P+1 loop is represented by the
2Fo-Fc map and contoured at 1.5 sv as a blue mesh. The structure was published with the PDB ID 5DMZ. All
images were created with CCP4MG.
It seems plausible that the electrostatic repulsion would lead to a conformational change of the
phosphorylated P+1 loop as demonstrated in the recently published structure of phosphorylated
Bub1740°1085 [224] (Figure 3.22). This published Bub1740°1085 construct is very similar to Bub1kinase
but lacks 14 amino acids (725-739) at the beginning of the N-terminal kinase extension, a segment
that is involved in establishing contacts with the activation segment. The structure of phosphory-
lated Bub1740°1085 might represent an “open” and active conformation of the P+1 loop, as it provides
the necessary space to accommodate a substrate peptide at the active site in contrast to phosphory-
lated Bub1kinase (Figure 3.26 and 6.9).
Figure 3.22: Overlay of Bub1 P+1 loop con-
formations. phosphorylated Bub1kinase (PDB
ID: 5DMZ, grey) with unphosphorylated
Bub1724°1085 (PDB ID: 4R8Q, left) and phos-
phorylated Bub1740°1085 (PDB ID: 4QPM,
right).
The P+1 loop of 4R8Q and 4QPM is coloured in
shades of blue, the loop of 5DMZ in green. Both
images were created with CCP4MG.
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PDB ID
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3.3.2 Validation of the phosphorylated Bub1kinase structure
To verify the actual positions and electron density of the respective P+1 loops of phosphorylated and
unphosphorylated Bub1 structures, I used the structure factors of unphosphorylated Bub1kinase and
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phosphorylated Bub1740°1085 (PDB IDs: 4R8Q, 4QPM) and reprocessed the data. In the reprocess-
ing, our phosphorylated Bub1kinase was used as a model for molecular replacement. The resulting
models were refined to Rfree factors below 0.3 for qualitative assessment (Figure 3.23).
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Figure 3.23: Bub1 structures have a clearly defined density around the P+1 loop.
Detailed view of the P+1 loop of phosphorylated Bub1740°1085 (4QPM, blue), unphosphorylated Bub1724°1085
(4R8Q, turquoise) and Bub1kinase (5DMZ, green), the side chains are shown as sticks. The electron density
around the P+1 loop for 4QPM and 4R8Q has been rebuilt and refined from the structure factors and is repre-
sented by the 2Fo-Fc map, contoured at 1.5 sv as a blue mesh for all structures. All images were created with
CCP4MG.
In fact, by rebuilding themodels wewere able to authenticate the published positions of the P+1 loop
of unphosphorylated Bub1 (covering the active site) and phosphorylated Bub1740°1085 (undergoing
structural rearrangement). Therefore, the three Bub1 kinase structures likely represent Bub1 each at
a different state of the phosphorylation process.
3.3.3 Bub1kinase autophosphorylation does not influence nucleotide binding
We have demonstrated that S969p is a crucial site for kinase activity, as shown in Figure 3.19, where
the mutation S969A disrupts activity. To account for the importance of S969p, we could envision
two scenarios where S969 either plays a role in the binding of ATP or a substrate peptide. To test
whether S969p had an impact on nucleotide binding of Bub1kinase, we compared the ATP binding of
phosphorylated and dephosphorylated Bub1kinase by titrating mant-ATPgS against phosphorylated
and dephosphorylated Bub1 (Figure 3.24).
Bub1kinase and phosphorylated Bub1kinase did not show a significant difference in the dissociation
constants (KD) of ATP (Figure 3.24), thus we conclude that S969p does not affect ATP binding. This
is initially at odds with our structure, which appears incompatible with binding of an ATP molecule
but rather provides more evidence, that the position of the P+1 loop we have crystallised is not the
conformation of active Bub1kinase. However, as S969 is located in the substrate-binding loop (Fig-
ure 3.21, 3.19 B) we hypothesise that phosphorylation of this residue induces a conformational rear-
rangement of the P+1 loop that is required for substrate-peptide binding.
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Figure 3.24: S969p does not interfere with ATP
binding of Bub1kinase.
The change in fluorescence emission of mant-
ATP∞S at 450 nm (excitation: 340 nm) upon
mixing with Bub1kinase (red) or phosphorylated
Bub1kinase (black) is plotted as a function of to-
tal mant-ATP∞S concentration. The data were fit-
ted with a one-site binding equation using Ori-
gin 9.0 with R2=0.99. Error bars represent SD of
a mean of at least two independent experiments.
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3.3.4 Substrate binding of phosphorylated Bub1kinase
Crystallisation attempts of substrate-bound Bub1
The available structures of phosphorylated and unphosphorylated Bub1 kinase domain only allow
speculation as to how and where a peptide substrate might bind. In order to obtain a crystal struc-
ture of a substrate-bound Bub1, I followed two strategies: First, co-crystallisation of phosphorylated
Bub1kinase with peptides of human or xenopus laevis H2A115°126 were tested (Figure 3.25 (a)). Pep-
tides encompassing residues 115-126 of the human and xenopus laevis H2A sequence were synthe-
sised by Sascha Gentz with either wild-type sequence or amutation in the phosphorylation site T120
(T120A). These peptides were co-crystallised with phosphorylated Bub1kinase and yielded crystals
very similar in shape to crystals of phosphorylated Bub1kinase (Figure 3.20) but in crystallising con-
ditions that were significantly different. The most promising condition for co-crystallisation found
during screening was 0.1 M Tris pH 7.0 and 20 % PEG MME 2000, that reproducibly gave rise to
crystals in refinement conditions around pH values of 7.0-7.2 and PEG MME 2000 concentrations
ranging from 20-22 %. An initial positive screening result was found with the wild-type H2A115°126
peptide in 0.1 M Hepes pH 7.5 and 20 % PEG 10000 but this result could not be reproduced. The
crystals co-crystallised with T120A peptides from refinement screens show X-ray diffraction and had
very similar space group and cell parameters as phosphorylated Bub1kinase without peptide. Upon
refining of the models it became evident that there was no additional density for a bound peptide,
neither was the position of the P+1 loop clearly defined. Unfortunately, the addition of higher con-
centrations of peptide (up to 100-times excess) to increase the peptide occupancy in the phosphory-
lated Bub1kinase crystal, caused the crystal quality to drop and the diffraction was lost.
In a parallel attempt, I designed a direct fusion of Bub1kinase and H2A, where the H2A115°130 pep-
tide was added with a triple or quadruple glycine-serine repeat (named GS3 and GS4, respectively)
to link the peptide sequence to the C-terminal helix of Bub1kinase. The H2A sequence was inserted
directly after E1079 omitting the last Bub1 residues to introduce less flexibility of the H2A peptide.
The GS3 construct was also constructed as a T120A (GS3TA) mutant. The proteins were expressed,
purified and autophosphorylated in the samemanner as the wild-type Bub1kinase, they also behaved
similarly, were obtained in comparable yields (1 mg/l insect cell culture) and show the same homo-
geneity (Figure 3.25 (b)).
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(a) Co-crystallisation of phospho-
rylated Bub1kinase with H2A pep-
tides.
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Figure 3.25: Crystallisation attempts for phosphorylated Bub1kinase with a H2A substrate peptide.
(a) The crystallising condition yielding the crystal is indicated on the right, the peptide sequence is indicated
on the top of each image with the phosphorylated residue T120 or its mutation T120A highlighted in red. h.s.-
homo sapiens; x.l.-xenopus laevis. (b) Left, SDS PAGE analysis of phosphorylated Bub1kinase-GSxH2A115°130
proteins, right, crystals of the different constructs as indicated in the images in different crystallising conditions.
All crystal conditions were obtained in sitting drop vapour diffusion at 4±C.
The three protein constructs were screened for crystallising conditions with one direct hit (0.1 M
MES pH 6, 10 % glycerol, 30 % PEG 600, 5 % PEG 1000; for the GS3TA construct, Figure 3.25(b) upper
right) that could not be reproduced. A second promising condition yielded quasi-crystals for the GS3
and GS4 construct (0.2MNaCl, 0.1MNa acetate pH 4.5, 40 % PEG 300; Figure 3.25(b) upper left) that
could be optimised with the addition of 3 %methanol (Figure 3.25(b), lower two panels)
In spite of numerous attempts and screened additives (summarised in Table 5.12), no condition
yielded crystals larger than 30 µm (as depicted in Figure 3.25(b)). Furthermore, none of the tested
crystals showed diffraction neither at the in-house X-ray source nor at the synchrotron. It is un-
clear whether the lack of X-ray diffraction was a result of the crystal size or an inherent quality of the
substrate-bound phosphorylated Bub1kinase crystals, as also observed for co-crystallised phospho-
rylated Bub1kinase.
Nevertheless, a promising advance towards a crystal structure of Bub1with a substrate peptide could
thus far be achieved by finding crystallising conditions for a Bub1 construct linked with a substrate
peptide. Further attempts to optimise the diffraction or the constructs by increasing linker length
and producing a GS4TA construct are currently in progress.
Conservationmapping discerns a substrate binding surface on the Bub1 kinase domain
Comprehensive attempts to crystallise Bub1kinase with substrate peptides have not been success-
ful in yielding diffracting crystals to date. In spite of the lack of structural information, we wanted to
validate the substrate binding specificity by modeling a substrate peptide onto the Bub1 structure.
The structure of phosphorylated Bub1kinase presented in Section 3.3 does not qualify for the model-
ing of substrate binding because the active site is obstructed (Appendix Figure 6.9). Therefore, the
phosphorylated Bub1740°1085 structure (PDB ID: 4QPM) was superposed with the structure of PKA
(PDB ID: 1APM) kinase that was co-crystallised with an inhibitor peptide (Figure 3.26).
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Figure 3.26: Superposition of PKA, with a bound substrate or inhibitor peptide and Bub1740°1085.
Only Bub1740°1085 (PDB ID: 4QPM, grey) and the co-crystallised pseudo-substrate inhibitor of PKA (PDB ID:
1APM, yellow) are shown. The activation loop is depicted in blue, the P+1 loop in green, the catalytic loop is
coloured red. S969p and putative residues involved in substrate recognition are depicted as sticks. The position
of the phosphorylated substrate residue (Ala in 1APM peptide) is denoted with a yellow asterisk, the -5 and -6
positions on the peptide are indicated in yellow.
In order to determine the conservation of residues on the surface of Bub1kinase and to identify a pos-
sible substrate-binding surface, I aligned Bub1 sequences from 12 organisms from yeast to human
using the MUSCLE algorithm [241]. The ConSurf programme [242] then allowed to elucidate the ex-
tent of sequence and structure conservation in the kinase domain of Bub1. The complete alignment
can be found in the Appendix Figure 6.10.
Mapping the conservation on the surface of Bub1kinase highlights a conserved patch around the ac-
tive site (magenta), which is expected for catalytic residues. Strikingly, the conservation also extends
beyond this site (Figure 3.27). The ribbon view in Figure 3.27 accentuates the positions of the con-
served residues outside the catalytic cleft, that reside on helices of the C-lobe of Bub1kinase, forming
the surface of the C-lobe. Interestingly, the combined extent of conservation and position of sub-
strate peptide binding, as modeled in Figure 3.26, suggests residues L875, N879 (aD helix), D921,
G1001 and Y1003 are likely to be candidates involved in stabilising or conceivably conferring speci-
ficity for substrate binding.
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Figure 3.27: Bub1kinase sequence and structure conservation of the C-lobe.
Conservation was determined by aligning Bub1kinase from 14 organisms with ConSurf [242], the scoring legend
is depicted in the center. Above, the kinase surface representation and ribbon diagramme are shown, the N-
and C-termini are indicated. Below, detailed view of the site of high conservation, the ÆD and ÆF helices are
indicated. The conserved residues exposed to the surface shown as sticks (L875, N879, D921, G1001 and Y1003)
correspond to the same residues shown in Figure 3.26. Conservation scores are considered to be unreliable if
theywere obtained for positions in the alignment that had less than 6 un-gapped amino acids or if the computed
confidence intervals for the rate of a specific position spans 4 or more colour grades. Such positions are colored
light yellow in the graphic visualisation output. Images were created with CCP4MG and Pymol.
Mutation analysis of these conserved kinase residueswas used to shed light on the role of this surface
on the kinase. To this end L875 and N879 on the aD helix, as well as G1001 and Y1003 on the loop
following the aF helix were mutated to alanine residues (LN mutant, GY mutant). Another mutant
was generated harbouring all four mutations (LNGY mutant). The kinase activity of these proteins
was assessed using the ADP-GloTM Kinase Assay and by SDS PAGE with phosphostaining analysis of
the individual kinase reactions (Figure 3.28).
The Bub1 kinase mutants LN, GY and LNGY all proved stable and were also able to autophosphory-
late to comparable levels as the wild-type Bub1 kinase (Appendix Figure 6.8). However, when tested
on their ability to phosphorylate H2A, the mutants exhibit considerably lower ATP hydrolysis (Fig-
ure 3.28 A) andH2A phosphorylation in contrast to Bub1wild-type (Figure 3.28 B). These results lend
strong support to the claim that both the aDhelix aswell as the residues of the loop succeeding the aF
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helix are implicated in substrate recognition. The positions of L875, N879, G1001 and Y1003 are at an
ample distance to the active site of Bub1 and the P+1-loop, which corroborates the proposed model
where these residues likely confer binding to substrate residues preceding the phosphorylation site
(Figure 3.26).
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Figure 3.28: Mutation of the conserved surface of Bub1kinase abrogates phosphorylation of H2A.
(A) The mutation of L875A/N879A (red), G1001A/Y1003A (blue) and the combined mutation
L875A/N879A/G1001A/Y1003A (teal) abolishes phosphorylation of H2A in comparison to the wild-type
(WT, yellow). The kinase activity as obtained by the ADP Glo Assay plotted as a function of substrate con-
centration allows fitting with the Michaelis-Menten equation with R2=0.97 (WT). Error bars represent SD
of a mean of at least 2 independent experiments. 10 nM kinase was consistently used for all experiments.
(B) The activity of the L875A/N879A (LN), G1001A/Y1003A (GY), and L875A/N879A/G1001A/Y1003A (LNGY)
mutants on GST-H2A C-terminal tail (GST-H2Ac) was compared to that of wild type Bub1kinase. GST-H2Ac
was incubated with 30 nM Bub1 constructs, with (+) and without (-) ATP, then analysed by SDS PAGE and
Coomassie blue staining (below). Phosphates were visualised using the Pro-Q® Diamond Phosphoprotein Gel
Stain (above). Phosphorylated Bub1kinase was used as a positive control for phosphostaining. Note that in all
phosphorylation reactions the auto-phosphorylation of the Bub1kinase domain was not observed because the
kinase was added is amounts that make it undetectable in this assay (~40 ng kinase against 2 µg substrate were
used).
In conclusion, we propose that the requirement for phosphorylation of S969 in Bub1 activity signifies
an indirect effect. S969p is not directly involved in establishing or stabilising interactions with the
substrate peptide, based upon the molecular model of peptide binding to Bub1 kinase (Figure 3.26).
Rather, we conceive the role of S969p to be the main driving force that causes the conformational
change from an inaccessible active site to a state that allows substrate binding, hence “activating”
the kinase. The conserved surface on the C-lobe of the Bub1 kinase domain has a crucial role in
recognising substrate peptides, as mutation of specific residues constituting this surface leads to a
significant loss of substrate phosphorylation but not autophosphorylation.
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3.4 Towards a structure of the BubR1 kinase domain
The structure of BubR1 kinase domain is hitherto unknown. Especially with regard to the fact that
it is catalytically inactive, it would be very insightful to know if and how the inactivity can be ex-
plained from a structural point of view. In the course of this work, I attempted to obtain structural
information on the BubR1 kinase domain.
3.4.1 Identification and design of BubR1 kinase constructs
BubR1543°1050 was expressed and purified, then subjected to limited proteolysis in order to obtain
stable and minimal kinase constructs suitable for crystallography (Figure 3.29A). A prominent band
of approximately 40 kDawas observed, whichwhen excised from the gel and identified bymass spec-
troscopy, corresponded to the C-terminal domain of BubR1. By performing N-terminal sequencing
of this proteolysis fragment, a short sequence was identified that corresponds to the region around
residue 700 of BubR1. This corresponds to the size of the Bub1 kinase domain (Bub1kinase) with its
N-terminal extension and also fits with secondary structure predictions obtained for BubR1 using
the online secondary structure prediction servers Phyre2 [243] and PSIPRED [244] (analyses can be
found in the Appendix Figure 6.12 and Figure 6.11).
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Figure 3.29: Designing constructs of BubR1 kinase domain suitable for crystallogenesis.
(A) Coomassie blue stained SDS PAGE analysis of a limited proteolysis performed on BubR1543°1050 with dif-
ferent proteases as indicated on top. Boxed in red is a recurring stable fragment of BubR1 of ~40 kDa, which
fits the size of the kinase domain. (B) Constructs designed following limited proteolysis, mass spectroscopic
analysis and N-terminal sequencing, high stability and purity of the purified proteins is indicated by a + sign,
only if both is present, the construct was used for crystallogenesis (+). (C) Purified constructs of BubR1 kinase
were analysed by SDS PAGE and Coomassie blue staining and used for crystallogenesis.
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Consequently, five additional constructs of BubR1 were designed (Figure 3.29B), starting at differ-
ent positions N-terminally of the kinase domain (residues 697, 705, 712, 718). The BubR1705°1044
construct additionally contained a C-terminal truncation to exclude the possibility that the very C-
terminal residues impede crystallisation. All of the BubR1 constructs were cloned as His6-tagged
proteins and tested for expression. BubR1705°1044 proved not to be stable, suggesting that an intact
C-terminus is required for protein stability. Furthermore, residues 1044-1049 may fold into a helix
as suggested by secondary structure predictions using Phyre2 [243] (Figure 6.12). BubR1 constructs
starting at amino acids 697, 705, 712, 718 proved to be expressable, soluble and stable. However, the
expression of BubR1712°1050 and BubR1718°1050 was significantly lower and the following purifica-
tion did not yield pure protein. Subsequently, BubR1543°1050, BubR1697°1050 and BubR1705°1050 were
purified to homogeneity and ultimately subjected to crystallogenesis (Figure 3.29B-C).
3.4.2 Crystallisation attempts of BubR1 kinase constructs
The constructs described in Figure 3.29B were subjected to diverse crystallisation trials, a compre-
hensive summary of the crystallisation strategies and can be found in Section 5.2.5 and Table 5.12.
In brief: The protein constructs (BubR1543°1050, BubR1697°1050 and BubR1705°1050) were purified to
homogeneity. Of note, BubR1543°1050 was phosphorylated in the course of expression in insect cells.
Phosphateswere removedprior to crystallogenesis to allow for a homogenous sample, BubR1697°1050
and BubR1kinase were not phosphorylated during expression (see also Figure 3.11). The constructs
did not yield any spherulites or quasi-crystals from any condition of the screens tested (Table 5.12)
that seemed promising for further refinement. Reductive lysine methylation [245, 246], a method
used to increase surface hydrophobicity did not increase the propensity of proteins to crystallise.
The screens were each set up using varying concentrations of protein and with different additives
including ADP, ATPgS, AppNHp. For further crystallisation trials, other additives, potential binding
partners or different temperatures could be tested and optimised.
In conclusion, twominimal constructs of BubR1 kinase, BubR1697°1050 andBubR1705°1050 were found
to be stable, nonetheless, a condition for successful crystallisation yet needs to be identified.
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3.5 Characterisation of Bub1 substrates
In addition to the kinase substrate interaction as discussed in Section 3.3.4, the range and number
of Bub1 kinase substrates and their specific characteristics remain largely unknown. In the course of
my work, I also set out to test several kinetochore proteins as substrates for Bub1 kinase in vitrowith
the aim to discern a common substrate sequence pattern and identify novel targets of Bub1 kinase
activity.
3.5.1 Screening identifies novel kinetochore substrates of Bub1
Kinetochore and centromere proteins were tested as potential substrates in phosphorylation reac-
tions with Bub1kinase. Among the proteins tested were histone H1, H3 and H2A (which has already
been shown to be a Bub1 substrate), Borealin:Survivin complex, Knl1, and the RZZ complex.
The phosphorylation reactions were analysed by SDS PAGE using Pro-Q® Diamond Phosphopro-
tein Gel- and Coomassie staining, shown in Figure 3.30. H1 and RZZ were not obvious substrates
and were not included.
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Figure 3.30: Kinetochore proteins
were tested for their potential of
being a Bub1 substrate.
Knl1138°161, Knl1138°191 and
Knl1138°225 (A) as well as H2A,
H3, and the Borealin:Survivin (B/S)
in (B) complex were incubated
with ATP and with (+) or with-
out (-) Bub1kinase. The reactions
were then analysed by SDS PAGE
and Coomassie blue staining (A,B
right), phosphates were specifically
stained using Pro-Q® Diamond
Phosphoprotein Gel Stain (A,B left).
Along with the established substrate H2A, the known kinetochore receptor of Bub1, Knl1, Borealin
and Bub1 itself were revealed as targets of Bub1 activity as they could be identified by phosphory-
lation staining. Histone H3 did not show any phosphorylation, highlighting that Bub1 phospho-
rylation on histones is specific for H2A. This specificity is also compatible with H2B and H4 not
being phosphorylated either, consistent with observations in phosphorylation reactions using re-
constituted nucleosomes (Figure 3.16 A). Phosphorylation on Knl1 reveals that while Knl1138°161
does not appear to be phosphorylated, by increasing the length of the Knl1 construct to Knl1138°191
or Knl1138°225, phosphorylation staining occurs and intensifies (Figure 3.30 A). This points towards
Bub1 phosphorylation sites being present in the region between 161 and 191 or beyond, correspond-
ing to the position of the KI1 and KI2 motifs (domain structure in Figure 3.8), the known interaction
sites of the Bub1 and BubR1 TPR domains with Knl1. Borealin is a part of the chromosomal passen-
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ger complex and reported to be highly phosphorylated, which is functionally important in its role
to anchor Aurora B at centromeres [247, 248, 249]. The role of these phosphorylation sites and their
relevance in vivo still remains to be established.
3.5.2 Phosphorylation sites of substrates reveal a consensus sequence
The proteins histone H2A, Borealin, Knl1 and also full-length Bub1 were identified to be Bub1 sub-
strates (Section 3.5.1). They were further evaluated by LC-MS/MS to determine the specific sites
of phosphorylation or, in the case of Bub1, auto-phosphorylation. Alignment of the specific phos-
phorylation sites of these substrates allowed the identification of a putative kinase consensus motif
(Figure 3.31).
Figure 3.31: Alignment of phosphorylation
sites found in Bub1-dependent phosphoryla-
tion reactions using Jalview [250].
Phosphosphorylation sites were identified by
LC MS/MS and the sequences of the substrates
comprising Bub1 itself, H2A, Knl1 and Bore-
alin were aligned at the site of the phosphory-
lation, which is denoted with an asterisk. Num-
bers correspond to protein boundaries; the con-
servation of residues is highlighted using the
Clustalx coloring scheme in the sequence align-
ment and numbers from 0-9 in the bar dia-
gramme. The -6 position is occupied by a hy-
drophobic residue indicated by ™ in the con-
sensus below. In a few cases this position is
filled by S or T. Note that also in between the
phosphorylated residue and the -6 position, the
occurrence of aliphatic residues is increased.
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The identified consensus predicts the presence of an hydrophobic residue at position -6 relative to
the acceptor, a site that is often followed by further aliphatic residues that may also contribute to
specific recognition by Bub1 kinase. This motif can be described as y-(x)5-T/S where y is an
aliphatic residue and x is any amino acid (Figure 3.31). The position of the conserved hydrophobic
residue of the substrate is structurally consistent with being in the immediate proximity of the highly
conserved surface of Bub1kinase as depicted in Figure 3.26 and 3.27.
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3.5.3 A consensus sequencemediates H2A-Bub1 specificity
The discovery of a well conserved sequence feature of Bub1 substrates led us to hypothesise that
these residuesmight be important in substrate-kinase specific interactions. To test this idea, wemu-
tated the H2A residues non-conservatively to V115D, L116N, L117N. To dissect the potential of this
‘DNN’ mutant as a Bub1 substrate in vitro, individual phosphorylation reactions were analysed by
SDS PAGE and Pro-Q® Diamond Phosphoprotein Gel staining (Figure 3.32).
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Figure 3.32: Bub1-dependent phosphorylation
of H2A can be strongly reduced by mutating
residues V115D, L116N, L117N onH2A.
Above, sequence of wild-type H2Ac and the
H2AcDNN mutant, the phosphorylated T is indi-
cated with an asterisk. Below, GST-H2A constructs
as wild-type (H2Ac) andmutated (H2AcDNN), 2 µg
each, were incubated with 10 nM Bub1kinase and
ATP, then analysed by SDS PAGE and Coomassie
blue staining (lower gel), phosphates were specifi-
cally stained using Pro-Q® Diamond Phosphopro-
tein Gel Stain (upper gel). Autophosphorylation of
Bub1kinase was used as a positive control for activ-
ity and phosphorylation staining.
Strikingly, the Bub1kinase phosphorylation efficiency of the H2A DNN-mutant is distinctly reduced
compared to the wild-type sequence.
Taken together, I was able to identify Borealin and Knl1 as previously unrecognised Bub1 kinase
substrates, which in combination with phosphorylation sites on H2A and Bub1 itself, reveal a novel
consensus sequence for Bub1 activity. This aliphatic sequence indeed contributes inmediating Bub1
kinase specificity, as corroborated by the reduced phosphorylation of the H2A consensus sequence
mutant. The determination of this motif might prove a useful tool in the verification of or screening
for other presumptive Bub1 substrates.
The requirement of this substrate sequence is in excellent agreement with the identification of a
highly conserved surface on the C-lobe of the Bub1 kinase domain (Section 3.3.4). Bub1 residues
L875, N879, G1001 and Y1003 that form this surface are modeled to contact the substrate peptide at
the -5 to -6 position, corresponding to the V115 and L116 residues on Bub1. Convincingly, mutation
of either, the conserved residues on Bub1 or on H2A was shown to result in a significant decrease in
phosphorylation.
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4 Conclusion and Perspectives
In this study, I have presented a biochemical and structural characterisation of the mitotic check-
point proteins Bub1 and BubR1. I have identified BubR1 to be a pseudo-kinase and defined the role
of autophosphorylation in the regulation of Bub1 kinase activity. The reconstitution of Bub1:Bub3
and BubR1:Bub3 complexes allowed me to disclose an unprecedented role of Bub1 in assembly of
the mitotic checkpoint complex and therefore expands its role as a scaffold protein in checkpoint
signalling.
4.1 The role of Bub1:Bub3 and BubR1:Bub3 complexes at the kinetochore
Bub1 and BubR1 reflect sub-functionalisations of paralogs generated by gene duplication [196, 197].
With regard to the distinct functions of Bub1 andBubR1, it is of extreme interest that several indepen-
dent duplication and sub-functionalisation events might have taken place in the course of evolution
[196, 197]. To what extent the biochemical evolution of the components of the paralog pairs that
were created by these distinct duplications followed similar or different paths, is currently unclear.
The investigation of this intriguing question may contribute to the understanding of how the SAC
network constrains the evolution of its components. Thus, encouraged by the desire to shed light on
this question, I set out to investigate in biochemical detail the regulation of human Bub1 and BubR1.
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Figure 4.1: Themolecular interactions of Knl1, Bub3, Bub1, BubR1 and Cdc20.
The regions or domains of interaction as determined in pull down assays or shown by cross-linking analy-
sis are depicted as grey dashed lines. Domain positions and protein construct boundaries are indicated by
residue number. TPR-tetratricopeptide repeat, Bub3BD-Bub3 binding domain, ABBA-ABBA-motif, KEN-lysine-
glutamate-asparagine motif, CDI/II-conserved domain I/II, WD-tryptophan-aspartate. The interaction of TPR
domains with KI1 (Bub1) and KI2 (BubR1), respectively, is omitted.
The similarity of Bub1 and BubR1 is reflected in the comparable domain organisation of both pro-
teins (Figure 4.1). As shown in the previous section, however, their respective domains behave sig-
nificantly differently. Hydrodynamic analysis demonstrates for the first time that both Bub1:Bub3
and BubR1:Bub3 form stable, monodisperse 1:1 complexes devoid of further oligomerisation. The
Bub1:Bub3 and BubR1:Bub3 complexes interact with a segment of Knl1 containing a single (Mps1-
generated) phosphorylatedMELT repeat and two previously identified KImotifs, which interact with
the TPR regions of Bub1 and BubR1 [208, 55, 171, 251] leading to a tight complex. Importantly,
BubR1:Bub3 binding depends upon the presence of Bub1:Bub3.
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Little was known thus far about the molecular nature of the interactions that lead to efficient MCC
catalysis. The complex of Bub1:Bub3-BubR1:Bub3 on Knl1 was capable of stably binding Cdc20,
leading to a network of protein interactions as determined by cross-linking analysis and pull-down
experiments (Figure 4.1). The complex of Knl1-Bub1:Bub3-BubR1:Bub3-Cdc20 could form the ba-
sis for the MCC, but it remains to be shown whether this composition actually occurs within a cell.
Although binding of Cdc20 appears to preferentially bind to Bub1 rather than BubR1, as corrobo-
rated by the cross-linking data, it is not evident where the Cdc20 molecule binds in this complex.
The Cdc20 binding motifs are divergent between Bub1 and BubR1. This is reflected in the fact that
Bub1:Bub3 readily binds to Cdc20 whereas BubR1:Bub3 binds to a much lesser extent, support-
ing the idea that BubR1-Cdc20 binding is Mad2-dependent [159, 133, 134]. The fact that Mad2 in
vitro was not sufficient to efficiently generate MCC complexes further argues in favour of a model
where the pre-formation of Mad2-Cdc20 is essential in order to build a complex with BubR1:Bub3.
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Figure 4.2: Model for Bub1 as a scaffold for MCC assembly.
Bub1:Bub3 is recruited to Knl1 phosphorylated by Mps1 and
binds a complex of BubR1:Bub3. Bub1 is also a receptor of
Cdc20, which can bind as single protein or possibly in a com-
plex with closed Mad2 (C-Mad2). This assembly on Bub1
allows close contact of BubR1:Bub3 and Mad2-Cdc20 com-
plexes that consequently have to be released to form the solu-
ble MCC competent to inhibit the APC/C. The precise mech-
anism of MCC release is yet unknown, it might involve a sec-
ond Cdc20 wedging in between Bub1 and evanescent MCC
complexes (marked “?”) [162, 159, 150] or the activity of
a checkpoint kinase, especially Bub1, which was shown to
phosphorylate Cdc20 in vitro [163].
The ABBA motif as a second independent
binding site on BubR1 may account for
why BubR1 binds Cdc20 in the absence
of Mad2, as observed in previous studies
[150, 159, 162]. However, whether a sec-
ond Cdc20 molecule is effectively required
for checkpoint signalling remains uncer-
tain. Possibly, Bub1 is initially a better
binder of Cdc20 as it combines the affinity
of ABBA motif (further confirmed in [210])
and KEN1, which is spatially further apart
in BubR1, although this hypothesis needs
to be tested.
Collectively, our findings lend support to
a hypothesis where Bub1 is a recruiting
scaffold at the kinetochore. Upon kineto-
chore binding, BubR1:Bub3 and Cdc20 are
recruited, where they intersect with Mad2
to form the MCC. A model of this process
that correlates very well with other recent
studies [179, 180, 210] is shown in Fig-
ure 4.2. Concerning the interplay between
Bub1:Bub3 and Mad1:Mad2, further bio-
chemical analysiswill be crucial to dissect stoichiometries aswell as themechanismofMCCcomplex
formation, taking into account the putative second Cdc20 molecule. Additionally, structural infor-
mation of this complex will be extraordinarily valuable in terms of revealing individual molecular
contributions with regard to understanding the overall mechanism ofMCC assembly and signalling.
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4.2 The structural basis of kinase regulation
4.2.1 Molecular basis of Bub1 activity and BubR1 inactivity
In order to resolve conflicting reports of kinase activity, I compared Bub1 and BubR1 activities and
established that BubR1 is not an active kinase. This finding is consistent with a recent report also
demonstrating BubR1 to be an inactive pseudo-kinase [196]. In extension of this previous study, I
could further show that the BubR1 kinase domain binds to nucleotides with a binding affinity com-
parable to that of Bub1. This is surprising, as the residues of the Gly-rich loop, a region of kinases
in the upper N-lobe, which is implicated in the stabilisation of nucleotide binding, are highly di-
vergent from a common kinase consensus. Another recent study found BubR1 to be incapable of
nucleotide binding [252], thus contradicting our finding. This discrepancy is probably due to the dif-
ferent methodologies employed to investigate nucleotide binding. Still, significant sequence diver-
gence from active kinases in the Gly-rich loop of BubR1, previously indicated as a possible cause of
loss of activity [196], may not affect the ability of BubR1 to bind nucleotides. This suggests that diver-
gence of BubR1 from Bub1 at other regions of the kinase domain, possibly in the catalytic loop [196],
may be the predominant cause of its impaired activity. The well-established kinase-inactivatingmu-
tation, such as K821R in Bub1, resulted in dramatically reduced yields of expressed andpurifiedBub1
proteins. This is in compliance with findings in BubR1 (K795R mutation [196]), which confirms the
idea that these kinase mutations are critical for kinase stability [196], transcending their potentially
deleterious effects on enzymatic activity. Mutation of the catalytic aspartate in Bub1 to asparagine
(D917N mutant), however, did not apparently perturb the stability of Bub1 but led to a loss of en-
zymatic activity. Collectively, based on the results obtained in this thesis that BubR1 is inactive and
binds to Bub1, we hypothesise that the kinase activity associated with BubR1 precipitates in previ-
ous studies can be attributed to Bub1 [218, 196]. Furthermore, as BubR1 is known to bind to PP2A,
the assumed effects of BubR1 kinase activity in chromosome congression could be explained by co-
precipitation of PP2A [113, 253]. Bub1, on the other hand, is an active kinase that hydrolyses ATP for
phosphoryl-transfer to a variety of substrates. Moreover, catalytic properties of Bub1 kinase activity,
reported here by their turnover rate (kcat) and catalytic efficiency (kcat/KM), are similar to those re-
ported for many other kinases [254].
4.2.2 Extrinsic regulation of Bub1 kinase activity
One of the motivations behind this thesis was to explore whether the interactions of Bub1 with its
most direct binding partners in the kinetochore, Bub3, Knl1, andBubR1, imposes an extrinsic level of
regulation on Bub1 kinase activity. Kinase regulation by binding partners is common, specifically in
the sense of relieving an auto-inhibitory feature of the kinase. The release of an inhibitory loop also
occurs in the case of Bub1, where the P+1 loop blocks substrate access to the active site. However, in
conclusion from the analysis presented here, this may not be true, at least when reconstituting the
Bub1 interactions with recombinant material in vitro. Another study, using deletion constructs in
HeLa cells, reaches similar conclusions [237] in support of the findings presented here. Previously,
independent reports described that the TPR region of Bub1 may also extrinsically contribute to the
regulation of Bub1 kinase activity [208, 225]. While the analysis of this dissertation seems inconsis-
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tent with the earlier claim, it remains possible that the discrepancy may be generated by inherent
differences in the Bub1 material utilised in these assays. Previous studies have used a precipitated
form of Bub1 from either HeLa cells [208] or mouse embryonic fibroblasts [225] as the source of
kinase activity, whereas it was purely recombinant protein here. In agreement with the findings pre-
sented above, where Bub1 kinase exhibits the same degree of activity as full-length Bub1, a recent
study also failed to identify differences in the kinase activity of full-length Bub1 compared to a TPR-
deleted construct [224].
4.2.3 Intrinsic regulation of Bub1 kinase activity
Activation of many kinases involves the phosphorylation of their activation loop [235, 236] thereby
inducing a structural rearrangement, leading to the activation of the kinase. This process might
involve an activating phosphorylation by another kinase or autophosphorylation. In Bub1, phos-
phorylation takes place on the P+1 loop that is in the region of the activation segment following the
acceptor site (P-loop) and involved in substrate recognition. In agreement with a recent study [224],
an auto-phosphorylation site on the substrate-binding P+1 loop of Bub1 is identified in this study
(S969p), which represents an atypical position for an activating auto-phosphorylation in kinases.
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Figure 4.3: Bub1 intramolecular activationand recruitment
to the kinetochore.
Bub1 kinase domain (orange) autophosphorylates (denoted
by a P) in the cytoplasm (left), which leads to its activation
by rearrangement of the substrate binding loop to relieve ob-
struction of the active site. Inmitosis Bub1becomes recruited
to the kinetochore by Knl1 where Bub3 recognises aMELT se-
quence (purple box) that is phosphorylated by Mps1, further
interaction of the TPR domain (grey) with KI1 (light-grey box)
on Knl1 might strengthen the binding. The intramolecular
activation and kinetochore recruitment allows Bub1 to reach
its substrates at the kinetochore and centromere.
This dissertation introduces a crystal struc-
ture of the phosphorylated Bub1 kinase
where the P+1 loop is captured in a con-
formation that creates a steric blockade
to the active site. The phosphate is at-
tached to the side chain of S969, pointing
towards the nucleotide-binding pocket of
Bub1. This structure adds to two previous
structures of the catalytic domain of Bub1
with an unphosphorylated, or a phospho-
rylated and rearranged P+1 loop [214, 224].
The unphosphorylated Bub1 structure dis-
plays the same “closed” arrangement of
the P+1 loop that seems unsuitable for
binding of a substrate peptide. In con-
trast, the phosphorylated Bub1 structure
presents an “open” conformation where
the phosphate on S969 points towards the
solvent (Figure 4.3). The structure pre-
sented here appears to be an intermediate
conformation of the P+1 loop after phosphate transfer but before extrusion from the active site (Fig-
ure 4.3), providing insight into the activation mechanism of Bub1 kinase.
The obtained results show that S969 is most likely the only phosphorylation site on Bub1 kinase.
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Phosphorylation of S969 is also critical for Bub1 activity, as the S969A mutant exhibits strongly re-
duced kinase activity while the S969D or S969E mutation still supports kinase activity. This finding
strongly argues in favour of the necessity of a negatively charged residue at the 969 position, as the
process of P+1 loop re-arrangement is likely to be driven by electrostatic repulsion from predomi-
nantly negatively charged residues in the direct environment of S969 (Appendix Figure 6.7). In par-
ticular, the catalytic residue D917 and E967 on the P+1 loop directly oppose the negatively charged
phosphate, thereby creating the driving force for the structural rearrangement of the P+1 loop. The
fact that the phosphorylation of the P+1 loop does to interfere with nucleotide binding of Bub1, ad-
vocates that it rather affects substrate peptide binding, which may be facilitated by “opening” the
active site of Bub1.
The conservation of S969 lends further support to this hypothetical mechanism. In other organisms
as yeasts, Drosophila melanogaster, or Caenorhabditis elegans, the serine is replaced by an aspar-
tate or glutamate at the equivalent position (Appendix Figure 6.10), circumventing a requirement for
phosphorylation. With regard to the apparent lack of extrinsic regulation of Bub1 kinase activity, it
remains unclear why other organisms rely on seemingly dispensable and redundant phosphoryla-
tion of the P+1 loop in order to activate Bub1 kinase.
4.2.4 Bub1 as a constitutively active kinase
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Figure 4.4: Bub1 kinase has an organised R-spine.
Protein kinase A (PKA) (PDB ID: 1APM, left) and phosphorylated
Bub1kinase (PDB ID: 5DMZ, right) are shown with the residues forming
the R-spine and ADP and S969 in Bub1 are shown as sticks, theMg2+ ion
is depicted as a grey sphere. The molecular surface around the R-spine
is highlighted in brown. The P+1 loop of Bub1 is coloured in green, the
catalytic loop in red (H915 is part of the HRD (HGD in Bub1) motif), the
activation loop is depicted in blue (L947 is part of the Mg-binding DFG
(DLG in Bub1) motif). The upper two residues of the R-spine emanate
from the aC helix and the beginning of the b4 strand, respectively. The
R-spine residues are partly degenerated in Bub1, specifically G834 in the
aC helix, still they form an intact hydrophobic spine. Both images were
created with CCP4MG.
Collectively, the structural and
biochemical analysis of Bub1 in-
dicates that it is a constitutively
active kinase. This is corrobo-
rated by the presence of an in-
tact regulatory spine (R-spine),
a structural motif within the ki-
nase domain that is a hallmark
for kinase activity (Figure 4.4)
[216, 217]. The presence of this
hydrophobic spine implies the
correct positioning of both the
catalytic loop and Mg-binding
loop as they form the lower part
of the spine, as well as the po-
sitioning of the integral aC he-
lix and the b4 strand shaping the
upper part of the spine. Even
though the catalytic motif and
Mg-binding loop of Bub1 devi-
ate from common kinase con-
sensus sequences, the catalytic motif being HGD (consensus HRD) while theMg-binding segment is
66 4 CONCLUSION AND PERSPECTIVES
DLG (consensus DFG), they align in a functional hydrophobic spine. Another unique aspect of this
conformation is the lack of a hydrophobic residue at the third position of the spine that is occupied
by L95 in protein kinase A (PKA), used as a reference model kinase here, but by G834 in Bub1. Likely,
the conformation of F852 that points downward in the Bub1 structure partly compensates for G834,
resulting in an altered, yet fully formed constitutive R-spine.
The fact that in other eukaryotes the 969 position is occupied by an aspartate, which embodies a
constantly active kinase conformation, strongly argues in favour of Bub1 being a constitutively active
kinase. This argument is substantiated by the finding that the level of phosphorylation of S969 does
not appear to change during the cell cycle [224]. Even being inherently active, Bub1 may need to
be specifically recruited to kinetochores in prometaphase in a Bub3- and Knl1-dependent manner.
Timely kinetochore recruitment of Bub1 is required in order to phosphorylate the physiologically
relevant Bub1 substrates at the kinetochore and centromere, implying spatial and temporal control
of its kinase activity (Figure 4.3). As a result of localisation to Knl1 duringmitosis, Bub1 is positioned
in close proximity to its substrates. Indeed, H2A as a centromere substrate of Bub1 is only found to
be phosphorylated in mitosis [111, 229]. Furthermore, the overall levels of Bub1 have been shown to
drop rapidly after mitosis [206, 255], insinuating that its regulationmay also be controlled by protein
degradation. Very recent evidence revealed another autophosphorylation site on Bub1 outside its
kinase domain that may contribute to the turnover of Bub1 at kinetochores [237], representing an
additional feature of the extent of Bub1 auto-regulation. Checkpoint silencing has been connected
to the activity and kinetochore recruitment of phosphatases [81, 189]. Therefore, an increased level
of phosphatase activity at the kinetochore could also lead to the inactivation of Bub1 by tipping the
balance towards dephosphorylation of S969p.
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4.3 Bub1 kinase substrates and specificity
4.3.1 Specific features of Bub1 substrates
Aside from H2A very little is known about the kinetochore substrates of Bub1, much less about the
functional consequence of Bub1 phosphorylation. Cdc20was also reported to be a substrate of Bub1,
the phosphorylation predicted to be involved in APC/C inhibition. The presence of this phosphory-
lation [163], however, could not be identified in cells [214]. Numerous other kinetochore substrates
have been reported for Bub1 kinase, amongst which are Mad1, Bub3, Incenp, and Bub1 itself [117,
224, 234, 237, 256]. The relevance of these phosphorylation events remains partly debatable. It is
shown here that Knl1, the kinetochore receptor of Bub1 and Borealin, a component of the chromo-
somal passenger complex, are also substrates of Bub1 kinase activity in vitro. The phosphorylation
sites on Knl1 are intriguing because they precede the KI1 motif of Knl1, that is known to bind the
TPR domain of Bub1 [55, 171, 208, 251]. Whether this phosphorylation of Knl1 influences the bind-
ing of the Bub1 TPR domain is a question that needs to be answered. The role of Bub1 in its own
recruitment has gained attention in light of recent findings where the activity of Bub1 was impli-
cated in its own kinetochore localisation [237]. Borealin, which is required to anchor Aurora B at
centromeres, is strongly phosphorylated in mitosis by numerous kinases [247, 248, 249], but the
role of these phosphorylation sites and their relevance in vivo remains largely elusive. Conceivably,
Bub1-phosphorylation sites on Borealin might cooperate with phosphorylation on H2A to recruit
Sgo in order to localise the CPC at centromeres.
Another facet of Bub1 substrates was discovered upon comparison of phosphorylation of free H2A
and H2A within the nucleosomal complex, where the latter was a significantly preferred substrate.
Notably, the in vitro binding of Bub1 to DNA might assist in recognising H2A as a substrate at the
centromere.
The analysis of the individual phosphorylation sites reveals that Bub1 substrates share a common
sequence motif up to 6 residues upstream of the phosphorylated residue. Particularly the -6 posi-
tion seems to preferentially be occupied by an aliphatic residue. The results presented here disclose
that mutations at the -6 to -4 positions in H2A are sufficient to abolish phosphorylation by Bub1. It
would be revealing to see whether this consensus prediction held true for other substrates as well
and to show that the hydrophobic residues preceding the phosphorylation site, at the -6 position in
particular, are crucial for the recognition by Bub1 kinase.
4.3.2 Substrate recognition on Bub1
The identification of distinct Bub1 substrate features, that might determine their affinity or speci-
ficity for Bub1, led to the assumption that similar distinct features must be discernible on the Bub1
kinase domain. In lack of a structure of Bub1 with a bound substrate, an overlay with PKA co-
crystallised with a bound inhibitor peptide was used to disclose residues on the C-lobe of Bub1 ki-
nase that would indicate a putative substrate-binding site (Section 3.26). The importance of residues
L875/N879 or G1001/Y1003 is corroborated by our finding that their mutation considerably dimin-
ishes Bub1 activity towards substrates. It is tempting to hypothesise that the residues L875, N879,
G1001 and Y1003 form a hydrophobic groove that allows the selective binding of substrates thus
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conferring specificity. Notably, the residues identified are highly conserved among Bub1 proteins.
Additionally, based on the structural alignment, G1001 and Y1003 might also contact the -5 or -6
position on the substrate peptide, which was consensually found to be a hydrophobic residue (Fig-
ure 3.31).
D921 is a fully conserved amino acid on the catalytic loop of Bub1 and the only acidic residue that
might contribute to the putative substrate-binding surface. Its orientation is not entirely clear from
the electron density as it could be both facing outwards or stabilising a water molecule that is in-
volved in coordinating theMg2+ ion, which in turn would also account for its conservation. Whether
the catalytic function can be uncoupled from the regulatory role is an important question for deter-
mining kinase specificities in general. Y1003 could be required for the establishment of hydrophobic
contacts whereas G1001 is much more likely to be a gate for substrate entry with its position at the
end of a loop. As an aromatic residue, Y1003 is further at a position of kinases that is in general highly
conserved in kinases. Moreover, a proline is usually present at the position of G1001, accentuating
the structural conservation of this loop arrangement [257].
A recent study used a computational approach aimed at identifying residues that determine kinase
specificity but are not necessarily directly involved in substrate binding. Thus, they identified two
residues on the aC helix (named aC-1 and aC-3 positions) that confer specificity for the second
residue following the phosphorylation site (P+2) on kinase substrates [257]. Although the arrange-
ment of the aC helix in Bub1 is different from other kinases, as it is held in place by the essential N-
terminal extension, the corresponding aC-1 residue (N827 in Bub1) points out towards the substrate-
binding loop, making it an attractive candidate for conferring specificity. With this computational
approach the study further identifies the seventh residue preceding the APEmotif (APE-7) at the end
of the P+1 loop of kinases (CVE in Bub1) to be implicated in substrate recognition at the P+1 posi-
tion of the substrate [257]. In Bub1, this APE-7 residue is equivalent to T968, immediately preceding
the autophosphorylation site S969. Furthermore, in the structure presented in [224], T968 is in a
position consistent with the accommodation of the P+1 residue of a substrate. Hence, the APE-7
position identified in [257] is in excellent agreement with the findings of this thesis highlighting the
importance of correct positioning of the P+1 loop in mediating substrate binding for efficient kinase
activity.
In conclusion, efficient catalytic activity in the case of Bub1 requires on one hand autophosphoryla-
tion of S969, which rearranges the P+1 loop, leading to a conformation suitable for substrate binding.
On the other hand, highly conserved residues on the C-lobe of Bub1 (L875/N879 and G1001/Y1003)
contribute to conferring specificity of the phosphorylation of kinetochore substrates.
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4.4 Perspectives
Bub1 has multiple functions during mitosis and is an important regulator in the spindle assembly
checkpoint. Bub1 is critical to localise the chromosomal passenger complex and to recruit the co-
hesin protector, Sgo1, to kinetochores by phosphorylating histone H2A. Bub1 further regulates the
recruitment of other checkpoint components, such as BubR1, Cdc20 andMad1 to kinetochores. It is
therefore important to understand themechanism of how Bub1 acts on its substrates and how Bub1
activity is regulated during the cell cycle. Within the scope of this dissertation, I aimed to answer
these questions by providing potential substrate determinants of Bub1 kinase and also generating
a possible substrate consensus sequence. Additionally, I set out to establish the role of autophos-
phorylation of Bub1 kinase while excluding regulation by Bub1 binding partners at the kinetochore.
Finally, my obtained results add to the understanding of the recruitment mechanism of BubR1 and
Cdc20 to the kinetochore.
Most evidence advancing our knowledge of kinetochore machinery is derived from observations in
cells, of phenotypes associatedwith proteinmutations in vivo, an approachwhich is limited in infer-
ring molecular mechanisms. Biochemical reconstitution of spindle checkpoint complexes building
upon a Knl1-Bub1:Bub3 scaffold will be revealing in determining direct dependencies and interac-
tions. Structural work on a Knl1-Bub1:Bub3-BubR1:Bub3-Cdc20 complex by electron microscopy
would allow determination of the recruitment process. The investigation of smaller protein con-
structs, notably around the interface of Bub1:Bub3-BubR1:Bub3, possibly in complex with Cdc20,
using X-ray crystallography would be very valuable as well.
Further structural studies will also be insightful for the analysis of the Bub1 substrate-bindingmech-
anism. Attaching a substrate peptide to theN-terminus of Bub1 rather than the C-terminusmight be
of use. Alternatively, coupling of a nucleotide to a substrate peptidemimicking a phosphoryl-transfer
transition state could prove a promising approach. It would be advantageous to further assess the
role of individual residues within the recognitionmotif of Bub1 substrates, whichmay be useful also
for the identification or characterisation of further Bub1 substrates. Although extensive attempts
have already been made here to obtain a crystal structure of the human BubR1 kinase, it might be
worthwhile making use of the BubR1 kinase domain from a different organism for crystallographic
purposes. A crystal structure might shed light on the molecular basis of kinase inactivity as well as
the evolutionary development of Bub kinases in general.
The concept of Bub1 as a constitutively active kinase has several implications for its regulation at the
kinetochore. Bub1 autophosphorylation is required for its activation but is most likely also involved
inmediating its own kinetochore turnover [237]. Therefore, it is crucial to ascertain howBub1 activity
is silenced and Bub1 is removed from those kinetochores that are correctly attached tomicrotubules.
Mechanisms that ensure the timely inactivation of a mitotic kinase are crucial to guarantee faithful
cell division. This might be achieved by phosphatase activity counterbalancing kinase activity. It is
appealing to identify an antagonistic bona fide phosphatase for Bub1 substrates and Bub1 itself. In
particular, whether phosphorylated S969 on the kinase itself could also be a phosphatase target is
an intriguing question. Particularly with regard to the presence of an acidic residue in this position
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in other eukaryotes, the identification of a phosphatase could reveal a difference in Bub1 regulation
between distinct species. Mutational studies of constitutively active Bub1 mutants (S969D) in hu-
man cell lines, or the artificial introduction of a serine in the corresponding position in yeast could
shed more light on this mechanism. On the other hand, aside from phosphorylation, other post-
translational modifications might be used as a Bub1 degradation or inactivation signal. Ultimately,
the factors that mediate and control Bub1 kinase silencing or removal are yet unknown. Elucidating
the factors and mechanisms that regulate kinase activity downstream of mitotic signalling will con-
tribute to a more general grasp of mitotic mechanisms and advance our understanding of upstream
cell cycle control.
In conclusion, this study significantly contributes to unraveling the elaborate mechanism of spin-
dle assembly checkpoint signalling by Bub1, Bub3, BubR1 and Cdc20 checkpoint proteins and to
unveiling molecular details of the regulation of Bub1 activity. Understanding how these molecular
interactions are orchestrated and supervised in the larger framework of the kinetochore and spindle
assembly checkpoint in the effort to govern cell division, remains a challenge for future studies.
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5.1 Materials
5.1.1 Chemicals and Reagents
The chemicals and reagents used in this thesis were obtained in the highest purity possible, they are
summarised together with used kits, enzymes andmolecular weight standards in Table 5.1.
Table 5.1: List of enzymes, kits and chemicals consistently used for the preparation of this manuscript.
ENZYMES / REAGENTS SUPPLIER
Acetic acid Sigma-Aldrich, St. Louis, USA
Acetonitrile LGC PromochemWesel, Germany
Acrylamide (30 %, Mix 37.5 : 1) AppliChem GmbH, Darmstadt, Germany
Adenosine-5‘-diphosphate (ADP) Jena Bioscience GmbH, Jena, Germany
Adenosine-5‘-triphosphate (ATP) Sigma-Aldrich, St. Louis, USA
Adenosine-5’-[(b,g)-imido]triphosphate (AppNHp) Jena Bioscience GmbH, Jena, Germany
Adenosine-5’-(3-thio)-triphosphate (ATPgS) Jena Bioscience GmbH, Jena, Germany
ADP-GloTM Kinase Assay Promega Corp., Madison, USA
Agarose ultrapure InvitrogenTM Life Technologies, Carlsbad, USA
Agarose LE (low electroendosmosis) Roche Applied Science, Penzberg, Germany
Ammoniumperoxosulfate (APS) Serva Electrophoresis GmbH, Heidelberg, Germany
Ampicillin Serva Electrophoresis GmbH, Heidelberg, Germany
b-Mercaptoethanol Serva Electrophoresis GmbH, Heidelberg, Germany
Bovine Serum Albumine (BSA) Carl Roth Chemie GmbH, Karlsruhe, Germany
Bradford Protein Assay Bio-Rad Laboratories Inc., Hercules, USA
Bromophenol blue Sigma-Aldrich, St. Louis, USA
Coomassie G250/R250 Serva Electrophoresis GmbH, Heidelberg, Germany
Dimethylsulfoxide (DMSO) Serva Electrophoresis GmbH, Heidelberg, Germany
Dithioerythritol (DTE ) Serva Electrophoresis GmbH, Heidelberg, Germany
DNA Polymerases Q5®/Phusion®, DNA ligase T4 New England Biolabs, Ipswich, USA
AccuPrimeTM Taq DNA Polymerase InvitrogenTM Life Technologies, Carlsbad, USA
DNA ladder GeneRulerTM 1kb Fermentas, St. Leon-Rot, Germany
Ethanol (EtOH) Thermo Fisher Scientific, Waltham, USA
Ethylenediaminetetraacetic acid (EDTA) Gerbu Biotechnik GmbH, Heidelberg, Germany
Fetal Calf Serum (FCS) Gibco® Life Technologies, Carlsbad, USA
FuGENE®HD Transfection reagent Promega Corp., Madison, USA
Gentamycine Serva Electrophoresis GmbH, Heidelberg, Germany
Glycerol Gerbu Biotechnik GmbH, Heidelberg, Germany, Sigma-Aldrich, St.
Louis, USA
Hydrochloric acid (HCl) AppliChem GmbH, Darmstadt, Germany
4-(2-Hydroxyethyl)-piperazine-1-ethanesulfonic acid (HEPES) Sigma-Aldrich, St. Louis, USA
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Table 5.1 continued
Imidazole Merck KGaA, Darmstadt, Germany/ Sigma-Aldrich, St. Louis, USA
Isopropyl-b-D-thiogalactopyranoside (IPTG) Carl Roth Chemie GmbH, Karlsruhe, Germany
Kanamycine Gerbu Biotechnik GmbH, Heidelberg, Germany
Laboratory Film - Parafilm Bemis Company Inc., Neenah, USA
Lactose Sigma-Aldrich, St. Louis, USA
L-Glutathione reduced AppliChem GmbH, Darmstadt, Germany
l-Phosphatase Dortmund Protein Facility (DPF), Dortmund, Germany
Magnesium chloride (MgCl2) J.T.Baker Chemicals, Center Valley, USA
N-methylanthraniloyl-(mant)-adenosin-5’-triphosphate-
gamma-S (mantATPgS)
Jena Bioscience GmbH, Jena, Germany
Methanol (MeOH) Sigma-Aldrich, St. Louis, USA
Midori Green Nippon Genetics, Düren, Germany
2-(N-morpholino)-ethanesulfonic acid (MES) Sigma-Aldrich, St. Louis, USA
N, N, N’, N’-Tetramethylethylenediamine (TEMED) Carl Roth Chemie GmbH, Karlsruhe, Germany
NucleoSpin® Plasmid Isolation Macherey-Nagel, Düren, Germany
Phenylmethylsulfonylfluorid (PMSF) Serva Electrophoresis GmbH, Heidelberg, Germany
Phos-tagTM Acrylamide AAC-107 Wako Pure Chemical Industries, Ltd., Osaka, Japan
Polyethylenglycol (PEG) 300, 3350, MME 550, 2000 Sigma-Aldrich, St. Louis, USA
Potassium Chloride (KCl) Sigma-Aldrich, St. Louis, USA
Potassium dihydrogenphosphate (K2HPO4) AppliChem GmbH, Darmstadt, Germany
Precision Plus Protein Unstained/Stained Standards Bio-Rad Laboratories Inc., Hercules, USA
Pro-Q® Diamond Phosphoprotein Gel Stain InvitrogenTM Life Technologies, Carlsbad, USA
Proteases (TEV, PreScission) Dortmund Protein Facility (DPF), Dortmund, Germany
Proteases (Trypsin, Chymotrypsin, Elastase, GluC, Subtilisin) Promega Corp., Madison, USA
Protease Inhibitor Mix HP Plus Serva Electrophoresis GmbH, Heidelberg, Germany
Restriction Endonucleases New England Biolabs (NEB), Ipswich, USA
Crystallisation Suites (JCSG Core I – IV JCSG+, Classics, PACT,
PEG I + II, ProComplex,AmSO4)
Qiagen, Hilden, Germany
Crystallisation-Additive Screen HT Hampton Research Aliso Viejo, USA
Sodium acetate (NaAc) Sigma-Aldrich, St. Louis, USA
Sodium Chloride (NaCl) Sigma-Aldrich, St. Louis, USA
Sodium dodecyl sulfate (SDS) Carl Roth Chemie GmbH, Karlsruhe, Germany
Sodium hydroxide (NaOH) Waldeck GmbH & Co. KG, Münster, Germany
Tetracycline Serva Electrophoresis GmbH, Heidelberg, Germany
Tris-(hydroxymethyl)-aminomethane (Tris) Sigma-Aldrich, St. Louis, USA
Tris-(2-carboxyethyl)-phosphine (TCEP) Sigma-Aldrich, St. Louis, USA
Triton X-100 Serva Electrophoresis GmbH, Heidelberg, Germany
Wizard® SV Gel and PCR Clean-Up System Promega Corp., Madison, USA
5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal) Thermo Fisher Scientific, Waltham, USA
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DNA oligonucleotides were exclusively ordered from Eurofins-MWGOperon (Ebersberg, Germany),
desalted and lyophylised. They were dissolved in TE or H2O to a stock solution of 100 pmol/µl and
diluted in H2O to 5 µMprior to use. An overview of the plasmids is given in Table 5.2. A comprehen-
sive list of oligonucleotides can be found in Table 6.2 (Appendix).
Table 5.2: Protein constructs and corresponding vectors created and used in the course of this work.
ENCODED PROTEIN CONSTRUCT VECTOR NAME SOURCE
Borealin 1-280, Survivin 1-142 pGEX-2rbs-BorealinSurvivin Musacchio lab
Bub1 1-1085, Bub3 1-328 pFG-Bub1:Bub3 this manuscript
Bub1 1-1085, Bub3 1-328 pFH-Bub1:Bub3 this manuscript
Bub1 1-1085 D917N, Bub3 1-328 pFH-Bub1_D917N:Bub3 this manuscript
Bub1 1-1085 K821R, Bub3 1-328 pFH-Bub1_K821R:Bub3 this manuscript
Bub1 1-1085 (KEN535-537AAA), Bub3 1-328 pFH-Bub1:Bub3_KEN1mut this manuscript
Bub1 1-1085 (F527A, F530A KEN535-537AAA), Bub3 1-328 pFH-Bub1:Bub3_ABBAmutKEN1mut this manuscript
Bub1 1-1085 (KEN535-537AAA, KEN625-627AAA), Bub3 1-328 pFH-Bub1:Bub3_KEN1mutKEN2mut this manuscript
Bub1 1-1085 (KEN625-627AAA), Bub3 1-328 pFH-Bub1:Bub3_KEN2mut this manuscript
Bub1 1-1085 (F527A, F530A), Bub3 1-328 pFH-Bub1:Bub3_ABBAmut this manuscript
Bub1 740-1085 pFH-Bub1C_740 this manuscript
Bub1 726-1085 pFG-Bub1C Musacchio lab
Bub1 726-1085, D917N pFG-Bub1C_D917N this manuscript
Bub1 726-1085, S969D pFG-Bub1C_S969D this manuscript
Bub1 726-1085, S969E pFG-Bub1C_S969E this manuscript
Bub1 726-1085, S969A pFG-Bub1C_S969A this manuscript
Bub1 726-1085, L875A, N879A pFG-Bub1C_LN this manuscript
Bub1 726-1085, G1001A, Y1003A pFG-Bub1C_GY this manuscript
Bub1 726-1085, L875A, N879A, G1001A, Y1003A pFG-Bub1C_LNGY this manuscript
Bub1 726-1085, H2A 115-130 pFG-Bub1C_(GS)3H2Ac this manuscript
Bub1 726-1085, H2A 115-130 T120A pFG-Bub1C_(GS)3H2AcTA this manuscript
Bub1 726-1085, H2A 115-130 pFG-Bub1C_(GS)4H2Ac this manuscript
BubR1 1-1050, Bub3 1-328 pFH-BubR1:Bub3 this manuscript
BubR1 543-1050 pFH-BubR1C-543 Musacchio lab
BubR1 697-1050 pFH-BubR1C-697 Musacchio lab
BubR1 705-1050 pFH-BubR1C-705 this manuscript
BubR1 705-1043 pFH-BubR1C-705DC this manuscript
BubR1 712-1050 pFH-BubR1C-712 this manuscript
BubR1 718-1050 FH-BubR1C-718 this manuscript
Cdc20 1-499 pFG-Cdc20 Musacchio lab
H2A 1-130 pET3-H2A Musacchio lab
H2A 115-130 pGEX-2rbs-H2Ac this manuscript
H2A 115-130 V114D, L115N, L116N pGEX-2rbs-H2AcDNN this manuscript
Knl1 138-161 pGEX-MBP-Knl1-MELT1 Musacchio lab
Knl1 138-191 pGEX-MBP-Knl1-MELT1KI1 Musacchio lab
Knl1 138-225 pGEX-MBP-Knl1-MELT1KI1,2 Musacchio lab
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5.1.2 Media and Solutions
Table 5.3 and Table 5.4 give an overview of media, solutions and buffers frequently used during the
production of this manuscript.
Table 5.3: Media for bacterial and insect cell culture. Bacterial media and agar plates were prepared by the
in-house media kitchen facility.
MEDIA RECIPE / SUPPLIER
Luria Bertani (LB)
10 g tryptone, 5 g yeast extract, 10 g NaCl ad 1 l H2O, pH 7.4
(media kitchen facility)
LB agarose plates
10 g tryptone, 5 g yeast extract, 10 g NaCl ad 1 l H2O, pH 7.4
+ 1,5% agar (media kitchen facility)
Terrific broth (TB)
12 g tryptone, 24 g yeast extract, 4 ml glycerol (ad 900 ml
H2O), 2,31 g KH2PO4 (0,17 M), 12,54 g K2HPO4 (0,72 M),
ad 100 ml H2O (media kitchen facility)
Sf-900 III Serum-free medium Gibco® Life Technologies, Carlsbad, USA
Table 5.4: Buffers and solutions frequently used for the preparation of this manuscript.
All buffers were prepared using ddH2O.
SOLUTIONS RECIPE
Coomassie Staining Solution
10 % acetic acid, 50 % ethanol, 2.5 % Coomassie G250,
2.5 % Coomassie R250
Phosphate buffered saline (PBS) 8 g/l NaCl, 0.2 g/l KCl, 0.2 g/l Na2HPO4, 0.2 g/l K2HPO4
Protein sample loading buffer
50 mM Tris-HCl, 4 % SDS, 10 % glycerol, 0.02 %
bromophenol blue, 1 % b-mercaptoethanol
SDS PAGE cathode buffer 0.1 M Tris pH 8.25, 0.1 M Tricine, 3.5 mM SDS
SDS PAGE anode buffer 0.2 M Tris pH 8.9
SDS PAGE gel buffer 4 x 3 M Tris pH 8.45, 10 mM SDS
Tris-Acetate-EDTA buffer (TAE) 1 mM Tris, 1.14 ml glacial acetic acid, 10 mM EDTA (pH 8)
5.1.3 E. coli and insect cell cloning and expression strains
DNA sequences coding for recombinant proteins were cloned and amplified using Omnimax cells,
then further overexpressed using either C41 or BL21 strains. Bacmids for insect cell expression were
recombined in E. coli EmBACY cells and then used for virus production and amplification in Sf9 cells.
Protein expression was subsequently carried out in Sf9 or Tnao38 cells.
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Table 5.5: Insect cell lines and bacterial strains used for the preparation of this manuscript.
CELL STRAIN SUPPLIER
E. coli One Shot® OmniMAXTM2 T1 Phage-Resistant Cells InvitrogenTM Life Technologies, Carlsbad, USA
E. coli OverExpressTMC41 DE3 Lucigen® Corporation, Middleton, USA
E. coli BL21-CodonPlus (DE3)-RIL Competent Cells Agilent Technologies, Santa Clara, USA
E. coli DH10MultiBacTurbo
ACEMBL Expression System SeriesMultibacTurbo,
ATG:biosynthetics, Merzhausen, Germany
Spodoptera frugiperda 9 (Sf9) InvitrogenTM Life Technologies, Carlsbad, USA
Trichoplusia ni 38 (Tnao38) Gift from Gary W. Blissard [258]
5.1.4 Equipment and Tools
Tables 5.6,5.7 and 5.8 comprise a list of the instruments, software and online tools used for the prepa-
ration of this manuscript.
Table 5.6: Equipment frequently used for the preparation of this manuscript.
APPLICATION/ITEM INSTRUMENT MODEL MANUFACTURER
Agarose gel
electrophoresis
Agarose gel electrophoresis system
Carl Roth Chemie GmbH, Karlsruhe,
Germany
Biological Safety
Cabinet
Heraeus HERAsafe® HS12 Thermo Fisher Scientific, Waltham, USA
Cell Counting
ScepterTM
Merck Millipore KGaA, Darmstadt,
Germany
Neubauer counting chamber
Marienfeld-Superior, Lauda-Königsfeld,
Germany
Cell lysis Sonifier® Cell Disruptor Branson Ultrasonics Corp., Danbury, USA
Centrifuges
Universal Centrifuge 320 R
Hettich Lab Technology, Tuttlingen,
Germany
Sorvall centrifuge RC3BP+ Thermo Fisher Scientific, Waltham, USA
Microcentrifuge 5418 R Eppendorf AG, Hamburg, Germany
Avanti centrifuge J-30I Beckman Coulter, Brea, USA
Analytical: ProteomeLabTM XL-A Beckman Coulter, Brea, USA
Concentrators Amicon Ultra, MWCO 3, 10, 50 kDa Merck KGaAMillipore, Darmstadt, Germany
Documentation
- DNA
Transilluminator 2.0 Thermo Fisher Scientific, Waltham, USA
Bioprint DS Videodocumentation
LTT Labortechnik Tasler GmbH, Würzburg,
Germany
- Fluorescence/
Luminescence
Microplate reader Infinity M200 Tecan, Männedorf, Switzerland
Typhoon 3.0
Amersham Biosciences Europe GmbH,
Freiburg, Germany
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Table 5.6 continued
- Vis-Photometer BioPhotometer® Eppendorf AG, Hamburg, Germany
Filter units
WhatmanTM Membrane filters 0.2 µm ME24 GE Healthcare, Chalfont St. Giles, UK
Filtropur S syringe filters 0.2 µm Sarstedt AG & Co, Nümbrecht, Germany
Rotilabo® syringe filters 0.8 µm
Carl Roth Chemie GmbH, Karlsruhe,
Germany
Fast protein liquid chromatography (FPLC)
- System ÄKTA
Purifier,
Prime
plus
GE Healthcare, Chalfont St. Giles, UK
- Affinity
GSTrapTM FF 5 ml GE Healthcare, Chalfont St. Giles, UK
Amintra Glutathione Resin Expedeon Inc., San Diego, USA
HisTrapTM FF 5 ml GE Healthcare, Chalfont St. Giles, UK
Nickel-NTA-Superose Beads GE Healthcare, Chalfont St. Giles, UK
HiTrap Heparin
HP 5
ml
GE Healthcare, Chalfont St. Giles, UK
- Anion-exchange Resource Q 6ml GE Healthcare, Chalfont St. Giles, UK
- Size exclusion
HiLoad Superdex
75 PG,
200 PG
GE Healthcare, Chalfont St. Giles, UK
Superdex 75, Superdex 200, Superose 6
10/300
GL
GE Healthcare, Chalfont St. Giles, UK
Glass Beads Glass beads (2.85-3.45mm) Carl Roth GmbH, Karlsruhe, Germany
Incubator Shaker Multritron®
Version
2
Infors AG, Bottmingen, Switzerland
Mass spectrometry
Finnigan LCQ Advantage Max Spectrometer Thermo Fisher Scientific, Waltham, USA
EASY-nLC 1000 HPLC system
Thermo Fisher ScientificTM, Odense,
Denmark
Quadrupole Orbitrap mass spectrometer (Q ExactiveTM) Thermo ScientificTM, Odense, Denmark
Microscopes
CX41 with camera Olympus DP21 RF200 Olympus Corporation, Tokyo, Japan
Leica with power supply KL1500 LCD M125 Leica Microsystems, Wetzlar, Germany
Mixer
Vortex-Genie® 2 Scientific Industries, Inc., Bohemia, USA
Magnetic stirrer IKA® RH Basic 2
IKA®-Werke GmbH & CO. KG, Staufen,
Germany
Programmable rotator
Bio
RS-24
BioSan, Riga, Latvia
Thermomixer Comfort Eppendorf AG, Hamburg, Germany
PCR Professional Trio Thermocycler Analytik Jena AG, Jena, Germany
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Table 5.6 continued
Pipettes
Eppendorf research pipettes Eppendorf AG, Hamburg, Germany
Tips: 2-10 µl, 2-200 µl, 100-1000 µl Sarstedt AG & Co, Nümbrecht, Germany
Multichannel: RAININ Pipet-lite XLS Mettler Toledo, Columbus, USA
pH-meter Basic Meter PB-11 Sartorius, Göttingen, Germany
Plasticware
Cuvettes, 15 ml-, 50 ml tubes Sarstedt AG & Co, Nümbrecht, Germany
Half-volume 96-well plates, white
Cayman Chemical Company, Ann Arbor,
USA
Reaction tubes 0.5 ml, 1.5 ml, 2 ml, 5 ml Eppendorf AG, Hamburg, Germany
Power Supply Unit Power Pac 300 Bio-Rad Laboratories Inc., Hercules, USA
Protein Crystallography
- Imaging System Rock Imager 1000 Formulatrix Inc.,Waltham, USA
- Manual Pipetting
Aid
Liquidator96
Steinbrenner Laborsysteme GmbH,
Wiesenbach, Germany
- Crystallisation
Robot
Mosquito® Nanodispenser TTP LabTech Ltd., Melbourn, UK
- Anode MICROSTAR Bruker AXS Corp., Billerica, USA
- Detector Mar Image Plate Detector 345 Marresearch, Norderstedt, Germany
- Screening
Corning® 3550 Protein Crystallisation Plate Corning Inc., New York, USA
Crystalquick plate 96 well
Greiner Bio-One GmbH, Frickenhausen,
Germany
96-well Microplate V-Shape
Greiner Bio-One GmbH, Frickenhausen,
Germany
Crystalgen SuperClearTM Plates, pregreased Jena Bioscience GmbH, Jena, Germany
Cryschem Plate 24 well, sitting drop Hampton Research, Aliso Viejo, USA
Quantification
DNA/protein
Nanodrop 1000 Thermo Fisher Scientific, Waltham, USA
Scales
Deltarange® PM 480 Mettler Toledo, Columbus, USA
Standard BA3100P Sartorius, Göttingen, Germany
Standard CP225D Sartorius, Göttingen, Germany
SDS PAGE Mini-PROTEAN® system Bio-Rad Laboratories Inc., Hercules, USA
Thermostat Metal Thermostat Dri-Block DB2A Bibby Scientific, Stone
Water-filtration unit Millipore Synergy Desalting Unit Merck KGaA, Darmstadt, Germany
78 5 MATERIALS ANDMETHODS
Table 5.7: Online services used for the preparation of this manuscript.
ONLINE TOOLS APPLICATION WEBSITE
ConSurf Conservation mapping http://consurf.tau.ac.il
MolProbity Structure validation http://molprobity.biochem.duke.edu
Phyre2 Secondary structure prediction http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index [243]
ProtParam Protein parameter calculation http://web.expasy.org/protparam/
PSIPRED Secondary structure prediction http://bioinf.cs.ucl.ac.uk/psipred/ [244]
Reverse Complement DNA sequence inverting http://www.bioinformatics.org/sms/rev_comp.html
Sednterp Parameters for AUC analysis http://sednterp.unh.edu/#
Sequence Alignment Protein sequence alignment http://www.ebi.ac.uk/Tools/msa/muscle/
TLSMD TLS parameter determination http://skuld.bmsc.washington.edu/ [259]
Uniprot Protein sequences http://www.uniprot.org/uniprot/
Table 5.8: Software used for the preparation of this manuscript.
SOFTWARE VERSION PROVIDER
CloneManager 9.0 Scientific & Educational Software, Morrisville, USA
Gimp 2.6 GNU General Public License, www. gimp.org
Illustrator CS4 14.0.0 Adobe Systems Inc., San Jose, USA
ImageJ 1.46r Public License, N.I.H., http://imagej.nih.gov/ij/
JalView 14.0 http://www.jalview.org [250]
MagTran [260]
MaxQuant 1.5.2.18 [261]
Office Suite 14.1.0 Microsoft Corp., Redmond, USA
Origin 9.0 OriginLab Corp., Northampton, USA
Phenix 1.9-1692 PHENIX Industrial Consortium, Berkeley, USA
Pymol 1.4 Schrödinger LLC, Cambridge, UK [262]
CCP4MG 2.9.0 http://www.ccp4.ac.uk/MG/index.html [263]
SedFit 14.4d Center for Information Technology N.I.H, Bethesda, USA
Unicorn Control Software 5.31 GE Healthcare, Chalfont St. Giles, UK
Xcalibur Thermo Fisher Scientific, Waltham, USA
XDS Program Package Max-Planck-Institut für medizinische Forschung, Heidelberg, Germany
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5.2 Methods
5.2.1 Molecular biologymethods
Polymerase chain reaction (PCR)
The polymerase chain reaction (PCR) was used for preparative production of DNA. Two primers with
restriction sites specific to the target vector that anneal at the 3’ and 5’ end of the desired sequence of
a gene of interest are used to create a PCR product. The standard protocol used for PCR is depicted
in Table 5.9. The cloning of DNA sequences was either performed using enzymatic restriction or
restriction-free cloning as described below.
Table 5.9: Preparative PCR procedure.
REACTION MIX PCR PROGRAMME
45 ng DNA template 30 s 98 °C
10 µM complementary oligonucleotides 15 s 98 °C
20
cy
cl
es
5 µl 10x Polymerase buffer 20 s 58 °C
0.5 µl AccuPrimeTM Taq DNA Polymerase 20 s 68 °C
3 % DMSO 10 min 68 °C
H2O ad 50 µl 1 4 °C
Restriction cloning
Sequence-specific cutting of PCR fragments could be obtained using restriction enzymes (New Eng-
land Biolabs, Ipswich, USA). The DNA was supplemented with enzyme buffer and enzymes in ratios
according to the manufacturer’s recommendations, incubated at 37 °C for 4 h and further purified
by agarose gel electrophoresis (Section 5.2.1). The target DNA-plasmid was digested by the corre-
sponding enzymes creating compatible overhangs with the addition of shrimp alkaline phosphatase
(New England Biolabs, Ipswich, USA) to prevent re-ligation of the plasmid. The digested PCR prod-
uct and plasmidwere ligated in amolar ratio of 2:1 for 4 hwith T4-DNA-ligase (New England Biolabs,
Ipswich, USA) at 20 °C or overnight at 4 °C. This reaction was subsequently transformed in compe-
tent bacteria E. coli Omnimax by applying a 42 °C heat shock for 30 sec and immediately plating
the mix on selective media containing the respective antibiotics. Positive clones were confirmed by
DNA-restriction and verified by DNA sequencing (Beckman Coulter Genomics; Takeley, UK).
DNA extraction and purification
Agarose gel electrophoresis is used for the separation of nucleic acids according to their size. For the
preparation of thismanuscript, 0.9%agarose in 1x TAEbufferwas used supplementedwith theDNA-
binding dye Midori Green. DNA samples were mixed with DNA loading buffer (Table 5.4), loaded in
the wells of the gel and then separated by applying a constant voltage of ~100 V. The nucleic acid
standard GeneRulerTM 1kb DNA Ladder (Fermentas, St. Leon-Rot, Germany) served as a reference
for the size of the DNA fragments. DNA fragments of appropriate sizes were excised from the gel
and were extracted using the Wizard® SV Gel and PCR Clean-Up System (Promega Corp., Madison,
USA). For the amplification of plasmids, ~100 ng were transformed in competent E. coli Omnimax
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and incubated at 37 °C in 4 ml LB-medium overnight. The plasmid DNA was then isolated using the
NucleoSpin® Plasmid Isolation Kit (Macherey-Nagel, Düren, Germany).
Restriction-free cloning
This method involves PCR amplification of the gene region encoding the desired amino acid se-
quence to produce a "megaprimer". This megaprimer was produced to possess compatible over-
hangswith the target vectorwhere itwas subsequently integrated in a secondPCR reaction (http://rf-
cloning.org). The following constructs were obtained by restriction-free cloning (see also Table 5.2):
pFH-Bub1740°1085, pFG-Bub1726°1085-(GS)3/4H2A115°130, pFG-Bub1726°1085-(GS)3/4H2A115°130T120A,
pGEX-2rbs-H2Ac.
Site-directedmutagenesis of DNA
Site-directed mutagenesis was used to introduce single- or multiple-base substitution into a DNA
sequence of choice to achieve amino acid mutations. All single-amino acid mutants were generated
using the QuikChange site-directed mutagenesis instructions (Stratagene, La Jolla, USA).
DNA Sequencing
The verification of cloned plasmid DNA sequences was carried out by the sequencing service offered
at MPI Dortmund (Dortmund, Germany) or by Beckman-Coulter Genomics (Takeley, UK).
Generation of infectious baculoviruses
The baculoviral expression system is a means of expressing recombinant proteins in a eukaryotic
system, insect cells. To this end, all protein constructs were cloned into Multibac vectors (pFG, pFH,
modified after [264, 265]) recombined in a bacmid using E. coli DH10MultiBacTurbo cells following
the manufacturer’s protocol (ATG:biosynthetics GmbH, Merzhausen, Germany). Recombined and
precipitated bacmids were resuspended in 30 µl TE and then used to generate recombinant bac-
uloviruses in insect Sf9 cells using the FuGENE system (Stratagene, La Jolla, USA), according to the
manufacturer’s instructions.
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5.2.2 Protein biochemical methods
Protein expression and purification
Recombinant baculoviruses encoding the His6-tagged Bub1 and untagged Bub3 were generated us-
ing the FuGENE (Stratagene) system 5.2.1. After two rounds of virus amplification (4 days each) Sf9
or Tnao38 (see Table 5.5) cells were infected at a multiplicity of infection of 1/20-1/50 and harvested
72 hours after infection (15 min at 1165 x g, 20 °C, rotor H6000A, Sorvall centrifuge RC3BP+, Thermo
Fisher Scientific). Insect cells are grown in suspension at 27.5 °C, 110 rpm in an incubator shaker
Multitron® (Infors AG, Bottmingen, Switzerland).
For proteins produced in bacteria, the constructs have been transformed in competent E. coli (5.5),
grown overnight to inoculate cultures at OD600 of 0.05 in TBmedia supplemented with 0.2 % lactose
and the corresponding antibiotic. Cells were then initially grown for 4 h, 37 °C at 150 rpm in an in-
cubator shaker Multitron® (Infors AG, Bottmingen, Switzerland), then temperature was reduced to
25 °C for another 20-24 h of expression before cells were harvested (20 min at 5895 x g, 20 °C, rotor
H6000A, Sorvall centrifuge RC3BP+, Thermo Fisher Scientific).
Pelleted cells were either stored at -80 °C or immediately resuspended in lysis buffer at 4 °C (50 mM
Tris pH 8, 300 mM KCl, 2 mM MgCl2 and 2 mM PMSF or 1x protease inhibitor mix HP plus (Serva
Electrophoresis GmbH, Heidelberg, Germany)), sonicated (Sonifier® Cell Disruptor, Branson Ultra-
sonics Corp., Danbury, USA) and cleared by centrifugation at 108800 x g, 4 °C (Rotor JA 30.50, Avanti
J-30I, Beckman Coulter Inc., Brea, USA) and filtration of the lysate using Rotilabo® syringe filters
0.45-0.8 µm (Carl Roth Chemie GmbH, Karlsruhe, Germany).
The cleared lysate was passed on 1 ml Nickel-NTA-Superose-/GSH beads (GE Healthcare, Amintra
Glutathione Resin Expedeon Inc., San Diego, USA) or a 5 ml HisTrap FF/GSTrap FF (GE Healthcare,
Chalfont St. Giles, UK) depending on the affinity tag of the protein. The bound complex was washed
with lysis buffer to eliminate unspecifically bound proteins followed by a one-step elution in 300mM
imidazole (Ni-affinity) or 25 mM glutathione (GSH-affinity).
The eluted protein was diluted to 50 mM KCl and either directly purified by anion exchange chro-
matography (Resource Q 6 ml), or first incubated with TEV protease (all pFH constructs) or PreScis-
sion (pFG constructs) overnight or for 4 h for complete tag-cleavage. The cut protein solution was
passed over the respective affinity resin to remove the protease and affinity tag before applying
the protein on the anion exchange column. Unspecifically bound proteins were removed from the
column in a washing step followed by elution in a linear gradient to 500 mM NaCl/KCl. The frac-
tions containing the protein were monitored by UV (245 nm, 280 nm), analysed on SDS PAGE (Sec-
tion 5.2.3), then pooled, concentrated (Section 5.2.2) and passed on a gel filtration column, the re-
spective buffers are listed in Table 5.10. Proteins not exceeding 70 kDa in size were passed on a
HiLoad Superdex 75 PGor Superdex 75 10/300GL, for complexes of bigger sizes a Superdex 200 10/300,
HiLoad Superdex 200 PG or Superose 6 10/300 GL was used (all anion exchange and gel filtration
columns: GE Healthcare, Chalfont St. Giles, UK). Each of the purification steps has been carried out
at 4 °C using the ÄKTA Purifier, or Prime plus systems (GE Healthcare, Chalfont St. Giles, UK).
The pH of the purification buffers was adjusted to the theoretical isoelectric point of the specific
protein, an overview of the gel filtration buffers for specific protein constructs can be found in Ta-
ble 5.10. MgCl2 was added to lysis and gel filtration buffers of protein kinases, NaCl or KCl was added
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to buffers in different amounts depending on the protein.
Pointmutants of amino acids or short protein truncations were expressed and purified equally to the
wild-type protein. The purification of MBP-Knl1 138-225 was carried out as described [179] with the
exception of changing the desalting column to a gelfiltration step.
Table 5.10: Protein constructs, their expression system and gel filtration buffers consistently used in the
preparation of this manuscript.
Amino acid mutants and truncations of proteins were purified under the same conditions.
CONSTRUCT EXPRESSION ION EXCHANGE BUFFER GEL FILTRATION BUFFER
Borealin:Survivin E. coli C41
A: 25 mMHEPES pH 7.4, 125 mMNaCl,
1 mMDTE
B: 25 mMHEPES pH 7.4, 2 M NaCl,
1 mMDTE
25 mMHEPES pH 7.4, 150 mMNaCl,
1 mMDTE, 5 % glycerol
Bub1:Bub3,
BubR1:Bub3
Sf9, Tnao38
A: 50 mM Tris pH 8, 50 mM KCl, 2 mMDTE
B: 50 mM Tris pH 8, 1 M KCl, 2 mMDTE
50 mM Tris pH 8, 150 mM KCl, 2 mMDTE,
2 mMMgCl2
Bub1kinase,
Bub1kinase-
H2A115°130
Tnao38
A: 50 mM Tris pH 8, 50 mMNaCl, 2 mMDTE
B: 50 mM Tris pH 8, 1 M NaCl, 2 mMDTE
25 mMHEPES pH 7.6, 100 mMNaCl,
2 mM TCEP, 5 mMMgCl2
BubR1kinase Tnao38
A: 50 mMHEPES pH 7.4, 50 mM KCl,
2 mM TCEP, 1 mM EDTA
B: 50 mMHEPES pH 7.4, 1 M KCl,
2 mM TCEP
20 mMHEPES pH 7.4, 150 mM sodium
citrate/KCl, 2 mM TCEP
Cdc20 Sf9 -
50 mMMes pH 6.5, 250 mMNaCl,
2 mM TCEP, 1 mMMgCl2, 5 % glycerol
H2A115°130 E. coli C41 - 50 mM Tris pH 8, 100 mM KCl, 2 mMDTE
Knl1138°225 E. coli BL21 RIL - 50 mM Tris pH 8, 150 mM KCl, 2 mM TCEP
Concentrating protein solutions
All protein solutions were concentrated using Amicon Ultra-0.5, Ultra-4 or Ultra-15 Centrifugal con-
centrators, 3, 10 or 50 kDa MWCO, at 4 °C. The Ultra-4 and -15 concentrators were used at 1520 x g
(Universal Centrifuge 320 R, Hettich Lab Technology, Tuttlingen, Germany), the Ultra-0.5 centrifu-
gal filter devices at 5500 x rcf (Microcentrifuge 5418 R, Eppendorf AG, Hamburg, Germany). Purified
protein was concentrated in the gel filtration buffer, then flash frozen in liquid nitrogen and stored
at -80 °C.
Preparative protein phosphorylation and -dephosphorylation
In order to generate fully auto-phosphorylated (Bub1 kinase) or dephosphorylated purified samples,
the protein solution was pooled after affinity chromatography and supplemented with 1 mM ATP
and 10mMMgCl2 or l-phosphatase and 10mMMnCl2, respectively, then incubated at 4 °C overnight.
Excess of ATP or l-phosphatase was removed in an subsequent anion-exchange chromatography
step.
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Preparation of histone H2A andmononucleosomes
Histone H2A was used as a Bub1 kinase substrate and expressed in E. coli from a pET3 vector and
further purified by isolation from inclusion bodies as previously described [266].
The reconstitution and purification of histone H3 and CENP-A containing nucleosomes, which con-
sist of either H3 or CENP-A and H4, H2A, H2B and a short sequence of centromeric DNA, was pro-
duced with slight modifications for CENP-A containing nucleosomes as published before [267, 266].
Briefly, the single histones H2A and H2B are mixed in equimolar amounts to obtain a dimer while
CENP-A andH4 aremixed to obtain a tetramer. A digested centromeric DNAwith eight repeats of the
601-145 bp sequencewas combinedwithH2A/H2Bdimer andCENP-A/H4 tetramer to obtainCENP-
A nucleosomes. Histone purification and nucleosome reconstitution was largely implemented by
Doro Vogt and Federica Basilico.
5.2.3 Analytical and biophysical methods
SDS Polyacrylamide gel electrophoresis (PAGE)
SDS Polyacrylamide gel electrophoresis (SDS PAGE) is a method to separate proteins on a gel ac-
cording to their size [268]. The protein sample is mixed with a 5x SDS-sample buffer (see Table 5.4),
reduced and boiled at 95 °C. The proteins and a molecular weight standard (Precision Plus Protein
Unstained/Stained Standards, Bio-Rad Laboratories Inc., Hercules, USA) were subsequently sepa-
rated on a SDSPAGE gel (see Table 5.11) by gel electrophoresis using SDS-PAGEbuffers (see Table 5.4)
at 100 V for around 45 min.
Table 5.11: Composition of SDS gels used in this manuscript. The amounts are calculated for two 10 % gels.
SOLUTION STACKING GEL SEPARATING GEL
4x buffer (Table5.4) 0.38 ml 2.5 ml
Acrylamide 4K solution (30 %) 0.5 ml 3.2 ml
APS (10 %) 50 µl 100 µl
TEMED 5 µl 10 µl
ddH2O 2.1 ml 3.9 ml
The protein bands were visualised by staining with heated Coomassie staining solution (Table 5.4)
followed by background destaining with 10 % (v/v) acetic acid and 20 % (v/v) ethanol.
Determination of protein and DNA concentrations
Concentrations of both protein and DNA solutions were measured with a Nanodrop 1000 (Thermo
Fisher Scientific, Waltham, USA) UV-Vis spectrophotometer.
Limited proteolysis
Limited proteolysis is a means to determine stable protein fragments that are potential candidates
for further structural or biochemical characterisation. A protein or complex of interest is incubated
84 5 MATERIALS ANDMETHODS
with low amounts of proteases that cut in intrinsically unstructured or flexible regions of a polypep-
tide chain. This yields smaller cleavage products that can be further analysed by mass spectrometry
or N-terminal peptide sequencing.
In this manuscript proteins or complexes were subjected to digestion by proteases with different
site specificities: Trypsin (R, K), Elastase (A, V), Chymotrypsin (large hydrophobics), Glu C (E) and
Subtilisin (large uncharged residues). 3 mg of protein or protein complex was incubated with 3 ml of
protease (1 mg/ml stock diluted 1:10, 1:100 and 1:1000 in protease dilution buffer, 20 mM HEPES
pH 7.5, 50mMNaCl, 10mMMgSO4), for 30minutes at 4 °C. The reaction was quenchedwith protein
sample loading buffer, then analysed by SDS PAGE (see 5.2.3) using undigested protein and protease
of the highest concentration as references.
Non-equilibrium binding experiments
Qualitative binding of proteins was tested in GST-pull down experiments using GST-tagged bait pro-
tein coupled to GSH beads. Beads were blocked with BSA and washed prior to use to prevent un-
specific binding of prey proteins. Beads were incubated with 1 µM protein, rotating for 1 h at 4 °C,
then washed three times with binding buffer (50 mM Tris pH 8, 100 mM KCl, 0.05 % Tween-20) to
remove unbound protein. The bound bait was then incubated with 3 µM prey protein, rotating for
1 h at 4 °C and washed again to remove unbound or unspecifically bound protein. Alternatively, bait
and prey were premixed and bound in one single step. Analysis of bound proteins was carried out by
SDS PAGE (see Section 5.2.3) loading bait and prey alone as input reference.
Electrophoretic Mobility Shift Assay (EMSA)
The electrophoretic mobility shift assay (EMSA) is a technique for determining and visualising of
DNA-protein interactions. This method exploits the fact that protein species bound to DNAmigrate
more slowly than free DNA when subjected to agarose gel electrophoresis. Moreover, it allows to
resolve different complex assemblies dependent upon their conformation or stoichiometry. Here,
protein binding to nucleosomes was studied by EMSA using 0.5 µM nucleosomes, 22.5 mM HEPES
pH 7.5, 90 mM NaCl, 1.8 mM TCEP, 4.5 mM MgCl2, 1 mM AppNHp in a final volume of 20 µl. Dif-
ferent concentrations of protein (0-40 µM) were added, incubated for 30 min on ice before adding
2.2 µl loading dye (20 mM TEA, 1 mM EDTA, 20 % glycerol). The mix was subjected to agarose gel
electrophoresis using a 0.7 % agarose gel (Agarose LE, Roche Applied Science, Penzberg, Germany),
run in 0.2 % TBE, at 20mA for about 2 h using free DNA and unbound protein as references. Staining
and analysis as in Section 5.2.1.
Analytical ultracentrifugation
The molecular mass and stoichiometry of protein complexes was assessed by measuring the sed-
imentation velocity of a protein species in analytical ultracentrifugation. Protein complexes were
used in concentrations corresponding to amolecular absorption at 280 nmof 0.6 using the individual
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extinction coefficients as determined by ProtParam (http://web.expasy.org/protparam/). Sedimen-
tation velocity experiments were performed in an Optima XL-A analytical ultracentrifuge with Epon
charcoal-filled double-sector quartz cells and an An-60 Ti rotor (all Beckman Coulter, Brea, USA).
Samples were dialysed against buffer (50 mMTris pH 8, 150mMKCl, 3 mMMgCl2, 2 mMTCEP) that
was used as a reference. Samples were centrifuged at 203,000 x g at 20 °C and 500 radial absorbance
scans at 280 nmwere collected with a time interval of 1min. The obtained data was further analysed
in terms of continuous distribution function of sedimentation coefficients (c(S)) using SedFit [269]
with fitting parameters for the protein partial specific volume, buffer viscosity and density as deter-
mined by SEDNTERP. Data were plotted using the program GUSSI comprised in the SedFit software
[269].
Electrospray ionisationmass spectrometry (ESI-MS)
Electrospray ionisation mass spectrometry (ESI-MS) [270] is a method for the accurate determina-
tion of the molecular weight of molecules. The application of an electrical field allows the enrich-
ment of ions of the same charge, which are collected in an ion trap, where they are separated and
detected according to their sizes by applying an altering electric field. For the analysis of protein
samples, 0.5 nmol protein were desalted via HPLC on a C4 column (HPLC system LC1100, Agilent
Technologies, Santa Clara, USA) and eluted a combination of 0.1 % TFA (trifluoroacetic acid) in H2O
(buffer A) and 0.08 % TFA in acetonitrile (buffer B) using a linear gradient to 20 % buffer A and 80 %
buffer B. The mass analysis of the samples was performed using a Finnigan LCQ Advantage MAX
mass spectrometer (Thermo Fisher Scientific, Waltham, USA). The software Xcalibur and MagTran
[260] were used for analysis and deconvolution of mass spectra; the accuracy of the weight determi-
nation of proteins via ESI-MS is estimated to be approximately 7 Da.
Phosphorylation-site analysis
Liquid chromatography coupled with mass spectrometry was used to assess the phosphorylation
status or novel phosphorylation sites. The proteins of interest (~10 µg) were incubated with 10 nM
kinase in buffer (25 mM Tris pH 7.6, 10 mMMgCl2, 150 mMNaCl, 5 mM TCEP) and 0.5 mM ATP for
at least 4 h at 25 °C. Samples were then digested with LysC/Trypsin and/or GluC and prepared for
LC-MS/MS analysis as previously described [271]. 100 ng of peptides were separated on a Thermo
ScientificTM EASY-nLC 1000 HPLC system (Thermo Fisher ScientificTM, Odense, Denmark); in an
one hour gradient from 5-60 % acetonitrile with 0.1 % formic acid and directly sprayed via a nano-
electrospray source in a quadrupole Orbitrapmass spectrometer [272] (Q ExactiveTM, Thermo Fisher
ScientificTM) . The Q ExactiveTM was operated in data-dependent mode acquiring one survey scan
and subsequently ten MS/MS scans [273]. Resulting raw files were processed with the MaxQuant
software (version 1.5.2.18) using a reduced database containing only the proteins of interest for the
search and giving phosphorylation on serine, threonine and tyrosine as variable modification [261].
A false discovery rate cut off of 1%was applied at peptide and protein levels and the phosphorylation
site decoy fraction. Proteolysis and phospho-peptide analysis was kindly performed by Franziska
Müller and Tanja Bange.
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Cross-linking analysis coupled withmass spectrometry
This method was used to identify potential sites of protein-protein interaction of larger protein as-
semblies. Experiments of cross-linking coupled with mass spectrometry were carried out and anal-
ysed in collaboration with Dr. Franz Herzog’s laboratory at the Ludwig Maximilian University in
Munich [274, 275].
5.2.4 Kinetic characterisation of kinase constructs
The kinetic parameters of the studied proteins were determined either by measuring the change in
fluorescence of a 2’-/3’-O-(N’-Methylanthraniloyl) (mant) [239] labeled nucleotide or using the ADP-
GloTM Kinase Assay. Reaction temperature for all experiments was 27 °C. The different methods will
be explained in more detail below.
Determination of catalytic parameters (ADP Glo Assay)
The ADP-GloTM Kinase Assay was implemented to allow for the quantitative measurement of ADP
produced in the kinase reaction. The schematic working principle is depicted in Figure 5.1. The
kinase reaction was carried out by mixing in a total volume of 45 µl, a first substrate (concentrations
from 0 to 200 µM)with a second substrate (saturating concentration 200 µM) in kinase buffer (25mM
Tris pH 7.6, 10 mM MgCl2, 150 mM NaCl, 5 mM TCEP) and starting the reaction by the addition of
10 nM kinase. For each time point (0, 3, 7, 14 min) 8 µl were taken from the mix and quenched in
ADP-Glo reagent and incubated for ∏ 45 min in 8 µl ADP Glo reagent already present in a white half-
volume 96-well plate. Kinase detection reagent (16 µl) was added and the mix further incubated for
30 min. Luminescence of the detection reaction was recorded using the plate reader Infinity M200
(Microplate reader M200, Tecan, Männedorf, Switzerland).
Kinase
Reaction
Quenching
Depletion
ADP-ATP    Reversion
ATP
ADP
Luminescence
Signal
Generation
Figure 5.1: Working principle of the ADP-GloTM Kinase Assay.
The assay was performed in two steps: after completion of the kinase reaction, the first reagent (ADP Glo
reagent) was added to quench the activity and deplete the remaining ATP; in a second step another reagent
was added, which reverts the remaining ADP into ATP to be detected by a luciferase/luciferin reaction. The
luminescent signal produced is linearly correlated to the amount of ADP produced in the kinase reaction and
therefore a readout for kinase activity. Modified from ADP-GloTM Kinase Assay Technical Manual (Promega
Corp., Madison, USA).
The catalytic parameters KM and kcat could be determined by means of measuring velocities from
time course experiments using different substrate concentrations. Plotting the initial reaction ve-
5.2 Methods 87
locities n0 as a function of the substrate concentrations used [S], considering the enzyme concen-
tration [E], obtained the kinetic parameters KM and kcat from the relation known in enzymology as
Michaelis-Menten equation (equation 5.1).
n0
[E ]
= [S]kcat
[S]+KM . (5.1)
n0 initial reaction velocity (nM sec°1)
[E] enzyme concentration (nM)
[S] substrate concentration (µM)
kcat turnover number (sec°1)
KM Michaelis-Menten constant (µM)
The obtained data plots were fitted and analysed using the Origin 9.0 software (OriginLab Corp.,
Northampton, USA).
Fluorescence anisotropy
The binding of nucleotides to the studied kinases was carried out as described in reference [240].
Mant-labeled nucleotide was titrated from 0-1 mM to the kinase using 1 mM kinase in all measure-
ments. Fluorescence emission at 450 nm (excitation at 340, detection 450 nm) was recorded using a
microplate reader Infinity M200 (Tecan, Männedorf, Switzerland); the emission of mant-nucleotide
alone was subtracted from the emission of the complex to obtain a binding isotherm. Data were fit-
ted to a one site binding model equation using the Origin 9.0 software (OriginLab Corp., Northamp-
ton, USA) to determine binding parameters.
5.2.5 X-ray crystallography
X-ray crystallography is amethod that allows to determine the structure of amolecule, like a protein,
on atomic level. To this end the molecule needs to be obtained as a crystal that is subjected to x-ray
and the diffracted rays are collected on a detector as a diffraction pattern. This diffraction pattern
is characteristic for each crystal and allows the determination of the electron density in the crys-
tal, which can then be used as a model to build a 3-dimensional structure of the molecule. In this
manuscript the structure of phosphorylated Bub1 kinase (726-1085) was solved. Initial crystallis-
ing conditions were obtained using 5 g/l protein and 2 mM ADP, a Mosquito® Nanodispenser (TTP
LabTech Ltd., Melbourn, UK), Corning® 3550 Protein Crystallisation Plates (Corning Inc., New York,
USA) and the Core I-IV crystallisation solutions (Qiagen, Hilden, Germany). The conditions were
refined to obtain diffraction-quality diamond-shaped crystals of 200 µm diameter after two days at
4 °C, in a sitting drop vapour diffusion Cryschemplate 24 well (Hampton Research, Aliso Viejo, USA).
The reservoir solution contained 15 % PEG 3350 and 0.2 M NaCl, crystals were cryo-protected in
this reservoir solution supplemented with 20 % (v/v) glycerol and then flash-frozen in liquid nitro-
gen. Different crystals of varied conditions were initially tested for diffraction at the Max-Planck-
Institute (MICROSTAR x-ray source, Bruker AXS Corp., Billerica, USA; Mar345 Image Plate Detector,
Marresearch GmbH, Norderstedt, Germany).
88 5 MATERIALS ANDMETHODS
Exhaustive attempts have been performed unsuccessfully to obtain crystals of the BubR1 kinase do-
main. Initial crystallising attempts of the MBP-Knl1138°225-Bub1:Bub3-BubR1:Bub3 complex failed
as well as the comprehensive effort to obtain crystals of sufficient diffraction quality of phosphory-
lated Bub1kinase co-crystallised- or as a direct fusion with H2A peptide (amino acids 115-128). Crys-
tals could be obtained for phosphorylated Bub1kinase by co-crystallisation with an H2A peptide but
the obtained electron density map showed no apparent density for either a bound peptide or the
substrate binding loop of Bub1. A summary of these protein constructs and crystallisation strategy
used can be found in Table 5.12.
Table 5.12: Protein constructs and crystallisation strategies.
Indicated for the crystallisation of BubR1 kinase domain, the Knl1-Bub1:Bub3-BubR1:Bub3 complex and the
crystallisation of phosphorylated Bub1 with a H2A peptide in fusion or co-crystallisation attempts. All success-
ful crystallisation conditions were obtained at 4 °C.
CONSTRUCT STRATEGY PROTEIN CONDITIONS
CRYSTALLISING
CONDITION
BubR1543°1050
JCSG Core I-IV, Classics, PACT, PEGs I-II
(Qiagen, Hilden, Germany)
8 g/l – none –
BubR1697°1050 JCSG Cores I-IV, JCSG+, ComPAS, AmSO4,
Anions, Cations, ClassicsI-II, Cryos, MPD,
PACT, PEGsI-II, ProComplex (Qiagen,
Hilden, Germany), Methylation [245, 246]
10 g/l, 1 mM
ADP/AppCp, 5 %
glycerol
– none –
BubR1705°1050
8-10 g/l, 150 mM
sodium citrate / 1M
KCl / 150 mM KCl
– none –
BubR1705°1044
expressed by DPF, not stable – none –
BubR1712°1050
BubR718°1050 expressed by DPF, insufficient purity – none –
Knl1-B1:B3-BR1:B3 JCSG Core I-IV (Qiagen, Hilden, Germany) 4 g/l – none –
Bub1740°1085
co-crystallisation with H2A peptide, amino
acids 115-128 (human, T120A)
5 g/l, 2 mM ADP,
autophosphorylated
– none –
Bub1726°1085
co-crystallisation with H2A peptide, amino
acids 115-128 (human, human T120A, or
xenopus laevis), 20 °C, 4 °C
5 g/l, 2 mM ADP /
ATPgS / AppNHp,
autophosphorylated
0.1 M Tris pH 7.0-7.2,
20-23 % PEGMME
2000 (by seeding)
co-crystallisation with H2A/H2B
5 g/l, 15 g/l H2A/H2B,
BeF3 / NaVO4,
autophosphorylated
– none –
Bub1kinase-
GS3/4H2A
115°130
Bub1kinase-
GS3/4H2A
115°130_T120A
JCSG Core I-IV, Opti Salts (Qiagen, Hilden,
Germany), Crystallisation-Additive Screen
HT (Hampton Research Aliso Viejo, CA,
USA)
4-5 g/l, 2-5 mM
ADP/ATPgS/AppNHp
0.1 M Na-acetate
pH 4.4-4.6, 0.2 M NaCl,
40 % PEG 300, 3 %
MeOH/EtOH, 2-5 mM
ADP (no diffraction)
Data collection and processing
Diffraction data were collected from crystals cooled to 100 K at the X-ray source X10SA of the Swiss
Light Source (Paul Scherrer Institute, Villigen, Switzerland) at a wavelength of 1 Å. Images were
recorded on a Pilatus 6M detector, indexed and integrated using XDS and scaled using XSCALE [276]
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in the CCP4 programme suite. Based on the unit cell volume the Matthews Coefficient suggested
two copies of phosphorylated Bub1kinase per asymmetric unit. The crystal diffracted to a minimum
Bragg spacing of 2.4 Å and exhibited space group P21 with cell parameters a= 62 Å, b=66 Å, c=107,
b=98. Data collection statistics and cell parameters are listed in Table 6.1 (Appendix).
Structure Solution and Refinement
Initial phases of the phosphorylated Bub1kinase were obtained by molecular replacement using the
programme PHASER [277]. The coordinates of human Bub1 kinase (PDB ID: 3E7E, [214]) were used
as initial search model. Note, that these coordinates have later been re-refined with ADP and a sec-
ondMg ion instead of ATP in the electron density of the active site, which was then resubmitted with
the PDB ID 4R8Q. The initial structure of the Bub1kinase was further refined using rigid-body refine-
ment and iterative rounds of restrained refinement using PHENIX [278] with TLS parameters [259]
to better account for anisotropic observed B factors, interspersedwithmanual rebuilding using Coot
[279, 280]. The final model was validated using MolProbity [281, 282]. Graphical representation or
movies were generated using CCP4MG 2.9.0 [263] or Pymol [262].
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Table 6.1: Data collection and refinement statistics for phosphorylated Bub1 kinase (PDB ID 5DMZ).
DATA COLLECTION
Wavelength (Å) 1.0000 Å
Resolution range (Å) 43.3 - 2.4 (2.486 - 2.4)
Space group P 1 21 1
Unit cell (a, b, c, a, b, g) 62.38 66.34 106.54
90 98.34 90
Total reflections 233252 (23340)
Unique reflections 33866 (3332)
Multiplicity 6.9 (7.0)
Completeness (%) 99.85 (99.70)
Mean I/sv (I) 11.24 (1.03)
Wilson B-factor 56.36
Rmerge 0.1133 (2.202)
Rmeas 0.1227 (2.620)
CC1/2 0.999 (0.592)
CC* 1 (0.863)
REFINEMENT STATISTICS
Reflections used for R-free 1694
Rwork 0.211 (0.386)
Rfree 0.245 (0.406)
Number of non-hydrogen atoms 5606
Macromolecules 5526
Ligands 56
Water 24
Protein residues 680
Missing residues A/B: 726-734; 807-815; 1084-1085
RMS (bonds) 0.004
RMS (angles) 0.853
Ramachandran favoured (%)* 98
Ramachandran outliers (%)* 0
Clashscore* 4.49
Average B-factor 78.6
Macromolecules 78.9
Ligands 63.1
Solvent 50.6
Data for the highest-resolution shell are given in parentheses.
Rmerge = 100PhPi ØØIh,i°hIhiØØ/PhPi Ih,i , where the outer sum (h) is over the unique reflections
and the inner sum (i) is over the set of independent observations of each unique reflection.
Rwork =
P
hkl ||Fobs |°|Fcalc ||/PFobs , where Fobs and Fcalc are the observed and calculated
structure factors of the respective reflexes hkl.
Rfree was determined corresponding to Rwork for random 5 % of the reflexes, which have been
excluded from use in the refinement.
* As defined by MolProbity [281]
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Figure 6.1: Sedimentation velocity absorption profiles.
Radial signals of the sedimentation velocity absorption profiles of the Bub1:Bub3 (left) and BubR1:Bub3 (right)
complexes and the corresponding residuals of the fits showing the deviation of the c(S)model from the observed
signals.
Figure 6.2: ADP standard used for the quantifica-
tion of kinase activity performed with the ADP-
GloTM Kinase Assay.
The amount of ADP (µM) is linearly correlated to
the luminescence (RLU) generated in a kinase re-
action by the ADP-GloTM Kinase Assay (Promega).
The slope of the curve was determined in a linear
curve fit as 5077 (RLU/µM) with R2=0.99.
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Figure 6.3: Mant-ATP is a substrate of Bub1kinase.
Unphosphorylated Bub1kinase (black) efficiently au-
tophosphorylates using ATP (red) as well as mant-ATP
(green) as a substrate. The autophosphorylation reac-
tion with and without mant-ATP was analysed by ESI-
MS. The theoretical weight of the unphosphorylated
and phosphorylated protein is given in parentheses.
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Figure 6.5: GST-H2Ac (H2A113°130) and not GST is a substrate of Bub1 kinase.
GST, GST-H2Ac and H2A were incubated with 30 nM Bub1kinase and ATP, then analysed by SDS PAGE and
Coomassie blue staining (right). Phosphates were visualised using the Pro-Q® Diamond Phosphoprotein Gel
Stain (left). Phosphorylated Bub1kinase was used as a positive control for phosphostaining.
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Figure 6.6: Bub1kinase S969E is an active
enzymewhile S969A is catalytically ineffi-
cient.
H2A phosphorylation was analysed on SDS
PAGE after incubation with Bub1kinase or
Bub1kinase S969E/A and ATP using Pro-
Q®Diamond Phosphoprotein Gel Stain.
The figure has been cropped showing only
the relevant lanes.
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Figure 6.7: The electrostatic potential of the sur-
face of Bub1kinase shows a highly negatively
charged cleft opposing S969p.
The electrostatic potential was drawn around
Bub1kinase, the residues contributing to the neg-
ative electrostatic potential are indicated; S969,
ADP and Mg are shown as sticks or sphere, re-
spectively. The position of Gly-rich loop, activa-
tion loop and P+1 loops ismarked. The imagewas
created with CCP4MG. P+1-
loop
ADP
P-S969
D917
Mg2+
activation
-loopGly-rich-loop
D921
D946 E967
Figure 6.8: Bub1kinase mutants LN, GY, LNGY
are active enzymes that autophosphorylate.
Autophosphorylation was analysed on SDS
PAGE after incubation of Bub1kinase proteins
with ATP using Pro-Q®Diamond Phosphopro-
tein Gel Stain. Note, the mutant proteins are
tagged with GST, leading to a higher mass. LN-
L875A/N879A, GY- G1001A/Y1003A, LNGY-
L875A/N879A/G1001A/Y1003A. M- Molecular
weight protein marker, indicated in kDa on the
left.
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Figure 6.9: The position of S969p is incompatible with substrate binding.
Superposition PKA with a bound substrate inhibitor peptide and Bub1kinase (PDB IDs: 1APM, 5DMZ) showing
only Bub1kinase (grey) and the co-crystallized peptide of PKA (yellow). The activation loop is shown in blue, the
P+1 loop in green, the catalytic loop is coloured red. ADP, S969p and putative residues involved in substrate
recognition are depicted as sticks. The position of the phosphorylated substrate residue (Ala in 1APM peptide)
is denoted with a yellow asterisk, the -5 and -6 positions on the peptide are indicated in yellow. The image was
created with CCP4MG.
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_ Insufficient data
V a r i a b l e      A v e r a g e    C o n s e r v e d
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_ Insufficient data
V a r i a b l e      A v e r a g e    C o n s e r v e d
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Figure 6.10: Alignment of Bub1 kinase domains from 12 organisms ranging from yeast to human.
The sequence alignment was produced by the MUSCLE server [241] and analysed for conservation using the
ConSurf tool [242]. The conservation score is indicated in colours ranging from blue (variable) to magenta
(conserved). Conservation scores are considered to be unreliable if they were obtained for positions in the
alignment that had less than 6 un-gapped amino acids or if the computed confidence intervals for the rate
of a specific position spans 4 or more colour grades. Such positions are colored light yellow in the graphic
visualisation output.
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Conf:
Pred:
CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
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LKTSESITSNEDVSPDVCDEFTGIEPLSEDAIITGFRNVT
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CCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCC
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ICPNPEDTCDFARAARFVSTPFHEIMSLKDLPSDPERLLP
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CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
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EEDLDVKTSEDQQTACGTIYSQTLSIKKLSPIIEDSREAT
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CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
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HSSGFSGSSASVASTSSIKCLQIPEKLELTNETSENPTQS
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690
700
710
720
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Pred:
CCCHHHHHHHHHCCCCCCCCCCCCEECCCCCCCCCCCEEE
Pred:
PWCSQYRRQLLKSLPELSASAELCIEDRPMPKLEIEKEIE
AA:
730
740
750
760
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Pred:
ECCCEEEEEEECCCCCCEEEEEEEECCCCCEEEEEECCCC
Pred:
LGNEDYCIKREYLICEDYKLFWVAPRNSAELTVIKVSSQP
AA:
770
780
790
800
Conf:
Pred:
CCHHHHHHHHHHHHHHCCCCCCCCEEEEECCEEEEECCCC
Pred:
VPWDFYINLKLKERLNEDFDHFCSCYQYQDGCIVWHQYIN
AA:
810
820
830
840
Conf:
Pred:
CCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEE
Pred:
CFTLQDLLQHSEYITHEITVLIIYNLLTIVEMLHKAEIVH
AA:
850
860
870
880
Conf:
Pred:
CCCCCCCEECCCCCCCCCCCCCCCCCEEEEECCCCCCCCC
Pred:
GDLSPRCLILRNRIHDPYDCNKNNQALKIVDFSYSVDLRV
AA:
890
900
910
920
Conf:
Pred:
CCCCEEEECCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Pred:
QLDVFTLSGFRTVQILEGQKILANCSSPYQVDLFGIADLA
AA:
930
940
950
960
Conf:
Pred:
HHHHCCCCEEEEECCCEEEECCCCCCCCCHHHHHHHHHHH
Pred:
HLLLFKEHLQVFWDGSFWKLSQNISELKDGELWNKFFVRI
AA:
970
980
990
1000
Conf:
Pred:
CCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Pred:
LNANDEATVSVLGELAAEMNGVFDTTFQSHLNKALWKVGK
AA:
1010
1020
1030
1040
Conf:
Pred:
HCCCCCCCCC
Pred:
LTSPGALLFQ
AA:
1050
Legend: = helix
 = strand 
 = coil 
Conf: 
 = confidence of prediction
-
+
Pred: predicted secondary structure
AA: BubR1 amino acid sequence
Figure 6.11: Secondary structure prediction of BubR1543°1050 by PSIPRED ([244]).
Only residues 561-1050 are shown, a legend is indicated in the figure.
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Figure 6.12: Secondary structure prediction of BubR1543°1050 by Phyre2 ([243])
A legend is indicated in the figure.
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Table 6.2: DNA oligonucleotides used for the preparation of this manuscript.
TARGET NAME DESCRIPTION SEQUENCE (5’-3’)
BubR1 CB019 BR1Trc2BamHIf GATCATGGATCCAGTCCTCCTGCAGATCCCCCACGAG
BubR1 CB022 BR1SalIrev GATCAT GTCGAC TTATCACTGAAAGAGCAAAGCCCC
BubR1 CB023 BR1 S697 GATCATGGATCCTCCATGAAATGTCTTCAAATTCCTGAGAAAC
BubR1 CB024 BR1 E705 GATCATGGATCCGAGAAACTAAGAACTTACTAATGAGACTTC
BubR1 CB025 BR1S697C700S GATCATGGATCCTCCATGAAATCTCTTCAAATTCCTGAGAAAC
BubR1 CB027 BR1S697C700S* GATCATGGATCCTCCATCAAATCTCTTCAAATTCCTGAGAAAC
BubR1 CB028 BR1 Trc3 E705* GATCATGGATCCGAGAAACTAGAACTTACTAATGAGACTTC
Bub1 CB029 Qc_Bub1FL_f CCTGATATTTCTGATGACAAAGATGAATGGC
Bub1 CB030 Qc_Bub1FL_r GCCATTCATCTTTGTCATCAGAAATATCAGG
Bub1 CB037 Bub1_d189fwd GATCATGGATCCGGTTCAGAGCTTTCTGGAGTGATATCTTCAGC
Bub1 CB038 Bub1_d189rev GATCATGTCGACTTATTTTCGTGAACGCTTACATTCTAAGAGCAGTAC
Bub3 CB039 Bub3QCfix GCTATGCATCAGCTGCTAGCTCAAGTACATGGTGACTTGGG
Bub3 CB040 Bub3QCfix CCCAAGTCACCATGTACTTGAGCTAGCAGCTGATGCATAGC
Bub3 CB041 Bub3NheIrev GATCATGCTAGCTCAAGTACATGGTGACTTGGGTTTTGTTTCTGC
Bub3 CB042 Bub3QCfix2f GGTGACTTGGGTTTTGTTTCTGCATCTGTCACTTGGCG
Bub3 CB043 Bub3QCfix2r CGCCAAGTGACAGATGCAGAAACAAAACCCAAGTCACC
Bub1 CB044 Bub1D917Nf GACTGTGAAATCATTCATGGAAACATTAAACCAGACAATTTC
Bub1 CB045 Bub1D917Nr GAA ATT GTC TGG TTT AAT GTT TCC ATG AAT GAT TTC ACA GTC
BubR1 CB046 BR1 E712 GATCATGGATCCGAGACTTCAGAAAACCCTACTCAG
BubR1 CB047 BR1 T718 GATCATGGATCCACTCAGTCACCATGGTGTTCACAG
BubR1 CB048 BR1 S724 GATCATGGATCCTCACAGTATCGCAGACAGCTACTG
BubR1 CB049 BR1 REVDC7 ATCATGGTCGACTTATCAACTAGTTAACTTCCCTACC
Bub1 CB050 B1mutAut1F GCTGATTTTCAAACTTTTAGCTGGGCTTTCTAAACCAGTGAGTTCC
Bub1 CB051 B1mutAut1R GGAACTCACTGGTTTAGAAAGCCCAGCTAAAAGTTTGAAAATCAGC
Bub1 CB054 B1S969Afwd CAGCAAAGTGTGAAACAGCTGGTTTTCAGTGTGTTGAG
Bub1 CB055 B1S969Arev CTCAACACACTGAAAACCAGCTGTTTCACACTTTGCTG
Bub1 CB056 B1S955Afwd GCTGATTTTCAAACTTTTAGCTGGGCTTGCTAAACCAGTGAGTTCC
Bub1 CB057 B1S955Arev GGAACTCACTGGTTTAGCAAGCCCAGCTAAAAGTTTGAAAATCAGC
Bub1 CB058 Bub1BamQCf CTGTTCCAGGGGCCCATGGGATCCATGGACACCC
Bub1 CB059 Bub1BamQCr GGGTGTCCATGGATCCCATGGGCCCCTGGAACAG
H2A CB060 H2ACtopMALf TGGCTGATGAGAATCTTTATTTTCAGTGCCATCAGTCCGTGCTGCTGCCC
H2A CB061 H2ACtopMALr CTGGGATTTAGGTGACACTATAGAATACTCAAGCTTTCACTTGCTCTTG GCCGACTTG
H2A CB062 H2ACtopGEXf GGAAGTTCTGTTCCAGGGGCCCCAGTCCGTGCTGCTGCCC
H2A CB063 H2ACtopGEXr GCTCAGATCTATCTCCTTCTTAAAGTTAAACAAAATTATTACTAGTGTTCACTTGCTCTTGGCCGACTTG
H2A CB064 H2AVLLDNNqc GGGCGGGGTCCTGCCCAACATCCAGTCCGACAACAACCCCAAGAAAACCGAGAGTTCCAAGTCGGCC
B1/H2A CB065 B1C3GS_H2Acf GGGCCCTACGTAATAGGCTAATTGTACTGCTCTTAGAAGGTTCCGGTTCAGGTTCCCAGTCCGTGCTGCTGCCC
B1/H2A CB066 B1CH2Acr TGGTACCGCATGCCTCGAGTTATCACTTGCTCTTGGCCGACTTG
B1/H2A CB067 B1C4GS_H2Acf GGGCCCTACGTAATAGGCTAATTGTACTGCTCTTAGAAGGTTCCGGTTCTGGTTCAGGTTCCCAGTCCGTGCTGCTGCCC
H2A CB068 H2AT121-Ala CATC CAGTC CGTGCTGCTG CCCAAGAAAG CCGAGAGTTC CAAGTCGGCC AAGAGCAAGT GA
Bub1 CB069 B1CS969E CAGCAAAGTGTGAAACAGAAGGTTTTCAGTGTGTTGAG
H2A CB070 H2AcVLLDNN1 GGAAGTTCTGTTCCAGGGGCCCCAGTCCACAACAACCCCAAGAAAACCGAG AGTTCCAAGTCGGCC
H2A CB071 H2AcVLLDNN2 GGAAGTTCTGTTCCAGGGGCCCCAGTCCGACAACAACCCCAAGAAAACCGAGAGTTCCAAGTCGGCC
Bub1 CB072 B1CS969D CAGCAAAGTGTGAAACAGACGGTTTTCAGTGTGTTGAG
Bub1 CB073 Bub1KEN1AAA GCTTTTCATGTGTTTGAAGATGGAAACGCAGCAGCTTATGGATTACCACAG CCTAAAAATAAACCC
Bub1 CB074 Bub1KEN2AAA GGAGTCAGTGCACATTTTAGAAGATGCAGCAGCTGTGGTAGCAAAACAGT GTACCCAGGCG
Bub1 CB075 Bub1C740pFHf CGACCGAAAACCTGTATTTTCAGGGCAACCCATGGGATGATAAGCTGATTT TCAA
Bub1 CB076 Bub1C740pFHr CGCGACTAGTGAGCTCGTCGACTTATTTTCGTGAACGCTTACATTCTAAGA GCAG
Bub1 CB077 Bub1PheboxAA GTCAATAAGATCATCTCTTCTTTGTCATCTGCTGCTCATGTGGCTGAAGATG GAAACGCAGC
Bub1 CB078 Bub1FboxA GTCAATAAGATCATCTCTTCTTTGTCATCTGCTGCTCATGTGGCTGAAGATGG AAACAAAG
Bub1 CB079 Bub1FboxA2 GATCATCTCTTCTTTGTCATCTGCTGCTCATGTGGCTGAAGATGGAAACAAA GAAAATTATGG
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Table 6.3: Intermolecular cross-links of theMBP-Knl1138°225-Bub1:Bub3-BubR1:Bub3-GST-Cdc20 complex
observed in the presence of DSS.
Mz- mass to charge ratio. n_seen- number of fragment ion spectra assigned to the cross-link in entire dataset.
TIC- fraction of total ion current of fragment ion spectrum assigned to cross-link. Note that the Cdc20 and
Knl1138°225 used for cross-linking were tagged with GST or MBP, which is omitted in the table.
CROSS-LINKED PEPTIDES PROTEIN
1
PROTEIN
2
ABS
POS1
ABS
POS2
MZ Z ERROR
[PPM]
N_
SEEN
TIC lD-
Score
KHEQWVNEDR-KLKEQR-a1-b3 Bub1 BubR1 292 430 570.553 4 -0.3 4 0.51 40.32
RKHEQWVNEDR-LKEQR-a2-b2 Bub1 BubR1 292 430 462.246 5 0.6 8 0.45 39.16
RLKTGHHHHHH-AVEALQGEKR-a3-b9 Knl1 BubR1 470 118 659.354 4 1.2 54 0.62 38.38
AVEALQGEKR-LKTGHHHHHH-a9-b2 BubR1 Knl1 118 470 620.328 4 0.9 319 0.69 38.36
VQSHQQASEEKK-YAFKCHR-a11-b4 BubR1 Bub3 397 222 630.064 4 0.8 34 0.5 38.23
KLHQVVETSHEDLPASQER-
LKEIQTTQQER-a1-b2
Bub1 BubR1 327 459 929.234 4 0.6 23 0.46 37.63
RKHEQWVNEDR-KLKEQR-a2-b3 Bub1 BubR1 292 430 487.865 5 0.2 5 0.53 35.55
KLHQVVETSHEDLPASQER-
KLKEIQTTQQER-a1-b3
Bub1 BubR1 327 459 961.259 4 1.8 13 0.41 34.22
KLHQVVETSHEDLPASQER-
KLKEIQTTQQER-a1-b1
Bub1 BubR1 327 457 769.208 5 1.6 6 0.44 34.09
LKTGHHHHHH-STLAELKSK-a2-b7 Knl1 BubR1 470 236 471.656 5 -0.3 8 0.6 33.26
AVEALQGEKR-KYHNDPR-a9-b1 BubR1 Bub1 118 89 434.232 5 0.5 1 0.41 33.2
HYMKR-LKEQR-a4-b2 Bub1 BubR1 305 430 386.965 4 -1.6 1 0.4 32.84
VQSHQQASEEKK-KYAFKCHR-a11-b5 BubR1 Bub3 397 222 662.087 4 0.1 4 0.4 32.66
KEANAFEEQLLK-EAELLTSAEKR-a1-b10 Bub1 BubR1 307 443 935.162 3 -0.7 9 0.57 32.57
LKTGHHHHHH-RESSLKYQTR-a2-b6 Knl1 Bub3 470 179 529.877 5 -0.4 3 0.27 32.46
LKTGHHHHHH-ESSLKYQTR-a2-b5 Knl1 Bub3 470 179 623.07 4 0.5 5 0.31 32.08
EANAFEEQLLKQK-EAELLTSAEKR-a11-
b10
Bub1 BubR1 318 443 977.849 3 -0.2 3 0.38 31.63
VGGALKAPSQNR-RLKTGHHHHHH-a6-
b3
BubR1 Knl1 255 470 547.096 5 -0.3 5 0.38 31.52
VDVEQVVMYCKEK-RESSLKYQTR-a11-
b6
Bub1 Bub3 267 179 758.637 4 0.4 2 0.6 31.3
KYHNDPR-YAFKCHR-a1-b4 Bub1 Bub3 89 222 410.405 5 0.3 1 0.46 31.23
VQSHQQASEEKK-RESSLKYQTR-a11-b6 BubR1 Bub3 397 179 701.615 4 1.4 4 0.46 31.21
ESSLKYQTR-MMYCKEK-a5-b5 Bub3 BubR1 179 405 746.693 3 1.5 6 0.3 31.17
VAVEYLDPSPEVQKK-AVEALQGEKR-a14-
b9
Bub3 BubR1 216 118 735.649 4 0.4 1 0.39 31.05
VQSHQQASEEKK-ESSLKYQTR-a11-b5 BubR1 Bub3 397 179 662.59 4 1.3 11 0.23 30.99
RKEANAFEEQLLK-EAELLTSAEKR-a2-
b10
Bub1 BubR1 307 443 592.721 5 -0.7 4 0.42 30.88
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Table 6.3 continued
VITISKSEYSVHSSLASK-YAFKCHR-a6-b4 Bub1 Bub3 244 222 764.397 4 -2.3 5 0.36 30.48
KLHQVVETSHEDLPASQER-
TGDQQEETMPTKETTK-a1-b12
Bub1 BubR1 327 480 833.608 5 1.2 4 0.49 30.3
ESSLKYQTR-EKLIR-a5-b2 Bub3 Bub1 179 269 636.358 3 -1.3 1 0.23 29.88
AFPNKQGYVLSSIEGR-
VGGALKAPSQNR-a5-b6
Bub3 BubR1 191 255 1034.225 3 1.2 1 0.46 29.54
KEANAFEEQLLKQK-EAELLTSAEKR-a12-
b10
Bub1 BubR1 318 443 1020.547 3 -0.2 7 0.37 29.52
VGGALKAPSQNR-LKTGHHHHHH-a6-
b2
BubR1 Knl1 255 470 515.876 5 -1.4 16 0.23 29.28
VITISKSEYSVHSSLASK-ESSLKYQTR-a6-
b5
Bub1 Bub3 244 179 796.925 4 1 3 0.28 29.22
VDVEQVVMYCKEK-ESSLKYQTR-a11-b5 Bub1 Bub3 267 179 959.145 3 -1 2 0.44 28.63
RLKTGHHHHHH-QVTDAETKPK-a3-b8 Knl1 Bub3 470 322 530.882 5 2.5 2 0.31 28.52
VGGALKAPSQNR-RESSLKYQTR-a6-b6 BubR1 Bub3 255 179 651.358 4 1.2 4 0.26 27.85
VITISKSEYSVHSSLASK-
VAVEYLDPSPEVQKK-a6-b14
Bub1 Bub3 244 216 944.508 4 0.4 2 0.68 27.68
AKENELQAGPWNTGR-ESSLKYQTR-a2-
b5
BubR1 Bub3 309 179 973.825 3 0.1 2 0.37 27.55
AKENELQAGPWNTGR-LKTGHHHHHH-
a2-b2
BubR1 Knl1 309 470 762.884 4 1.8 2 0.4 27.54
KLHQVVETSHEDLPASQER-
ETTKLQIASESQK-a1-b4
Bub1 BubR1 327 484 951.493 4 0.6 2 0.29 26.39
RESSLKYQTR-KYHNDPR-a6-b1 Bub3 Bub1 179 89 467.647 5 2.8 1 0.32 26.24
VGGALKAPSQNR-QVTDAETKPK-a6-b8 BubR1 Bub3 255 322 817.78 3 1.6 6 0.38 25.88
IDTTSFLANLKLHTEDSR-
VGGALKAPSQNR-a11-b6
Knl1 BubR1 434 255 849.702 4 -1.8 5 0.31 25.85
LKYQHTGAVLDCAFYDPTHAW
SGGLDHQLK-KHEQWVNEDR-a2-b1
Bub3 Bub1 52 292 701.77 7 0.3 4 0.38 25.58
VAVEYLDPSPEVQKK-VGGALKAPSQNR-
a14-b6
Bub3 BubR1 216 255 759.916 4 0.8 1 0.49 25.52
LKTGHHHHHH-QVTDAETKPK-a2-b8 Knl1 Bub3 470 322 499.661 5 1.8 7 0.24 25.29
MMYCKEK-EKLIR-a5-b2 BubR1 Bub1 405 269 446.983 4 -1.2 2 0.26 25.08
LKYQHTGAVLDCAFYDPTHAW
SGGLDHQLK-EAELLTSAEKR-a2-b10
Bub3 BubR1 52 443 963.279 5 -1.9 5 0.37 25.08
VGGALKAPSQNR-YAFKCHR-a6-b4 BubR1 Bub3 255 222 579.805 4 -2.3 1 0.3 24.74
TPCNAGTFSQPEKVYTLSVSGDR-
AQKYNQR-a13-b3
Bub3 Bub1 139 286 890.436 4 -1.8 2 0.34 24.72
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Table 6.3 continued
TPCNAGTFSQPEKVYTLSVSGDR-
RKHEQWVNEDR-a13-b2
Bub3 Bub1 139 292 830.404 5 0.2 1 0.34 24.68
ENQPENSQTPTKK-AQKYNQR-a12-b3 Cdc20 Bub1 340 286 509.86 5 1.1 2 0.32 24.06
TPCNAGTFSQPEKVYTLSVSGDR-
KHEQWVNEDR-a13-b1
Bub3 Bub1 139 292 998.726 4 -2 2 0.28 23.64
QVTDAETKPKSPCT-VGGALKAPSQNR-
a10-b6
Bub3 BubR1 324 255 724.877 4 0.5 1 0.33 22.92
VAVEYLDPSPEVQKK-KYHNDPR-a14-b1 Bub3 Bub1 216 89 692.863 4 0.6 2 0.35 22.4
VQSHQQASEEKKEK-YAFKCHR-a11-b4 BubR1 Bub3 397 222 555.68 5 0.5 2 0.27 22.3
RVITISKSEYSVHSSLASK-
VAVEYLDPSPEVQKK-a7-b14
Bub1 Bub3 244 216 787.027 5 -0.2 3 0.46 22.23
LKYQHTGAVLDCAFYDPTHAW
SGGLDHQLK-KEANAFEEQLLK-a2-b1
Bub3 Bub1 52 307 997.899 5 1 4 0.26 22.15
VQTTPSKPGGDR-YAFKCHRLK-a7-b4 Cdc20 Bub3 304 222 521.275 5 -4 1 0.18 20.53
Table 6.4: Intramolecular cross-links of theMBP-Knl1138°225-Bub1:Bub3-BubR1:Bub3-GST-Cdc20 complex
observed in the presence of DSS.
Mz- mass to charge ratio. n_seen- number of fragment ion spectra assigned to the cross-link in entire dataset.
TIC- fraction of total ion current of fragment ion spectrum assigned to cross-link. Note that the Cdc20 and
Knl1138°225 used for cross-linking were tagged with GST or MBP, which is omitted in the table.
CROSS-LINKED PEPTIDES PROTEIN
1
PROTEIN
2
ABS
POS1
ABS
POS2
MZ Z ERROR
[PPM]
N_
SEEN
TIC lD-
Score
IAYSKDFETLK-IKGLVQPTR-a5-b2 Cdc20 Cdc20 113 11 616.602 4 -0.1 2 0.61 41.05
VTVEHPDKLEEK-LKTGHHHHHH-a8-b2 Knl1 Knl1 43 470 561.091 5 -0.4 57 0.54 40.68
RKHEQWVNEDR-AQKYNQR-a2-b3 Bub1 Bub1 292 286 509.06 5 -0.3 3 0.54 40.06
KHEQWVNEDR-AQKYNQR-a1-b3 Bub1 Bub1 292 286 597.047 4 -1.6 8 0.52 39.99
KADAIFQEGIQQK-VGGALKAPSQNR-a1-
b6
BubR1 BubR1 175 255 937.512 3 1.3 14 0.52 39.96
AKENELQAGPWNTGR-AVEALQGEKR-
a2-b9
BubR1 BubR1 309 118 727.879 4 0.4 6 0.53 39.13
AVEALQGEKR-STLAELKSK-a9-b7 BubR1 BubR1 118 236 738.75 3 0.3 6 0.65 39.1
VGGALKAPSQNR-STLAELKSK-a6-b7 BubR1 BubR1 255 236 771.104 3 -0.3 6 0.5 38.47
GYNGLAEVGKK-FEKDTGIK-a10-b3 Knl1 Knl1 26 30 553.299 4 0.9 22 0.69 38.25
KRIEAIPQIDK-YLKSSK-a1-b3 Cdc20 Cdc20 181 194 544.071 4 0 5 0.54 38.15
VQSHQQASEEKK-MMYCKEK-a11-b5 BubR1 BubR1 397 405 505.843 5 0 12 0.64 37.92
VGGALKAPSQNR-AVEALQGEKR-a6-b9 BubR1 BubR1 255 118 812.453 3 2.1 7 0.51 37.47
KLHQVVETSHEDLPASQER-
KHEQWVNEDR-a1-b1
Bub1 Bub1 327 292 920.959 4 2.4 5 0.43 37.45
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KFEKDTGIK-MKIEEGK-a4-b2 Knl1 Knl1 30 2 510.029 4 -0.8 4 0.54 37.42
KADAIFQEGIQQK-SKGKK-a1-b2 BubR1 BubR1 175 238 720.74 3 1.3 4 0.57 36.17
LKEIQTTQQER-KLKEQR-a2-b1 BubR1 BubR1 459 428 463.265 5 -0.3 4 0.25 35.77
RESSLKYQTR-KYAFK-a6-b1 Bub3 Bub3 179 218 516.034 4 -1.3 8 0.43 35.38
KEANAFEEQLLK-KHEQWVNEDR-a1-b1 Bub1 Bub1 307 292 725.117 4 0.2 3 0.46 35.36
VTVEHPDKLEEK-RLKTGHHHHHH-a8-
b3
Knl1 Knl1 43 470 592.31 5 -2.2 15 0.48 35.29
RESSLKYQTR-YAFKCHR-a6-b4 Bub3 Bub3 179 222 597.308 4 -0.4 16 0.64 34.82
KLHQVVETSHEDLPASQER-
RKHEQWVNEDR-a1-b2
Bub1 Bub1 327 292 640.324 6 -0.6 6 0.45 34.78
ESSLKYQTR-YAFKCHR-a5-b4 Bub3 Bub3 179 222 558.283 4 0.2 32 0.29 34.49
LKTGHHHHHH-IDFNDFIKR-a2-b8 Knl1 Knl1 470 467 509.866 5 1.4 6 0.63 34.48
ESSLKYQTR-KYAFK-a5-b1 Bub3 Bub3 179 218 477.009 4 -0.3 7 0.36 34.43
AKENELQAGPWNTGR-EAELLTSAEKR-
a2-b10
BubR1 BubR1 309 443 1018.858 3 3 2 0.44 34.03
KLHQVVETSHEDLPASQER-AQKYNQR-
a1-b3
Bub1 Bub1 327 286 812.668 4 0.8 9 0.4 33.89
ESSLKYQTR-KYAFKCHR-a5-b5 Bub3 Bub3 179 222 590.307 4 0.8 9 0.35 33.88
KLHQVVETSHEDLPASQER-HYMKR-a1-
b4
Bub1 Bub1 327 305 615.717 5 1.5 8 0.52 33.69
KLKEIQTTQQER-LKEQR-a3-b2 BubR1 BubR1 459 430 578.83 4 0.6 3 0.28 33.6
LSGKPQNAPEGYQNR-LKVLYSQK-a4-b2 Cdc20 Cdc20 367 380 694.377 4 0.4 4 0.49 33.55
KADAIFQEGIQQK-STLAELKSK-a1-b7 BubR1 BubR1 175 236 863.81 3 0.4 3 0.43 33.5
KEANAFEEQLLK-AQKYNQR-a1-b3 Bub1 Bub1 307 286 822.1 3 0.2 5 0.28 33.34
VDFLSKLPEMLK-IKGLVQPTR-a6-b2 Cdc20 Cdc20 125 11 642.877 4 -0.1 4 0.54 33.33
VGGALKAPSQNR-LKEQR-a6-b2 BubR1 BubR1 255 430 502.789 4 1.1 4 0.36 33.06
LKEIQTTQQER-LKEQR-a2-b2 BubR1 BubR1 459 430 546.805 4 -1.3 3 0.29 32.97
ETTKLQIASESQK-LKEIQTTQQER-a4-b2 BubR1 BubR1 484 459 744.15 4 0.8 1 0.35 32.95
KLKEIQTTQQER-VGGALKAPSQNR-a3-
b6
BubR1 BubR1 459 255 709.897 4 0.6 1 0.44 32.78
DFETLKVDFLSK-IKGLVQPTR-a6-b2 Cdc20 Cdc20 119 11 648.368 4 -0.6 3 0.6 32.64
GPSVPFSIFDEFLLSEKK-NKSPPADPPR-
a17-b2
BubR1 BubR1 544 547 814.681 4 1.8 22 0.48 32.57
ETTKLQIASESQK-KLKEIQTTQQER-a4-
b1
BubR1 BubR1 484 457 776.172 4 -1.9 1 0.35 32.46
IDTTSFLANLKLHTEDSR-
LKTGHHHHHH-a11-b2
Knl1 Knl1 434 470 688.554 5 -0.3 8 0.49 32.37
ETTKLQIASESQK-KLKEIQTTQQER-a4-
b3
BubR1 BubR1 484 459 776.172 4 -1.2 3 0.36 32.15
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VDFLSKLPEMLK-IAYSKDFETLK-a6-b5 Cdc20 Cdc20 125 113 718.643 4 0.7 2 0.53 32.08
RESSLKYQTR-KYAFKCHR-a6-b5 Bub3 Bub3 179 222 629.331 4 -2.1 5 0.61 31.87
TGDQQEETMPTKETTK-LKEIQTTQQER-
a12-b2
BubR1 BubR1 480 459 834.415 4 0.8 2 0.38 31.86
AEMQKQIEEMEK-KLKEIQTTQQER-a5-
b3
BubR1 BubR1 449 459 783.904 4 0.4 4 0.49 31.83
EAELLTSAEKR-KLKEQR-a10-b3 BubR1 BubR1 443 430 729.078 3 0 8 0.54 31.79
VGGALKAPSQNR-EAELLTSAEKR-a6-b10 BubR1 BubR1 255 443 861.137 3 0.5 3 0.38 31.78
EKLIRGESEFSFEELR-AQKYNQR-a2-b3 Bub1 Bub1 269 286 603.514 5 0.1 5 0.43 31.57
RAEMQKQIEEMEK-KLKEIQTTQQER-a6-
b3
BubR1 BubR1 449 459 822.929 4 -0.1 5 0.37 31.5
AKENELQAGPWNTGR-
VGGALKAPSQNR-a2-b6
BubR1 BubR1 309 255 1002.523 3 -0.7 4 0.47 31.33
LVIWINGDKGYNGLAEVGK-
DKPLGAVALK-a9-b2
Knl1 Knl1 16 298 799.453 4 1.5 2 0.54 31.32
DTGIKVTVEHPDKLEEK-
GYNGLAEVGKK-a5-b10
Knl1 Knl1 35 26 1070.903 3 0.9 4 0.32 31.1
LKTGHHHHHH-YENGKYDIK-a2-b5 Knl1 Knl1 470 176 502.252 5 -0.9 10 0.24 30.99
KEANAFEEQLLK-HYMKR-a1-b4 Bub1 Bub1 307 305 764.401 3 0.4 5 0.36 30.94
AEMQKQIEEMEK-EAELLTSAEKR-a5-b10 BubR1 BubR1 449 443 720.112 4 0.1 8 0.59 30.86
TGDQQEETMPTKETTK-
KLKEIQTTQQER-a12-b3
BubR1 BubR1 480 459 693.351 5 -1.5 5 0.35 30.79
FVSTPFHEIMSLKDLPSDPER-
KLSPIIEDSR-a13-b1
BubR1 BubR1 634 673 748.791 5 0.1 4 0.42 30.53
KLHQVVETSHEDLPASQER-
KEANAFEEQLLK-a1-b1
Bub1 Bub1 327 307 940.736 4 -0.1 3 0.42 30.42
KHEQWVNEDR-EKLIR-a1-b2 Bub1 Bub1 292 269 428.03 5 0.3 5 0.31 30.14
EAELLTSAEKR-LKEQR-a10-b2 BubR1 BubR1 443 430 686.38 3 -0.1 4 0.42 30.11
LSGKPQNAPEGYQNR-VAELKGHTSR-a4-
b5
Cdc20 Cdc20 367 671 724.13 4 2.1 2 0.46 29.75
KYHNDPR-EFLDKK-a1-b5 Bub1 Bub1 89 87 369.996 5 -1.3 4 0.36 29.66
LKEIQTTQQER-QIEEMEKK-a2-b7 BubR1 BubR1 459 456 849.112 3 0.4 5 0.33 29.08
KLHQVVETSHEDLPASQER-EKLIR-a1-b2 Bub1 Bub1 327 269 500.606 6 0.2 2 0.38 29.03
EAELLTSAEKR-LKEIQTTQQER-a10-b2 BubR1 BubR1 443 459 690.121 4 -1.2 4 0.45 29
STLAELKSK-GKKTAR-a7-b3 BubR1 BubR1 236 241 592.02 3 0.4 1 0.44 28.59
DKPLGAVALKSYEEELAK-
AFQDKLYPFTWDAVR-a10-b5
Knl1 Knl1 306 89 989.52 4 0.9 5 0.31 28.38
LSGKPQNAPEGYQNR-
VLYSQKATPGSSR-a4-b6
Cdc20 Cdc20 367 386 798.163 4 0 5 0.47 28.23
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VTVEHPDKLEEKFPQVAATGDGPDIIF
WAHDR-MKIEEGK-a8-b2
Knl1 Knl1 43 2 765.724 6 0.2 2 0.37 28.09
AKENELQAGPWNTGR-
KADAIFQEGIQQK-a2-b1
BubR1 BubR1 309 175 821.674 4 0.6 4 0.36 27.81
KLKEIQTTQQER-EAELLTSAEKR-a3-b10 BubR1 BubR1 459 443 962.525 3 0.4 2 0.36 27.78
TGDQQEETMPTKETTK-
KLKEIQTTQQER-a12-b1
BubR1 BubR1 480 457 866.438 4 0.7 3 0.45 27.75
TGDQQEETMPTKETTK-EAELLTSAEKR-
a12-b10
BubR1 BubR1 480 443 1069.857 3 -0.5 4 0.37 27.73
KLHQVVETSHEDLPASQER-
RKEANAFEEQLLK-a1-b2
Bub1 Bub1 327 307 784.011 5 0.3 1 0.37 27.61
RKEANAFEEQLLK-QKMDELHK-a2-b2 Bub1 Bub1 307 320 549.093 5 1.3 2 0.42 27.1
YISWTEQNYPQGGKESNMSTLLER-
VGGALKAPSQNR-a14-b6
BubR1 BubR1 99 255 1042.272 4 1.1 3 0.38 26.73
APCLPVTYQQTPVNMEKNPR-
KLHQVVETSHEDLPASQER-a17-b1
Bub1 Bub1 381 327 937.472 5 -0.4 2 0.51 26.58
QTLLALEKEEEEEVFESSVPQR-
VGGALKAPSQNR-a8-b6
BubR1 BubR1 215 255 1309.016 3 3.6 6 0.37 26.29
EANAFEEQLLKQK-MDELHKK-a11-b6 Bub1 Bub1 318 326 862.446 3 -2.5 3 0.34 26.03
VGGALKAPSQNR-VQSHQQASEEKK-a6-
b11
BubR1 BubR1 255 397 684.114 4 2.2 2 0.35 25.85
RKHEQWVNEDR-EKLIR-a2-b2 Bub1 Bub1 292 269 459.251 5 0 2 0.19 25.72
KLHQVVETSHEDLPASQER-
QKMDELHK-a1-b2
Bub1 Bub1 327 320 562.289 6 1.4 3 0.38 25.68
VTVEHPDKLEEKFPQVAATGDGPDIIF
WAHDR-MKIEEGK-a12-b2
Knl1 Knl1 47 2 918.665 5 -1.8 2 0.32 25.63
RKEANAFEEQLLK-RKHEQWVNEDR-a2-
b2
Bub1 Bub1 307 292 642.735 5 0 2 0.32 25.53
IMSTLQGALAQESACNNTLQQQKR-
VGGALKAPSQNR-a23-b6
BubR1 BubR1 64 255 1007.022 4 0 2 0.43 25.4
RESSLKYQTR-KKYAFK-a6-b2 Bub3 Bub3 179 218 548.058 4 0.4 1 0.3 25.25
KADAIFQEGIQQKAEPLER-
VGGALKAPSQNR-a13-b6
BubR1 BubR1 187 255 877.226 4 1.7 1 0.3 25.2
EKLIR-HYMKR-a2-b4 Bub1 Bub1 269 305 510.626 3 0.1 2 0.34 24.91
AFPNKQGYVLSSIEGR-
VAVEYLDPSPEVQKK-a5-b14
Bub3 Bub3 191 216 901.98 4 1.4 2 0.42 24.84
EAELLTSAEKR-AVEALQGEKR-a10-b9 BubR1 BubR1 443 118 828.784 3 2.5 1 0.32 24.15
DKPLGAVALKSYEEELAKDPR-
AFQDKLYPFTWDAVR-a18-b5
Knl1 Knl1 314 89 865.455 5 1.7 2 0.36 24
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AFPNKQGYVLSSIEGR-QVTDAETKPK-
a5-b8
Bub3 Bub3 191 322 1007.197 3 0 2 0.29 23.66
NKHMNADTDYSIAEAAFNK-
TWEEIPALDKELK-a2-b10
Knl1 Knl1 203 138 962.973 4 0 3 0.53 23.38
QTLLALEKEEEEEVFESSVPQR-
KADAIFQEGIQQK-a8-b1
BubR1 BubR1 215 175 1401.713 3 -3 6 0.32 23.14
TGDQQEETMPTKETTK-LKEQR-a12-b2 BubR1 BubR1 480 430 659.33 4 0.7 2 0.25 23.13
KHEQWVNEDR-QKMDELHK-a1-b2 Bub1 Bub1 292 320 627.309 4 -1.3 3 0.18 23.06
EAELLTSAEKRAEMQK-KLKEIQTTQQER-
a10-b1
BubR1 BubR1 443 457 868.966 4 2.2 1 0.3 22.08
IDTTSFLANLKLHTEDSR-
GLLDNPISEKSTK-a11-b10
Knl1 Knl1 434 420 900.728 4 2.6 1 0.48 22.06
RAEMQKQIEEMEK-KLKEQR-a6-b3 BubR1 BubR1 449 430 647.844 4 -0.2 1 0.22 21.84
KLHQVVETSHEDLPASQER-KYHNDPR-
a1-b1
Bub1 Bub1 327 89 654.734 5 2.7 2 0.55 21.61
EFLENYLLTDEGLEAVNKDKPLGAVALK-
SYEEELAKDPR-a20-b8
Knl1 Knl1 298 314 913.476 5 2.1 1 0.18 21.55
LSGKPQNAPEGYQNR-
ENQPENSQTPTKK-a4-b12
Cdc20 Cdc20 367 340 824.911 4 1.3 4 0.47 21.52
AEMQKQIEEMEKK-EAELLTSAEKR-a5-
b10
BubR1 BubR1 449 443 752.137 4 1.9 1 0.55 20.45
ITVFDENADEASTAELSKPTVQPWIAPPM
PR-VGGALKAPSQNR-a18-b6
BubR1 BubR1 294 255 1187.115 4 2 4 0.3 20.13
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Protein sequences
Bub1 (homo sapiens)
1 MDTPENVLQM LEAHMQSYKG NDPLGEWERY IQWVEENFPE NKEYLITLLE 50
51 HLMKEFLDKK KYHNDPRFIS YCLKFAEYNS DLHQFFEFLY NHGIGTLSSP 100
101 LYIAWAGHLE AQGELQHASA VLQRGIQNQA EPREFLQQQY RLFQTRLTET 150
151 HLPAQARTSE PLHNVQVLNQ MITSKSNPGN NMACISKNQG SELSGVISSA 200
201 CDKESNMERR VITISKSEYS VHSSLASKVD VEQVVMYCKE KLIRGESEFS 250
251 FEELRAQKYN QRRKHEQWVN EDRHYMKRKE ANAFEEQLLK QKMDELHKKL 300
301 HQVVETSHED LPASQERSEV NPARMGPSVG SQQELRAPCL PVTYQQTPVN 350
351 MEKNPREAPP VVPPLANAIS AALVSPATSQ SIAPPVPLKA QTVTDSMFAV 400
401 ASKDAGCVNK STHEFKPQSG AEIKEGCETH KVANTSSFHT TPNTSLGMVQ 450
451 ATPSKVQPSP TVHTKEALGF IMNMFQAPTL PDISDDKDEW QSLDQNEDAF 500
501 EAQFQKNVRS SGAWGVNKII SSLSSAFHVF EDGNKENYGL PQPKNKPTGA 550
551 RTFGERSVSR LPSKPKEEVP HAEEFLDDST VWGIRCNKTL APSPKSPGDF 600
601 TSAAQLASTP FHKLPVESVH ILEDKENVVA KQCTQATLDS CEENMVVPSR 650
651 DGKFSPIQEK SPKQALSSHM YSASLLRLSQ PAAGGVLTCE AELGVEACRL 700
701 TDTDAAIAED PPDAIAGLQA EWMQMSSLGT VDAPNFIVGN PWDDKLIFKL 750
751 LSGLSKPVSS YPNTFEWQCK LPAIKPKTEF QLGSKLVYVH HLLGEGAFAQ 800
801 VYEATQGDLN DAKNKQKFVL KVQKPANPWE FYIGTQLMER LKPSMQHMFM 850
851 KFYSAHLFQN GSVLVGELYS YGTLLNAINL YKNTPEKVMP QGLVISFAMR 900
901 MLYMIEQVHD CEIIHGDIKP DNFILGNGFL EQDDEDDLSA GLALIDLGQS 950
951 IDMKLFPKGT IFTAKCETSG FQCVEMLSNK PWNYQIDYFG VAATVYCMLF 1000
1001 GTYMKVKNEG GECKPEGLFR RLPHLDMWNE FFHVMLNIPD CHHLPSLDLL 1050
1051 RQKLKKVFQQ HYTNKIRALR NRLIVLLLEC KRSRK
Bub3 (homo sapiens)
1 MTGSNEFKLN QPPEDGISSV KFSPNTSQFL LVSSWDTSVR LYDVPANSMR 50
51 LKYQHTGAVL DCAFYDPTHA WSGGLDHQLK MHDLNTDQEN LVGTHDAPIR 100
101 CVEYCPEVNV MVTGSWDQTV KLWDPRTPCN AGTFSQPEKV YTLSVSGDRL 150
151 IVGTAGRRVL VWDLRNMGYV QQRRESSLKY QTRCIRAFPN KQGYVLSSIE 200
201 GRVAVEYLDP SPEVQKKKYA FKCHRLKENN IEQIYPVNAI SFHNIHNTFA 250
251 TGGSDGFVNI WDPFNKKRLC QFHRYPTSIA SLAFSNDGTT LAIASSYMYE 300
301 MDDTEHPEDG IFIRQVTDAE TKPKSPCT
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BubR1 (homo sapiens)
1 MAAVKKEGGA LSEAMSLEGD EWELSKENVQ PLRQGRIMST LQGALAQESA 50
51 CNNTLQQQKR AFEYEIRFYT GNDPLDVWDR YISWTEQNYP QGGKESNMST 100
101 LLERAVEALQ GEKRYYSDPR FLNLWLKLGR LCNEPLDMYS YLHNQGIGVS 150
151 LAQFYISWAE EYEARENFRK ADAIFQEGIQ QKAEPLERLQ SQHRQFQARV 200
201 SRQTLLALEK EEEEEVFESS VPQRSTLAEL KSKGKKTARA PIIRVGGALK 250
251 APSQNRGLQN PFPQQMQNNS RITVFDENAD EASTAELSKP TVQPWIAPPM 300
301 PRAKENELQA GPWNTGRSLE HRPRGNTASL IAVPAVLPSF TPYVEETAQQ 350
351 PVMTPCKIEP SINHILSTRK PGKEEGDSLQ RVQSHQQASE EKKEKMMYCK 400
401 EKIYAGVGEF SFEEIRAEVF RKKLKEQREA ELLTSAEKRA EMQKQIEEME 450
451 KKLKEIQTTQ QERTGDQQEE TMPTKETTKL QIASESQKIP GMTLSSSVCQ 500
501 VNCCARETSL AENIWQEQPH SKGPSVPFSI FDEFLLSEKK NKSPPADPPR 550
551 VLAQRRPLAV LKTSESITSN EDVSPDVCDE FTGIEPLSED AIITGFRNVT 600
601 ICPNPEDTCD FARAARFVST PFHEIMSLKD LPSDPERLLP EEDLDVKTSE 650
651 DQQTACGTIY SQTLSIKKLS PIIEDSREAT HSSGFSGSSA SVASTSSIKC 700
701 LQIPEKLELT NETSENPTQS PWCSQYRRQL LKSLPELSAS AELCIEDRPM 750
751 PKLEIEKEIE LGNEDYCIKR EYLICEDYKL FWVAPRNSAE LTVIKVSSQP 800
801 VPWDFYINLK LKERLNEDFD HFCSCYQYQD GCIVWHQYIN CFTLQDLLQH 850
851 SEYITHEITV LIIYNLLTIV EMLHKAEIVH GDLSPRCLIL RNRIHDPYDC 900
901 NKNNQALKIV DFSYSVDLRV QLDVFTLSGF RTVQILEGQK ILANCSSPYQ 950
951 VDLFGIADLA HLLLFKEHLQ VFWDGSFWKL SQNISELKDG ELWNKFFVRI 1000
1001 LNANDEATVS VLGELAAEMN GVFDTTFQSH LNKALWKVGK LTSPGALLFQ 1050
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